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Microbial infections remain the leading cause of increased morbidity and 
mortality rates of patients suffering from infectious diseases. While thousands of 
pathogenic bacteria have been recognized, the majority of healthcare-associated 
infections are caused by only a few opportunistic pathogens (e.g., Pseudomonas 
aeruginosa, Staphylococcus aureus, Escherichia coli), which are associated with 
increased antibiotic resistance. The rapid detection, reliable identification and real-time 
monitoring of these pathogens remain not only a scientific problem but also a practical 
challenge of vast importance, especially in tailoring effective treatment strategies. 
Various approaches, such as conventional culturing, molecular methods and mass 
spectrometry techniques, have been employed to identify and quantify pathogenic agents. 
Yet, these procedures are costly, time-consuming, mostly qualitative, and are indirect 
detection methods. A great challenge is therefore to develop rapid and quantitative 
methods for the detection of microbes. As an alternative, electrochemical techniques have 
been explored as a means for the detection of infection-related biomarkers. This thesis 
 xii 
presents the development and application of a robust electrochemical platform using 
transparent carbon ultramicroelectrode arrays (T-CUAs) for the in vitro detection of 
bacterial warfare toxin, pyocyanin, and other phenazine metabolites produced by P. 
aeruginosa. This antibiotic-resistant pathogen is commonly found in chronic wounds and 
the lungs of cystic fibrosis patients. During early infection stages, P. aeruginosa produces 
various phenazines as virulence factors, which are highly diffusible signals that are toxic 
to surrounding host cells and other competing microorganisms. Although phenazines play 
important roles in cellular functions, very little is known about how their concentrations 
fluctuate and influence cellular behaviors and population-dependent responses (quorum 
sensing) during infection and growth. Therefore, quantitative, real-time electrochemical 
monitoring of distinct redox-active phenazine metabolites from P. aeruginosa in 
simulated growth media is demonstrated using T-CUAs. Moreover, electrochemical 
monitoring of the influence of polymicrobial infections on P. aeruginosa phenazine 
production is presented. In addition to quantifying phenazine concentrations in complex 
environments, changes in phenazine dynamics are observed in the biosynthetic route for 
pyocyanin production. Finally, desorption electrospray ionization and nanoelectrospray 
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Chapter 1: Introduction1 
The development and spread of pathogenic infections remain the leading causes 
for increased morbidity and mortality rates affecting over 250 million people 
worldwide.1-5 These infections commonly occur through water and food contaminations 
and/or various bodily fluids. Additionally, severe diseases spread in clinical facilities 
where immune-compromised host patients come in contact with pathogenic bacteria 
heavily populating hospital surfaces. These infections are typically initiated by only a few 
clinically relevant microbial species, including Pseudomonas aeruginosa, Staphylococcus 
aureus, Escherichia coli, Enterococcus faecium, Klebsiella pneumoniae, and 
Acinetobacter baumannii, which lead to deleterious consequences as they are majorly 
responsible for disease progress by rapidly developing antimicrobial resistance 
mechanisms.6 Therefore, the advancement of methodologies for detection, identification, 
and monitoring of pathogens is necessary for selecting the most effective treatment and 
intervention strategies.7  
The design and development of rapid, reliable, cost-efficient, specific and 
sensitive methods remain challenging, however, as pathogen detection still heavily relies 
on the standard microbiology tests and diagnostic schemes.8 Specifically, the major 
conventional methods used to identify pathogenic species and determine resistance are: 
(1) selective cell culturing, (2) molecular methods and (3) mass spectrometry, some of 
which can be relatively time-consuming and/or can require technically trained personnel 
and regular maintenance.9,10  
                                                
1Portions of this chapter were published in a review article by Simoska, O. and Stevenson, K. J. titled 
“Electrochemical Sensors for Rapid Diagnosis of Pathogens in Real Time” Analyst, 2019, 144, 6461–6478.  
This review article was an invited contribution for the themed collection “Versatile Electrochemical 
Approaches” in the Analyst. Copyright © 2019 The Royal Society of Chemistry. Simoska, O. wrote the 
review article. All authors contributed in editing the manuscript. 
 2 
Health-care facilities typically use cell culture platforms, which involve 
incubation of specimens in an array of distinct growth media with varying nutrients and 
antibiotics. Thus, pathogen identification is determined visually based on the distinct 
growth patterns observed. Since they include numerous steps (e.g., selective enrichment, 
biochemical screening, bodily fluid confirmation), cell culturing approaches are laborious 
and time-costly, requiring 24–72 hours for initial results in pathogen identification.7,11,12 
Moreover, cell cultures are associated with low sensitivity and selectivity, as well as the 
risk of microbial contamination that could inhibit bacterial growth rates.11  
As a result, molecular-based techniques, including polymerase chain reaction 
(PCR) and nucleic acid sequencing, have taken a prominent role as diagnostic methods in 
replacing cell culture-based techniques.10,13,14 While they provide more sensitive, highly 
specific, and accurate identification of microorganisms and significantly reduce diagnosis 
time (1–4 h) molecular approaches have certain limitations compared to cell culture.10 In 
particular, they require the most sample preparation and manipulation, in addition to 
expensive imaging equipment.13 Additionally, false negatives could result due to sample 
cross-contamination, inhibition of amplification reaction by matrix sample compounds 
and/or challenges in differentiating viable from non-viable cells as nucleic acid is present 
in both.10,11 
Another alternative to cell culturing approaches are mass spectrometry (MS) 
methods,15-17  which provide qualitative results within minutes through the detection of a 
broad range of unique molecules produced by bacteria at different concentrations.10,18-23 
Various MS procedures,16 specifically matrix-assisted laser desorption time-of-flight 
(MALDI-TOF), electrospray ionization (ESI), and desorption electrospray ionization 
(DESI), have been employed in various clinical and microbiology studies for the 
identification of several pathogens, including E. coli, P. aeruginosa, S. aureus, and S. 
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agalacriae.15,19,21,22 However, in addition to requiring the use of expensive equipment, 
MS methods are associated with biases in sample preparation. Particularly pathogens are 
isolated from their natural growth environments prior to MS analysis. While being 
sensitive and rapid, MS-based pathogen identification requires the use of reference 
database libraries,23 making the detection of potential candidate biomarkers from 
complex biological samples challenging.15 
Recent research has focused on the design and development of electrochemical 
sensing platforms (Figure 1.1). Electrochemical sensors have emerged as a promising 
alternative to the traditional approaches for pathogen detection,2,3,12 due to their ability to 
provide increased sensitivity, fast response times, simplicity of operation, and lower cost. 
Since most electrochemical-based sensors are label-free devices, their potential for direct 
detection of bacterial pathogens has been considered a powerful alternative to the 
benchmark methods. Moreover, electrochemical sensors are attractive due to the 
possibility of device miniaturization, combined with the ability to design and assemble 
low-cost, disposable, flexible, wearable and/or implantable electrochemical devices. 
Therefore, electrochemical strategies have been recognized as effective tools for the 
successful detection of whole bacteria, cellularly derived signaling molecules, bacterial 
metabolites and byproducts, and enzymes.3,24-26 
The use of electrochemical sensing devices started with glucose oxidase-based 
biosensors, which are based on amperometric detection of glucose in the blood. In 
contrast to glucose biosensors, electrochemical sensors for pathogen detection have yet to 
enter the market as real-time monitoring devices. As a result, in the last decade, 
significant research has focused on improving the performance of bioelectroanalytical 
sensors, specifically with respect to limits of detection, sensitivity, linear dynamic ranges, 
 4 
selectivity, specificity, rapid experimental analysis times (e.g., 5–7 min), and no pre-
enrichment steps, which are all required for manufacturing clinical diagnosis devices.24 
Various published literature reviews have provided an overview of fundamental 
sensing principals, case studies, and challenges in developing point-of-care sensors for 
monitoring in a clinical setting.3,27,28 Particularly, an extensive summary of advantages 
and disadvantages of electrochemical sensing platforms was published by Monzó et al. in 
2015.3 Extensive emphases were given on the development of synthetic polymers and 
cost-efficient nanomaterials, along with the design of microarray and microfluidics 
devices. The authors concluded that limitations intrinsic to sample preparation steps, 
analysis times and sensor sensitivity are reasons for the slow-paced entrance of 
electrochemical sensors into the global market.3 Additionally, Justino and co-workers in 
2016 published a comprehensive review of clinical sensing platforms for detection of 
bacteria and physiologically relevant analytes.28 A detailed comparison of analytical 
sensors performance was presented, highlighting the advantages of microfluidics and lab-
on-a-chip platforms due to significant advances in reducing analysis times for pathogen 
detection and identification.28 Moreover, two additional reviews have been published 
more recently in 2018 on electrochemical methodologies for identification of pathogenic 
microorganisms. Specifically, Amiri and co-workers published an overview of biosensors 
for the detection of pathogens associated mainly with water and food contaminations, 
providing a summary of surface modification strategies and types of electrochemical 
detection schemes used.2 Additionally, another review was published by Kuss et al. in 
2018,29 providing an extensive summary of biosensors for bacteria detection developed 
since 2015. The review emphasized compelling advances towards the development of 
portable point-of-care sensors.29 The authors discussed future challenges in designing 
portable electrochemical devices that are cost-efficient, sensitive and selective. 
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In this chapter, a brief summary is given of the latest advances in the design and 
development of electrochemical sensing strategies for detection of pathogenic bacteria, 
with a particular focus on a major clinically relevant species, P. aeruginosa. While it 
rarely establishes persistent antibiotic-resistant infections in otherwise healthy 
individuals, this opportunistic human pathogen can establish chronic infections in 
individuals with compromised immune systems, and those suffering from conditions, 
such as severe burns, chronic wounds and cystic fibrosis.30-34 During initial infection 
stages, P. aeruginosa produces various redox-active metabolites, which can have toxic 
effects on surrounding host cells and/or other microbes. Therefore, electrochemical 
methods offer rapid, direct, and sensitive detection of these redox P. aeruginosa 
metabolites, thus providing important evidence about the onset of P. aeruginosa 
infections. To prevent disease progress and determine effective treatment strategies, 
prompt detection, pathogen identification and real-time monitoring of early infection 
stages, pathogenic responses and metabolism dynamics are necessary.34,35 Yet the 
development of simple, cost-efficient sensors with the necessary figures of merit (e.g., 
detection limits and linear ranges, fast sensor responses and rapid analysis times) remains 
challenging. Herein, recent advances in electrochemical devices based on P. aeruginosa 
detection via electrochemically-active biological target metabolites and byproducts are 
discussed, highlighting the advantages of micro- and nano-electrode array platforms.  
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Figure 1.1: Electrochemical sensors for pathogen detection and quantification in 












1.1 ELECTROCHEMICAL SENSORS BASED ON PATHOGEN IDENTIFICATION VIA THE 
DETECTION OF REDOX-ACTIVE CELLULAR METABOLITES  
An extensive number of electrochemical-based devices for the detection of 
clinically relevant pathogens (in particular, P. aeruginosa) have been recently developed 
and reported in the literature. These sensing devices often include (1) complex electrode 
platforms, modified with specific nanomaterials, nanostructure, and antibodies, (2) 
combined multiplexed sensing systems (e.g., electrochemical lab-on-a-chip platforms), 
and (3) electroanalytical sensing methodologies based on the direct detection of unique 
cellular redox biogenic molecules at electrode surfaces. The principle of pathogen 
identification via direct detection of cellular biogenic metabolites on an electrode surface 
represents a desirable, straightforward electrochemical sensing approach, which does not 
require use of highly specialized materials and/or instruments. This method typically 
relies on the use of voltammetric methodologies to directly sense P. aeruginosa 
metabolites and byproducts. The electrochemical detection of bacterial toxins has 
recently received attention because of its applicability for biodiagnosis in healthcare 
settings. Various bacterial toxins and exotoxins secreted by P. aeruginosa have been 
recently detected via electrochemical methods,25,37-41 thereby making these approaches 
applicable in wound diagnostics and biosensing technologies.42 Additionally, 
electrochemical sensors for the detection of siderophores and virulence factors produced 
by P. aeruginosa strains have been recently described.43,44 An overview of recent 
literature of these electrochemical sensors is provided, emphasizing the advantages of 
micro- and nano-electrode arrays, for the real-time, quantitative detection of P. 
aeruginosa target metabolites and intermediates. Table 1.1 provides a detailed summary 
of the literature on electrochemical sensors for the detection of cellular P. aeruginosa 
biogenic metabolites and intermediates. 
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Cernat et al. reported the design of a nanohybrid electrode platform based on 
graphene, polypyrrole and gold nanoparticles for the detection of biomarker, pyoverdine, 
secreted by P. aeruginosa.43 The developed composite material demonstrated catalytic 
activity for electron transfer rate and enhanced surface area. Using differential pulse 
voltammetry (DPV), the authors examined the sensor’s selectivity in the presence of 
common interferences found in biological samples and hospital settings and obtained 
excellent recovery rates. Finally, the sensor performance was successfully tested for 
detection of pyoverdine from real biological samples, including human serum and saliva, 
with a total analysis time of 165 s.43 Similarly, in a more recent example, Gandouzi and 
co-workers developed an electrochemical sensor for sensitive and selective detection of 
pyoverdine.44 This sensing platform used graphene/graphite-modified screen-printed 
electrodes, which were electrochemically reduced and decorated with gold nanoparticles. 
The limit of detection (LOD) and linear dynamic range (LDR) for pyoverdine detection 
achieved on these sensors were 66.9 nM and 1–100 µM, respectively.  In optimizing 
sensor performance, the authors showed the detection of pyoverdine in serum, saliva, and 
tap water using DPV. Thus, these sensing platforms for pyoverdine detection show an 
effective principle for early diagnosis of P. aeruginosa species.  
In addition to electrochemical sensors for the detection of pyoverdine, a 
significant amount of research has been devoted to the development of biodiagnostic 
devices based on the electrochemical conversion of pyocyanin (PYO). Redox-active PYO 
is exclusively secreted by P. aeruginosa, hence making it a unique diagnostic biomarker 
for detecting P. aeruginosa infections.45 Consequently, several electroanalytical systems 
for the detection and quantification of PYO have been reported, using voltammetry,38,46-49  
amperometry,37 and scanning electrochemical microscopy.50,51 In recent studies, 
Alatraktchi et al. have demonstrated use of disposable, screen-printed gold electrodes,37,46  
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as well as carbon paper-based sensors,46 for PYO detection, achieving LODs in the 
micromolar range and LDRs up to 100 µM. Additionally, carbon disk electrodes and 
carbon-based, disposable electrodes have been employed by Sismaet et al. and Santiveri 
et al., respectively,48,49 for P. aeruginosa recognition via square-wave voltammetric 
detection of PYO. Most recently, Jarosǒva et al. demonstrated the use of inkjet-printed 
carbon nanotube electrodes as small, flexible and disposable sensors52 for the 
electrochemical detection of both PYO and uric acid from P. aeruginosa in would-like 
fluid stimulated media.40 Furthermore, Buzid et al. developed boron-doped diamond 
electrodes, which were optimized and successfully used for the simultaneous detection of 
three P. aeruginosa biomarkers, PYO, 2-heptyl-3-hydroxy-4-quinolone (PQS) and 2-
heptyl-4-hydroxyquinoline (HHQ).53,54 The authors utilized cationic surfactant 
hexadecyltrimethylammonium bromide to improve effectiveness of unmodified boron-
doped diamond electrodes for direct detection of PYO, PQS, and HHQ from P. 
aeruginosa cell cultures and biological samples. Using DPV, Buzid and co-workers 
determined the LODs to fall in the nanomolar range for all three cellularly derived 
biomolecules.54 While these boron-doped diamond electrodes allow for simultaneous 
detection of three biological metabolites, they are quite costly compared to other low-cost 
carbon electrodes for PYO detection.55   
In addition to the aforementioned electrochemical methods based on voltammetric 
detection of P. aeruginosa pathogens via the redox conversion of PYO, Bellin et al. have 
shown miniaturization and arrangement of multiplex electrochemical devices into high-
density arrays. The chip-based system allowed the authors to image colonies based on 
spatial, voltammetric, quantitative measurements of P. aeruginosa phenazine 
metabolites.56,57 Phenazines are small, redox-active, nitrogen-containing heterocyclic 
compounds, which engage in redox processes in the presence of molecular oxygen. 
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Produced during early P. aeruginosa infection stages, phenazines play key roles in 
altering metabolism, modify immune responses and damage host tissue.58-61 Using square 
wave voltammetry (SWV) measurements, phenazine concentrations as low as 2.6 µM 
were detected by Buzid and co-workers. In earlier work, the authors’ designed system 
consisted of an array of 60 gold electrodes in 5 channels, containing integrated trans-
impedance amplifiers organized in 12 working electrodes.56 This integrated circuit device 
allowed spatially resolved electrochemical imaging of redox-active phenazine 
metabolites from wild-type and mutant P. aeruginosa colonies and biofilms. In more 
recent research, the authors improved the sensor design by dramatically increasing the 
working electrode array and the number of parallel output channels via a complementary 
metal-oxide semiconductor (CMOS) process.57 This facilitated electrochemical imaging 
of whole-colony P. aeruginosa biofilms for the first time, however, the device may bias 
the time-dependent analysis of spatially resolved results. Although the authors 
demonstrated imaging of phenazine signals at various time points, this method takes up to 
10 minutes to acquire information from all integrated electrodes in the array.57 
Additionally, in this electrochemical camera chip, bacterial colonies were grown on <15-
µM thick agar-soaked membranes placed directly on top of the integrated chip. This 
sensor design raises a question about real-time measurements of P. aeruginosa phenazine 
production as transport parameters are neither quantified nor reported. While the device 
allows for simultaneous, spatially resolved detection of redox phenazine metabolites from 
P. aeruginosa, this approach could involve quite costly and highly specialized equipment 
and skills to perform a simple, rapid, quantitative analysis in a clinical facility. 
Therefore, bacterial products and secreted metabolites are motivating targets for 
the direct detection of P. aeruginosa strains and their biomarkers. The electrochemical 
conversions of P. aeruginosa’s biogenic molecules allow for fairly simple 
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electrochemical sensor design. The electroanalytical sensors summarized in this section 
do not require sample pretreatments before quantitative analysis and pathogen detection, 
which is desirable in sensor design for detection of pathogens. 
1.2 CARBON MICROELECTRODE ARRAYS 
Research in the 1980s demonstrated that microelectrodes (electrodes with a 
diameter of 25 µm or less) have several advantages relative to typical macroelectrodes.62-
64 Generally, the diameter of microelectrodes is at least one dimension smaller than the 
thickness of the diffusion layer for an electrochemically active species.62-64 The radial 
diffusion at microelectrodes permit for enhanced, fast steady state diffusional profiles.65 
As a result of their small sizes, microelectrodes have low non-faradaic background 
currents, small ohmic (resistive) drops, and reduced double layer capacitance.62 Thereby, 
microelectrodes can detect low analyte concentrations with small capacitive currents and 
display large current densities; however, the absolute signal at the microelectrode is 
extremely low (picoamperes to nanoamperes range).66,67 This drawback can be bypassed 
by using an array consisting of tens to hundreds to thousands of microelectrodes, where 
the current increases proportionally with the number of electrodes within the array;65,68,69  
making the resulting current outputs of microelectrode arrays are up to several orders of 
magnitude larger than those of a single microelectrode.65,68,69   
For microelectrode arrays, the voltammetric responses are directly related to the 
geometric features of the arrays (e.g., average radius of microelectrode, average inter-
electrode distance) and the scan rate.65-69 Thereby, the diffusion profiles of individual 
microelectrodes within the array dependent on the size and distance between each 
microelectrode in the array. For equal scan rates, microelectrode arrays with smaller 
inter-electrode diameter result in voltammetric responses similar to those of 
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macroelectrodes, while microelectrodes with larger inter-electrode distances display true 
microelectrode behaviors.  
While there are many options in terms of electrode materials, carbon-based 
substrates are primarily used due to their inertness, hardness, low cost, and high 
biocompatibility. As a result of their outstanding analytical qualities, carbon 
microelectrode arrays have received a significant amount of interest in various 
bioanalytical sensing applications.38,66,67,69-79 In particular, they have been widely used to 
measure oxygen and nitric oxide levels from fibroblast cells,80 nucleic acids,81 and release 
of neurotransmitters.82,83 Additionally, cellular functions, including release and/or 
consumption of chemicals (e.g., oxygen, glucose) and enzymatic activities, can be 
monitored using microelectrode arrays.73,74 
1.3 TRANSPARENT CARBON ULTRAMICROELECTRODE ARRAYS 
P. aeruginosa identification based on the detection of redox biogenic molecules 
secreted from cells can be also achieved with microelectrode array devices.72-74 The 
Stevenson research group recently reported a low-cost, facile, and versatile fabrication of 
transparent carbon ultramicroelectrode arrays (T-CUAs) and their characterization.38,70,71 
Preparation of T-CUA electrodes used throughout studies in this dissertation follows a 
microsphere lithography process where micrometer-diameter (here, 1.54 µm) polystyrene 
spheres (PSS) are drop cast onto a conductive carbon pyrolized photoresist film electrode 
followed by atomic layer deposition of an insulating metal oxide layer (Al2O3), which 
enables the thickness to be controlled precisely (here, 10 nm). Upon removal of PSS, 
disk-shaped carbon areas remain where the PSS were in contact with carbon film, thus 
forming an array of microelectrodes. The steps of T-CUA electrode fabrication process 
are illustrated in Figure 1.2.70  
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The T-CUA platform offers various benefits relative to other electrochemical 
detection methods. Specifically, in addition to the aforementioned advantages of 
microelectrodes, T-CUAs provide an additional benefit of amplified currents resulting 
from individual microelectrodes in the array functioning in a parallel circuit.70 Their 
nanometer-scale sizes permit analytical measurements on smaller samples in biological 
environments with fast response times.70,84 Additionally, the small electroactive area 
allows for lower non-faradaic background currents, thereby resulting in improved signal-
to-noise (S/N) ratios and enhanced limits of detection with large linear dynamic ranges. 
Moreover, the electroactive material of T-CUAs, pyrolized photoresist film, is similar to 
glassy carbon, thus it is chemically stable, extremely conductive, and highly 
biocompatible.  
The complex environments in which cells interact can have diverse cellular 
populations and be susceptible to changes that influence cellular survival, division, 
differentiation, and virulence. Such dynamic responses are often mediated, at least in 
part, by changes in the concentrations of signaling biomolecules. Hence, the in vitro 
electrochemical detection of cellular biogenic species allows real-time monitoring of 
cellular communication in mono- and poly-microbial environments, thus providing 
information about chemically and environmentally dependent bacterial responses. In a 
previous study, members of the Stevenson research group characterized analytical 
responses of T-CUAs to hydrogen peroxide (H2O2),38,70,71 a biogenic metabolite produced 
by various pathogenic bacteria, such as Streptococcus gordonii. Additionally, we have 
shown successful modification of T-CUAs for the detection of cellularly derived nitric 
oxide (NO•), a biogenic signaling molecule produced by immune host cells such as 
macrophages.84 
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Figure 1.2: Schematic of fabrication steps of transparent carbon ultramicroelectrode 











Polystyrene spheres (PSS) are drop-cast on a pyrolized photoresist film, followed by 
atomic layer deposition of 10 nm Al2O3 layer, after which PSS are removed by sonication 
and chemical dissolution steps to give an array of ultramicroelectrodes (side and top-view 
illustrated). Figure courtesy of Dr. Jonathon Duay of the Stevenson research group. 
(Reprinted with permission from ref. 70. Copyright 2014 American Chemical Society). 
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1.4 OUTLINE OF CHAPTERS 
This dissertation describes the development, optimization and application of T-
CUAs for the in vitro, temporal, rapid, and highly sensitive detection of bacterial warfare 
toxin, pyocyanin, and various other phenazine metabolites produced by the opportunistic 
human pathogen P. aeruginosa. This antibiotic-resistant pathogen causes various 
hospital-acquired infections, and is most commonly found in chronic wound infections 
and in lungs of cystic fibrosis patients. During early infection stages, P. aeruginosa 
produces phenazines as virulence factors, which are highly diffusible chemical signals 
that are toxic to surrounding mammalian host cells and other competing microorganisms. 
Therefore the detection of these metabolites is of high importance as it could provide 
insights regarding P. aeruginosa virulence mechanisms. Although phenazines are known 
to play important roles in cellular functions, very little is known about how their 
concentrations fluctuate and influence cellular behaviors over the course of infection and 
growth.   
Herein, this collective body of work reports the use of easily assembled, low-cost 
T-CUAs as electrochemical sensors providing rapid response times, improved sensitivity 
and high reproducibility for the real-time, simultaneous detection and monitoring of 
phenazine metabolites from P. aeruginosa, which has not been previously demonstrated. 
In comparison with other carbon-based sensors described previously (Table 1.1), T-
CUAs have enhanced sensitivity due to their nanometer sizes, thus allowing for 
simultaneous detection and quantification not only of PYO, but also of multiple other 
phenazine molecules. Additionally, the fast response times of T-CUAs allow readouts to 
be obtained in approximately 15 s only from all ultramicroelectrodes in the array. 
Contrary to other aforementioned approaches, T-CUAs do not require use of 
‘permselective’ membranes due to their high degree of biological compatibility, allowing 
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to sense P. aeruginosa markers in complex biological environments. Finally, optical 
imaging of P. aeruginosa cells on T-CUAs can be performed in tandem with 
electrochemical analysis, which allows for simultaneous determination of bacterial 
growth rates from correlated optical density measurements. 
This dissertation is organized into five chapters, with Chapter 1 providing a broad 
overview of the motivation and scope of this work, as well as providing a detailed 
summary of electrochemical-based sensors developed for the detection of P. aeruginosa. 
Additionally, the design and advantages of T-CUA electrodes, developed by the 
Stevenson research group, are described. The remaining four chapters outline the 
application of T-CUAs as an electrochemical sensing platform for rapid, sensitive, 
diagnostic, quantitative and real-time monitoring of P. aeruginosa metabolism dynamics. 
Chapter 2 describes the characterization and optimization of T-CUAs analytical 
figures of merit for the electrochemical detection of P. aeruginosa redox-active, 
virulence metabolite, PYO, from solutions with pathogenic bacteria. Square wave 
voltammetry was used to quantify PYO concentrations on T-CUAs with and without 
chitosan gold nanoparticles (CS/GNP) and planar transparent macroelectrodes (T-
Macro). The response time (RT), limit of detection (LOD) and linear dynamic range 
(LDR) differ for each electrode type due to subtle influences in how the detectable signal 
varies in relation to the charging time and resistive and capacitive noise. The determined 
LODs and LDRs fall within the range of PYO concentrations for a variety of in vitro and 
in vivo cellular environments and offer promise of the application of T-CUAs for the 
quantitative study of biotoxins, quorum sensing and pathogenesis. Successful use of T-
CUAs for the electrochemical detection of PYO secreted from P. aeruginosa strains 




Figure 1.3: Application of T-CUAs for the real-time electrochemical detection of P. 















Specifically, PYO, 5-MCA, OHPHZ and an unknown biomolecule are electrochemically 
detected from living unperturbed cell cultures in simulated growth media. 
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Chapter 3 discusses the application of T-CUAs for the in vitro, simultaneous 
detection of various redox-active phenazine metabolites, including PYO, an extremely 
reactive species, 5-methylphenazine-1-carboxylic acid (5-MCA), and the side-product 1-
hydroxyphenazine (OHPHZ), from a highly virulent P. aeruginosa PA14 strain in 
simulated growth media (Figure 1.3). In addition to quantifying phenazine metabolite 
concentrations over 48 hours, changes in phenazine dynamics are observed in the 
biosynthetic route for the production of PYO. Additionally, environmental effects on 
phenazine dynamics and PYO concentrations in two growth media, tryptic soy broth 
(TSB) and lysogeny broth (LB), are explored. Finally, desorption electrospray ionization 
(DESI) and nano-electrospray ionization (nano-ESI) mass spectrometry are used to 
confirm the detection and identification of reactive phenazine metabolites. 
Chapter 4 details the electrochemical monitoring of the impact of polymicrobial 
infections on P. aeruginosa and growth dependent medium, where the differences in P. 
aeruginosa phenazine production and dynamics in polymicrobial communities are 
investigated (Figure 1.4). Specifically, P. aeruginosa is co-cultured with two pathogens 
of clinical relevance, S. aureus and E. coli, which typically populate infection sites with 
P. aeruginosa. Phenazine production rates and biosynthesis dynamics are 
electrochemically monitored during a 48-h period using T-CUAs. Moreover, the effect on 
phenazine production rates and dynamics is explored in two growth media, LB and TSB. 
The concentrations of PYO and highly reactive 5-MCA are determined in different 
polymicrobial culture samples in both media. The results demonstrate that other bacterial 
pathogens noticeably influence P. aeruginosa phenazine production and dynamics. 
Conclusively, the media type significantly influences phenazine product distribution, 
especially in polymicrobial co-cultures, signifying the need for analytical standardization 
of simulation media in the study of polymicrobial communities. 
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Figure 1.4: T-CUAs for the real-time electrochemical detection of P. aeruginosa 













Chapter 5 presents a summary of initial studies performed for future work. Using 
T-CUAs, temporal electrochemical detection of PYO from P. aeruginosa grown in a 
synthetic cystic fibrosis sputum medium, SCFM2 (developed by the Whiteley lab) is 
evaluated while simultaneously performing confocal microscopy imaging of cellular 
aggregates. The characterization of PYO diffusion coefficients and the viscoelastic 
properties of SCFM2 are described. Additionally, the interaction between two biogenic 
species of importance, specifically pathogenic PYO and immunological nitric oxide 
(NO•), is investigated on T-CUA sensors. The in vitro detection of these cellular species 
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Table 1.1 Acronyms: LOD – limit of detection; LDR – linear dynamic range; PYO – pyocyanin; Au – 
gold; CV – cyclic voltammetry; SWV – square wave voltammetry; DPV – differential pulse 
voltammetry; AuNPs – gold nanoparticles; PQS – 2-heptyl-3-hydroxy-4-quinolone  (Pseudomonas 








(1) Ventola, C. L. P T, 2015, 40, 344–352. 
(2) Amiri, M.; Bezaatpour, A.; Jafari, H.; Boukherroub, R.; Szunerits, S. ACS Sensors 
2018, 3, 1069–1086. 
(3) Monzó, J.; Insua, I.; Fernandez-Trillo, F.; Rodriguez, P. Analyst 2015, 140, 7116–
7128. 
(4) Boucher, H. W.; Talbot, G. H.; Bradley, J. S.; Edwards, J. E.; Gilbert, D.; Rice, L. 
B.; Scheld, M.; Spellberg, B.; Bartlett, J. Clin. Infect. Dis. 2009, 48, 1–12. 
(5) Dye, C. Philos. Trans. R. Soc. Lond., B, Biol. Sci. 2014, 369, 20130426–
20130435. 
(6) Pogue, J. M.; Kaye, K. S.; Cohen, D. A.; Marchaim, D. Clin. Microbiol. Infect. 
2015, 21, 302–312. 
(7) Hudu, S. A.; Alshrari, A. S.; Syahida, A.; Sekawi, Z. J Clin Diagn Res 2016, 10, 
DE01–DE05. 
(8) Swaminathan, B.; Feng, P. Annu. Rev. Microbiol. 1994, 48, 401–426. 
(9) Lazcka, O.; Campo, F. J. D.; Muñoz, F. X. Biosens. Bioelectron. 2007, 22, 1205–
1217. 
(10) Buchan, B. W.; Ledeboer, N. A. Clinical Microbiology Reviews 2014, 27, 783–
822. 
(11) Paniel, N.; Baudart, J.; Hayat, A.; Barthelmebs, L. Methods 2013, 64, 229–240. 
(12) Goluch, E. D. Trends Biotechnol 2017, 35, 1125–1128. 
 25 
(13) Douterelo, I.; Jackson, M.; Solomon, C.; Boxall, J. Appl Microbiol Biotechnol 
2015, 100, 3301–3311. 
(14) Cho, J. C.; Tiedje, J. M. Applied and Environmental Microbiology 2001, 67, 
3677–3682. 
(15) Ho, Y. P.; Reddy, P. M. Clinical Chemistry 2010, 56, 525–536. 
(16) Krásný, L.; Hynek, R.; Hochel, I. Int. J. Mass Spectrom. 2013, 353, 67–79. 
(17) Hou, T.-Y.; Chiang-Ni, C.; Teng, S.-H. J Food Drug Anal 2019, 27, 404–414. 
(18) Emonet, S.; Shah, H. N.; Cherkaoui, A.; Schrenzel, J. Clinical Microbiology and 
Infection 2010, 16, 1604–1613. 
(19) Phelan, V. V.; Fang, J.; Dorrestein, P. C. J. Am. Soc. Mass Spectrom. 2015, 26, 
873–877. 
(20) Watrous, J. D.; Dorrestein, P. C. Nature Rev. Microbiol. 2011, 9, 683–694. 
(21) Watrous, J.; Roach, P.; Alexandrov, T.; Heath, B. S.; Yang, J. Y.; Kersten, R. D.; 
van der Voort, M.; Pogliano, K.; Gross, H.; Raaijmakers, J. M.; Moore, B. S.; 
Laskin, J.; Bandeira, N.; Dorrestein, P. C. Proc Natl Acad Sci USA 2012, 109, 
E1743–E1752. 
(22) Ge, M.-C.; Kuo, A.-J.; Liu, K.-L.; Wen, Y.-H.; Chia, J.-H.; Chang, P.-Y.; Lee, 
M.-H.; Wu, T.-L.; Chang, S.-C.; Lu, J.-J. J Microbiol Immunol Infect 2017, 50, 
662–668. 
(23) Angeletti, S. J. Microbiol. Methods 2017, 138, 20–29. 
(24) Ivnitski, D.; Hamid, I. A.; Atanasov, P.; Wilkins, E.; Stricker, S. Electroanalysis 
2000, 12, 317–325. 
 26 
(25) Tang, Y.; Ali, Z.; Zou, J.; Jin, G.; Zhu, J.; Yang, J.; Dai, J. RSC Adv. 2017, 7, 
51789–51800. 
(26) Shahdordizadeh, M.; Taghdisi, S. M.; Ansari, N.; Langroodi, F. A.; Abnous, K.; 
Ramezani, M. Sensor Actuat B-Chemical 2017, 241, 619–635. 
(27) Kokkinos, C.; Economou, A.; Prodromidis, M. I. Trends in Analytical Chemistry 
2016, 79, 88–105. 
(28) Justino, C. I. L.; Duarte, A. C.; Rocha-Santos, T. A. P. Trends in Analytical 
Chemistry 2016, 85, 36–60. 
(29) Kuss, S.; Amin, H. M. A.; Compton, R. G. Chem. Asian J. 2018, 13, 2758–2769. 
(30) Ringen, L. M.; Drake, C. H. J. Bacteriol. 1952, 64, 841–845. 
(31) Walker, T. S. Plant Physiol. 2004, 134, 320–331. 
(32) Fetzer, A. F.; Werner, A. S.; Hagstrom, J. W. Am. Rev. Respir. Dis. 1967, 96, 
1121–1130. 
(33) Bedrossian, C. W. M.; Greenberg, S. D.; Singer, D. B.; Hansen, J. J.; Rosenberg, 
H. S. Hum. Pathol. 1976, 7, 195−204.  
(34) Fick, R. B. Chest. 1989, 96, 158–164. 
(35) Magill, S. S.; Edwards, J. R.; Bamberg, W.; Beldavs, Z. G.; Dumyati, G.; Kainer, 
M. A.; Lynfield, R.; Maloney, M.; McAllister-Hollod, L.; Nadle, J.; Ray, S. M.; 
Thompson, D. L.; Wilson, L. E.; Fridkin, S. K. N Engl J Med 2014, 370, 1198–
1208. 
(36) Bowler, P. G.; Duerden, B. I.; Armstrong, D. G. Clinical Microbiology Reviews 
2001, 14, 244–269. 
 27 
(37) Alatraktchi, F.; Breum Andersen, S.; Krogh Johansen, H.; Molin, S.; Svendsen, 
W. Sensors 2016, 16, 408–410. 
(38) Elliott, J.; Simoska, O.; Karasik, S.; Shear, J. B.; Stevenson, K. J. Anal. Chem. 
2017, 89, 6285–6289. 
(39) Simoska, O.; Sans, M.; Fitzpatrick, M. D.; Crittenden, C. M.; Eberlin, L. S.; 
Shear, J. B.; Stevenson, K. J. ACS Sensors 2019, 4, 170–179. 
(40) Jarošová, R.; Mcclure, S. E.; Gajda, M.; Jović, M.; Girault, H. H.; Lesch, A.; 
Maiden, M.; Waters, C.; Swain, G. M. Anal. Chem. 2019, 91, 8835–8844. 
(41) Do, H.; Kwon, S.-R.; Fu, K.; Morales-Soto, N.; Shrout, J. D.; Bohn, P. W. 
Langmuir 2019, 35, 7043–7049. 
(42) McLister, A.; McHugh, J.; Cundell, J.; Davis, J. Adv. Mater. 2016, 28, 5732–
5737. 
(43) Cernat, A.; Tertis, M.; Gandouzi, I.; Bakhrouf, A.; Suciu, M.; Cristea, C. 
Electrochemistry Communications 2018, 88, 5–9. 
(44) Gandouzi, I.; Tertis, M.; Cernat, A.; Saidane-Mosbahi, D.; Ilea, A.; Cristea, C. 
Materials 2019, 12, 1180–1193. 
(45) Dietrich, L. E. P.; Price-Whelan, A.; Petersen, A.; Whiteley, M.; Newman, D. K. 
Mol. Microbiol. 2006, 61, 1308–1321. 
(46) Alatraktchi, F. A.; Johansen, H. K.; Molin, S.; Svendsen, W. E. Nanomedicine 
2016, 11, 2185–2195. 
 28 
(47) Alatraktchi, F. A.; Noori, J. S.; Tanev, G. P.; Mortensen, J.; Dimaki, M.; 
Johansen, H. K.; Madsen, J.; Molin, S.; Svendsen, W. E. PLoS ONE 2018, 13, 
e0194157–e0194159. 
(48) Santiveri, C. R.; Sismaet, H. J.; Kimani, M.; Goluch, E. D. ChemistrySelect 2018, 
3, 2926–2930. 
(49) Sismaet, H. J.; Pinto, A. J.; Goluch, E. D. Biosens. Bioelectron. 2017, 97, 65–69. 
(50) Koley, D.; Ramsey, M. M.; Bard, A. J.; Whiteley, M. Proc. Natl. Acad. Sci. 
U.S.A. 2011, 108, 19996–20001. 
(51) Connell, J. L.; Kim, J.; Shear, J. B.; Bard, A. J.; Whiteley, M. Proc Natl Acad Sci 
USA 2014, 111, 18255–18260. 
(52) Moya, A.; Gabriel, G.; Villa, R.; del Campo, F. J. Current Opinion in 
Electrochemistry 2017, 3, 29–39. 
(53) Buzid, A.; Reen, F. J.; Langsi, V. K.; Muimhneacháin, E. Ó.; O’Gara, F.; 
McGlacken, G. P.; Luong, J. H. T.; Glennon, J. D. ChemElectroChem 2017, 4, 
533–541. 
(54) Buzid, A.; Shang, F.; Reen, F. J.; Muimhneacháin, E. Ó.; Clarke, S. L.; Zhou, L.; 
Luong, J. H. T.; O’Gara, F.; McGlacken, G. P.; Glennon, J. D. Sci. Rep. 2016, 6, 
1–9. 
(55) Takahashi, Y.; Zhou, Y.; Fukuma, T. Current Opinion in Electrochemistry 2017, 
5, 121–125. 
(56) Bellin, D. L.; Sakhtah, H.; Rosenstein, J. K.; Levine, P. M.; Thimot, J.; Emmett, 
K.; Dietrich, L. E. P.; Shepard, K. L. Nat. Commun. 2014, 5, 3256–3265. 
 29 
(57) Bellin, D. L.; Sakhtah, H.; Zhang, Y.; Price-Whelan, A.; Dietrich, L. E. P.; 
Shepard, K. L. Nat. Commun. 2016, 7, 10535–10544. 
(58) Mavrodi, D. V.; Blankenfeldt, W.; Thomashow, L. S. Annu. Rev. Phytopathol. 
2006, 44, 417–445. 
(59) Pierson, L. S.; Pierson, E. A. Appl Microbiol Biotechnol 2010, 86, 1659–1670. 
(60) Glasser, N. R.; Kern, S. E.; Newman, D. K. Mol. Microbiol. 2014, 92, 399–412. 
(61) Hendiani, S.; Pornour, M.; Kashef, N. Photodiagnosis and Photodynamic 
Therapy 2019, 26, 8–12. 
(62) Wightman, R. Anal. Chem. 1981, 53, 1125A–1134A. 
(63) Pons, S.; Fleischmann, M. Anal. Chem. 1987, 59, 1391A–1399A. 
(64) Bard, A. J.; Faulkner, L. R. Electrochemical Methods Fundamentals and 
Applications, 2nd ed.; Harris, D., Ed.; John Wiley & Sons, Inc., 2001; pp 1–850. 
(65) Chen, R.; Li, Y.; Huo, K.; Chu, P. K. RSC Adv. 2013, 3, 18698–18716. 
(66) Hood, S. J.; Kampouris, D. K.; Kadara, R. O.; Jenkinson, N.; del Campo, F. J.; 
Muñoz, F. X.; Banks, C. E. Analyst 2009, 134, 2301–2305. 
(67) Arrigan, D. W. M. Analyst 2004, 129, 1157–1165. 
(68) Koehne, J. E.; Marsh, M.; Boakye, A.; Douglas, B.; Kim, I. Y.; Chang, S.-Y.; 
Jang, D.-P.; Bennet, K. E.; Kimble, C.; Andrews, R.; Meyyappan, M.; Lee, K. H. 
Analyst 2011, 136, 1802–1805. 
(69) Guo, J.; Lindner, E. Anal. Chem. 2009, 81, 130–138. 
(70) Duay, J.; Goran, J. M.; Stevenson, K. J. Anal. Chem. 2014, 86, 11528–11532. 
 30 
(71) Duay, J.; Elliott, J.; Shear, J. B.; Stevenson, K. J. Anal. Chem. 2015, 87, 10109–
10116. 
(72) Ino, K.; Shiku, H.; Matsue, T. Current Opinion in Electrochemistry 2017, 5, 146–
151. 
(73) Ino, K.; Yamada, Y.; Kanno, Y.; Imai, S.; Shiku, H.; Matsue, T. Sensor Actuat B-
Chemical 2016, 234, 201–208. 
(74) Kurosawa, H.; Utsunomiya, H.; Shiga, N.; Takahashi, A.; Ihara, M.; Ishibashi, 
M.; Nishimoto, M.; Watanabe, Z.; Abe, H.; Kumagai, J.; Terada, Y.; Igarashi, H.; 
Takahashi, T.; Fukui, A.; Suganuma, R.; Tachibana, M.; Yaegashi, N. Hum. 
Reprod. 2016, 31, 2321–2330. 
(75) Gardner, R. D.; Zhou, A.; Zufelt, N. A. Sensor Actuat B-Chemical 2009, 136, 
177–185. 
(76) Orozco, J.; Fernández-Sánchez, C.; Jiménez-Jorquera, C. Sensors 2010, 10, 475–
490. 
(77) Feeney, R.; Kounaves, S. P. Electroanalysis 2000, 12, 677–684. 
(78) Albers, J.; Grunwald, T.; Nebling, E.; Piechotta, G.; Hintsche, R. Anal Bioanal 
Chem 2003, 377, 521–527. 
(79) Nebling, E.; Grunwald, T.; Albers, J.; Schäfer, P.; Hintsche, R. Anal. Chem. 2004, 
76, 689–696. 
(80) Patel, B. A.; Arundell, M.; Quek, R. G. W.; Harvey, S. L. R.; Ellis, I. R.; 
Florence, M. M.; Cass, A. E. G.; Schor, A. M.; O’Hare, D. Anal Bioanal Chem 
2008, 390, 1379–1387. 
 31 
(81) Arumugam, P. U.; Yu, E.; Riviere, R.; Meyyappan, M. Chemical Physics Letters 
2010, 499, 241–246. 
(82) Yakushenko, A.; Schnitker, J.; Wolfrum, B. Anal. Chem. 2012, 84, 4613–4617. 
(83) McKnight, T. E.; Melechko, A. V.; Fletcher, B. L.; Jones, S. W.; Hensley, D. K.; 
Peckys, D. B.; Griffin, G. D.; Simpson, M. L.; Ericson, M. N. J. Phys. Chem. B 
2006, 110, 15317–15327. 
(84) Elliott, J.; Duay, J.; Simoska, O.; Shear, J. B.; Stevenson, K. J. Anal. Chem. 2017, 
89, 1267–1274. 
(85) Simoska, O.; Sans, M.; Eberlin, L. S.; Shear, J. B.; Stevenson, K. J. Biosens. 















Chapter 2: Electrochemical Detection of a Bacterial Warfare Toxin, 
Pyocyanin, using Transparent Carbon Ultramicroelectrode Arrays2 
2.1 INTRODUCTION 
Numerous infectious diseases are easily spread through hospitals when patients 
are exposed to pathogenic bacteria contaminating heavily trafficked hospital surfaces, in 
some instances having established dense, antibiotic-resistant biofilm communities. The 
opportunistic pathogen, Pseudomonas aeruginosa, is responsible for various severe 
hospital-contracted infections.1,2 While it rarely establishes persistent infections in 
otherwise healthy individuals, this microorganism can establish chronic infections in 
individuals with compromised immune systems, and suffering from other conditions, 
such as severe burns (and other wounds) and cystic fibrosis.3-7  
P. aeruginosa secretes several biotoxins as virulence factors that cause infections 
in host organisms to thrive.8,9 One of these factors is pyocyanin (PYO), a blue pigment, 
redox-active nitrogen-containing aromatic compound in the family of phenazine 
compounds.10-12 It is exclusively secreted as a secondary metabolite by quorum sensing (a 
population-dependent response to diffusible signals) P. aeruginosa bacteria, which makes 
this molecule an effective diagnostic marker for identifying developing infections.13 PYO 
has been isolated and detected within in vivo environments in the low- to mid-micromolar 
range.14-16 It readily reacts with cellular metabolites to generate reactive oxygen species 
(ROS) that damage host tissue.10 PYO is also involved in quorum sensing (QS), a cell-to-
cell communication process allowing bacteria to regulate gene expression based on the 
                                                
2Adapted with permission from Simoska, O.; Elliott, J.; Karashik, S.; Shear, J. B.; Stevenson, K. J. 
Transparent Ultramicroelectrode Arrays for the Electrochemical Detection of Bacterial Warfare Toxin, 
Pyocyanin. Anal. Chem. 2017, 89, 6285–6289. Copyright © 2017 American Chemical Society. Elliott, J. 
and Simoska, O. contributed equally to the work both in taking the data and writing the manuscript. All 
authors contributed in editing the manuscript. 
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effective cell density.13,17 Therefore, detecting and quantifying PYO could provide a 
better understanding of P. aeruginosa’s pathogenesis.  
PYO is most commonly detected using spectrophotometric methods,18,19 which 
typically require time-consuming sample pre-treatments. Using ultraviolet absorption, 
PYO has been detected at concentrations ranging from 12–38 µM.18 Additionally, high 
performance liquid chromatography (HPLC) in combination with mass spectrometry is a 
frequently employed approach for detecting PYO.20,21 Although such methods generally 
yield good analytical sensitivities, they require time-consuming preparative steps, large 
sample volumes and relatively costly equipment. Unlike these conventional procedures, 
electrochemical approaches have been demonstrated to be low cost, rapid, sensitive, and 
direct methods for detection of PYO.22-25 Hence, they are becoming increasingly popular 
alternatives to standard optical or separation based analytical methods.  
Previous studies have successfully used voltammetric techniques for the detection 
and quantification of PYO from P. aeruginosa strains and from human fluid samples.22-
24,26 Additionally, a recent study reported on an amperometric method for the selective 
detection and quantification of PYO27 and scanning electrochemical microscopy (SECM) 
has been employed to examine PYO at the surface of biofilms with high spatial 
resolution.28,29 However, none of the aforementioned electroanalytical techniques have 
demonstrated the use of optically transparent ultramicroelectrode arrays for the detection 
of PYO. In addition to easy fabrication, low cost, and simple modification procedures, 
the optical transparency of these electrodes provides a means to analyze P. aeruginosa 
cells on electrode surfaces while simultaneously monitoring changes in electrochemical 
signals of cellularly derived PYO.  Thus, this electrode platform has the potential to 
provide simultaneous optical information about cell modulation in addition to real-time, 
continuous electrochemical analyses of cellular PYO. 
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The Stevenson research group has previously reported a facile, low-cost, versatile 
approach for the fabrication of transparent carbon ultramicroelectrode arrays (T-CUAs).30 
These electrodes offer several advantages relative to typical bulk electrodes. Their small 
size allows for the use of less supporting electrolyte, thus achieving enhanced mass 
transport and fast steady state responses.30 T-CUAs retain the benefits of microelectrodes, 
but have the additional advantage of amplified currents because the individual electrodes 
in the array function in parallel.30 In addition, these electrodes achieve lower background 
current due to their small electroactive areas, which result in higher signal-to-noise (S/N) 
ratios and lower limits of detection (LODs).30 The active electrode material of T-CUAs is 
a pyrolyzed photoresist film (PPF), which provides advantages similar to glassy carbon: 
inert, highly conductive, chemically stable, and biocompatible. We have recently 
characterized T-CUA analytical response to hydrogen peroxide (H2O2), a biogenic 
metabolite produced by various types of cells.31 Using cyclic voltammetry, the LOD was 
determined to be in the nanomolar range (~35 nM).31 In addition, we recently employed 
T-CUAs for the detection of another biogenic ROS, nitric oxide (NO•), achieving an 
LOD of 0.2  ± 0.1 µM using square wave voltammetry (SWV).32 The optical 
transparency of the electrodes allows for the bright-field imaging of cells as well as the 
ability to perform fluorescence experiments on cells.   Furthermore, the T-CUA and T-
Macro electrodes’ biocompatibilities are comparable to glass, deeming them extremely 
biocompatible surfaces. 
Herein, we demonstrate use of T-CUAs for the detection of PYO with the goal of 
incorporating this device with biological systems for the electrochemical detection of 
PYO secreted by cells. We evaluated PYO responses at different electrodes using square 
wave voltammetry to determine respective LODs and LDRs. The LODs determined fall 
within the micromolar ranges for PYO detection from P. aeruginosa infected sputum 
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samples and biofilm aggregates, indicating that our approach could be useful for 
measuring PYO concentration in in vitro and/or in vivo biological environments. Finally, 
as a proof-of-concept study, T-CUAs were used as a sensing platform to detect PYO 
from bacterial strains, while concurrently performing bright-field imaging of the cells. 
2.2 EXPERIMENTAL METHODS 
2.2.1 General 
All chemicals were used as received. Photoresist AZ 1518 was purchased from 
Microchemicals.  Potassium chloride, acetic acid, cyclohexanone, isopropanol, and nitric 
acid were acquired from Sigma-Aldrich Co.  Polystyrene spheres (Polybead®) with a 
diameter of 1.54 µm were purchased from Polysciences, Inc. Pyocyanin was purchased 
from Cayman Chemical Company. Ethanol, Monosodium phosphate, disodium 
phosphate were purchased from Thermo Fisher Scientific Inc. 
2.2.2 Fabrication of T-Macro and T-CUA Electrodes 
Preparation of the T-CUAs and T-Macro follows a previously described 
procedures.30,31 Quartz microscopic slides (6.45 cm2 and 1 mm thick, Technical Glass 
Products) were treated with piranha (3:1 H2SO4: 30% H2O2) to remove any organic 
contaminants. A 1:3 dilution of AZ 1518 photoresist with PGMEA (1-methoxy-1-
propanol acetate) was spun onto the piranha cleaned quartz slides at 6000 rpm for 60 s. 
Following spin coating, the photoresist slides were soft baked at 90 °C for 10 min and 
then transferred to a tube furnace. After 15 min of purging with 5% H2: 95% N2 (~100 
mL/min), the photoresist slides were pyrolized by heating to 1000 °C at 5 °C/min and 
holding at that temp for 1 h before allowing them to cool slowly back to room 
temperature at 5°C/min. The pyrolized photoresist film (PPF) slides were then removed 
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from the furnace and stored for 3 days prior to use to allow for the oxide layer to 
stabilize. T-CUAs fabrication involved a lithography method using polystyrene 
microspheres (PSS) with a diameter of 1.54 µm, which were drop cast from a 5.4 wt % 
methanol suspension onto the conductive PPF electrodes. The organization of the spheres 
is that of a hexagonal close-packed two-dimensional ordered network. After this 
microsphere lithography step, 10 nm of Al2O3 layer was deposited via atomic layer 
deposition (ALD) technique at 80 °C. The ALD process was calibrated by the 
manufacturer (Cambridge Nanotech Savannah 100) to deposit 0.089 nm conformal Al2O3 
layer per cycle. Thus, cycling this process for 112 times formed a 10 nm ALD layer. This 
ALD step is then followed by removal of PSS via sonication with methanol, acetone, 
isopropanol and water. Disk-shaped carbon areas remained where the PSS made contact 
with the PPF, thus forming a carbon ultramicroelectrode array. T-Macro refers to the 
planar carbon electrode where no PSS were used during the fabrication process to create 
an array of electrodes. Details on characterization of T-CUA electrodes have been 
reported in previous research studies from our group.30,31 
2.2.3 Preparation of Chitosan-Gold Nanoparticles (CS/GNP) 
The CS/GNP solution was prepared according to modified procedures described 
in previous literature.32,33 Briefly, a 10.00 mg/mL solution of chitosan (CS) in 0.05 M 
acetic acid and a 3.76×10–3 M solution of chloroauric acid (HAuCl4) were prepared and 
mixed in a 20:1 (v/v) ratio, respectively. The mixture was well-shaken and placed in a 
heated sonic bath for 1 h until the solution color went from cloudy white to pink, 
indicating gold nanoparticles (GNP) formation. The solution pH is adjusted to 2.0 using 
nitric acid (HNO3) to dissolve the CS. 
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2.2.4 Preparation of CS/GNP Modified T-CUA Electrodes 
The CS/GNP film was electrodeposited on the T-CUA and T-Macro electrodes 
using chronoamperometry by holding a potential at –1.00 V vs SCE for 60 s in the 
aforementioned CS/GNP solution.  The selected potential and time for the deposition was 
previously determined by Wang et al.33 Upon the electrodeposition step, the T-CUA and 
T-Macro electrodes were rinsed with deionized water and gently dried with N2 gas.  
2.2.5 Preparation of Standard Pyocyanin Solutions 
A 2 mM PYO stock solution was prepared in ethanol and was diluted to make a 
500 µM stock solution in sodium phosphate buffer solution (SPB, 7.0 pH).  From the 500 
µM stock solution the respective PYO standard solutions were prepared having the 
following concentrations: 0.5 µM, 1 µM, 5 µM, 10 µM, 25 µM, 50 µM, 100 µM, and 250 
µM, in SPB. 
2.2.6 Electrochemical Measurements 
The electrochemical measurements were done using a three-electrode cell system. 
Electrochemical experiments, including square wave voltammetry (SWV) and cyclic 
voltammetry (CV), were performed using an Autolab PGSTAT30 potentiostat. T-CUA or 
T-Macro was the working electrode with a total exposed geometric area of 0.495 cm2, 
defined by the electrode area exposed to a solution in a homemade Teflon 
electrochemical well.  A platinum mesh was used as the counter electrode and a saturated 
calomel electrode (SCE) was used as the reference electrode. CV experiments were 
performed at scan rates of 2.5, 25, and 50 mV s-1.  SWV measurements were performed 
using a current of 5 µA, 3 mV step potential, and a frequency of 15 Hz.  The potential 
ranged from –0.3 or –0.4 to (–0.1) V vs SCE. The background solution used was sodium 
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phosphate buffer solution (SPB, 7.0 pH).  After a background CV or SWV curve was 
collected using SPB, subsequent PYO measurements were obtained. 
2.2.7 Bacterial Strains Cell Culture and Optical Imaging 
Wild-type PA14 and a clinically relevant PA11 LESB58 (SED11)34 P. aeruginosa 
strains were used in these studies. The growth medium for these experiments was a 1:15 
(vol/vol) mixture of lysogeny broth (LB) (5 g/L yeast extract, 10 g/L NaCl, and 10 g/L 
tryptone) buffered to pH of 7.2 with sodium succinate (20 mM) as the carbon source. 
Cultures were grown aerobically overnight at 37 °C. Cells were diluted with sodium 
phosphate buffer (SPB, pH 7.0) for electrochemical measurements. Using UV-Vis 
spectrometry (Agilent Instrument 8453 UV−vis−NIR spectrometer), the ODs at 600 nm 
were measured to be 0.763 and 1.628 for PA11 and PA14 in 1:3 (v/v) LB:SPB, 
respectively. The ODs at 600 nm were measured to be 1.674 and 0.934 for Pa11 and 
Pa14 in 1:1 (v/v) LB:SPB, respectively. Images of bacterial strains on T-CUAs were 
obtained using bright-field illumination settings using an Olympus PlanApo 60×, 1.40 
N.A. oil- immersion objective on an inverted microscope (Zeiss; Axiovert). An ORCA-
Flash 2.8 scientific-grade complementary metal oxide semiconductor camera 
(Hamamatsu) controlled by HCImage Live software (Hamamatsu) was used. 
2.3 RESULTS AND DISCUSSION 
2.3.1 Evaluation of Electrochemical Behavior of PYO at T-CUA and T-Macro 
Electrodes 
Cyclic voltammetry (CV) was employed to evaluate the electrochemical activity 
of pyocyanin (PYO) at the T-CUA and T-Macro electrodes. The structural half-reactions 
of PYO are shown in Figure 2.1a. Figure 2.1b depicts a quasi-reversible, CV response 
with an anodic peak at −0.21 V and cathodic peak at −0.28 V with E1/2 = −0.245 V vs 
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SCE.  In addition, a non-reversible phenolic oxidation24 of pyocyanin (I−III) occurs at 
+0.89 V (Figure 2.1b), which is responsible for the polymerization of PYO. The product 
of the polymerization, III, undergoes a reversible conversion to IV. This transformation 
occurs at the same redox potential as PYO in solution.  The conversion of soluble PYO to 
its polymerized form as well as the cycling between III and IV causes an increase in the 
reversible peak heights (Figure 2.1b).24 This polymerization can be avoided by reducing 
the scan range to a range of −0.4 to −0.1 vs SCE (Figure 2.1c). Within this potential 
window, the redox couple observed is exclusively caused from the conversion between 
soluble, monomeric forms of PYO, I and II (Figure 2.1a). To allow a comparison, cyclic 
voltammograms, under the same conditions, for the other two electrode configurations 
used in this work (T-Macro and CS/GNP modified T-CUA) are shown in Figure 2.2. 
The electrochemical behavior of PYO observed at the T-Macro and T-CUA is not 
a purely reversible outer-sphere electron transfer reaction, as it undergoes a quasi-
reversible redox mechanism with Ep > 59 mV/n that is scan rate dependent.  Figure 2.1c 
shows that at a very slow scan rate of 2.5 mV s-1 PYO experiences an irreversible 
reduction. At faster scan rates (>25 mV s-1) the reversibility of the current-potential 
response improves, which is corroborated by the presence of an anodic peak. Therefore 
the reduced chemical product is stable on the time scale of CV experiments at or below a 
scan rate of 2.5 mV s-1. The observation of chemical reversibility is related to how fast 
the voltammetric experiment is conducted. Being that the pKa of PYO is 4.95, the 
reduced product is re-oxidizes in the solution with pH 7.4.  
A particular redox couple may appear chemically irreversible when voltammetric 
experiments are performed on a slow time scale. Whereas during the acquisition of a 
faster measurement, the rate of reversible electron transfer is faster than the rate of 
formation for the stable, reduced chemical product achieving chemical reversibility for 
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the system. To further illustrate the quasi-reversible nature of PYO redox, peak anodic 
(ia) and peak cathodic (ic) current responses were plotted as a function of the square root 
of the scan rates at T-CUA electrodes (Figure 2.3a). As described by the Randles-Sevcik 
equation ia does equal ic for a purely reversible couple,35 which does not hold true here. 
Consequently, the ratio of peak anodic current to peak cathodic current does not equal 1 
(Figure 2.3b, Table 2.1). 
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Figure 2.1: Pyocyanin (PYO) electrochemical behavior at T-CUA electrodes. 
(a) PYO redox reaction for its monomeric and polymeric forms. (b) Cyclic 
voltammograms of PYO polymerization due to high anodic potentials at different scans, 
with 100 µM PYO, at T-CUA electrode, scan rate of 100 mV s-1. (c) Cyclic voltammetric 
current responses of PYO at scan rates of 2.5, 25 and 50 mV s-1, as indicated, with 100 
µM PYO, at T-CUA electrode. The limited scan range from – 0.40 V to – 0.10 V 
prevents PYO polymerization. 
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Cyclic voltammetry response curves of PYO at scan rates of 2.5, 25 and 50 mV s-1, as 
indicated, with 100 µM PYO, at (a) T-Macro, and (B) CS/GNP modified T-CUA 









(a) Plot of current responses obtained from cyclic voltammograms as a function of the 
square root of the scan rate for peak anodic and peak cathodic currents for PYO redox at 
T-CUA electrode. (b) Ratio of anodic to cathodic currents (ia/ic) as a function of 
corresponding scan rates. This is also depicted in Table 2.1. 
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ν (mV s-1) ia/ic 
25 0.4 ± 0.1 
50 0.56 ± 0.04 
75 0.64 ± 0.01 
100 0.69 ± 0.01 
250 0.78 ± 0.09 
Table 2.1: The scan rate, ν, and corresponding anodic to cathodic current (ia/ic) ratio of 
PYO redox at T- CUA electrode. 
 
2.3.2 Figures of Merit and Electrochemical Characterization of PYO at T-CUA and 
T-Macro Electrodes 
The T-Macro, T-CUA, and CS/GNP T-CUA electrodes were used to detect 
pyocyanin using SWV (Figure 2.4). Figure 2.4b shows SWV current-potential curves and 
the corresponding calibration curve (Figure 2.4e) for the T-CUA electrode. The LOD was 
calculated as 3σ/slope of our calibration curve, utilizing standard approach 1 (SA1).36 
The LDR and LOD for PYO differ for each type of electrode.  The determined LOD for 
the T-Macro is 0.51 µM with a linear range of 0.75– 25 µM, respectively (Figure 2.4a 
and Figure 2.4d).  The LOD for the CS/GNP modified T-CUA is 1.6 µM with a LDR of 
1–100 µM, and the LOD of the T-CUA with a LDR of 1–250 µM is 1.0 µM, respectively 
(Figure 2.4c and Figure 2.4f).  The maximum level of pyocyanin produced by wild-type 
biofilm aggregates is ~2.7 µM.28,29,37 The concentration of pyocyanin in the sol phase 
(colloidal solution) of sputa from infected patients has been reported to be in the range of 
0.2 to 27.3 µg/ml (1–130 µM) with a median value 1.7 µg/ml (8.1 µM).14,26,38 Therefore 
our detection limits are in the range to detect PYO from individual P. aeruginosa biofilm 
aggregates and from the sputa of infected patients. To demonstrate this, we performed in 
vitro studies to probe PYO responses from two different P. aeruginosa strains, PA11 and 
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PA14 (Figure 2.6) using T-CUA electrodes as sensing detectors. The PA14 strain is a 
wild-type highly virulent P. aeruginosa strain,39 while the PA11 (CEB11) strain is a 
clinically significant P. aeruginosa strain, isolated from cystic fibrosis patient sputum 
sample.34 Our results show that after 24 hours of growing cultures at 37 °C, 
concentrations of secreted PYO were measured to be 50 ± 4 µM and 45 ± 5 µM from 
PA11 clinical strain, and 6 ± 6 µM and 3 ± 2 µM from wild-type PA14 strain (Figure 
2.7a-b, Table 2.2). Furthermore, while performing the electrochemical analyses, we also 
performed optical bright-field imaging of the two P. aeruginosa strains (Figure 2.7c-d) 
on T-CUA electrodes. These results indicate that we can successfully detect secreted 
PYO while optically imaging the cells.  
The linear range differs between the T-Macro and the T-CUA series. This 
divergence is primarily related to the varying RC time constants and subsequent response 
times40,41 of the electrodes to the PYO redox mechanism.  For these electrodes, the 
inherent response times are predicated upon the resistive and capacitive components of 
the electrodes. Since all electrodes examined here are constructed from the same 
electroactive material, PPF, they inherently share the same sheet resistance. Additional 
solution resistance results from the charge transfer process through the thin carbon film to 
and from the solution. Thus, increases in carbon area exposed to the solution cause an 
increase in overall resistance.  As a consequence, electrodes with greater exposed carbon 
(T-Macro electrodes) have higher overall resistance and greater response times than 













The graphs in the top row depict background corrected square wave voltammetric 
response curves for various different concentrations of PYO at: (a) T-Macro, (b) T-CUA, 
and (c) CS/GNP T-CUA electrodes. The bottom row (d–f) shows the corresponding 
calibration curves.  
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Furthermore, the capacitance is correspondingly related to the electroactive area, 
which is responsible for producing the double layer capacitance. Essential to the RC time 
constant, the capacitive component plays a prominent role in determining the response 
time (Figure 2.5).40,41 As a potential is applied to the electrode, molecules within the 
solution organize and distribute by charge to create a capacitive double layer. The double 
layer capacitance increases the thermodynamic barrier consequentially increasing the 
energy required to transfer charge between analyte and electrode, thus increasing the 
response time. It follows that as the electroactive area increases the greater the double 
layer capacitance and the slower the kinetics of charge transfer with the electrode.  The 
faster kinetics permitted at the T-CUA series facilitates a faster conversion of analyte to 
product at the electrode, increasing the amount of analyte reacting at the electrode over a 
given amount of time.  Therefore, higher concentrations of PYO can be determined by 
the T-CUA electrode series than the T-Macro, accounting for a larger LDR (Figure 2.4). 
The observed linear range of the T-CUA is diminished by the CS/GNP 
modification, an effect that appears counterintuitive given numerous reports examining 
the ability of GNPs to enhance the rate of electron transfer.33 GNPs have been shown to 
be biocompatible and catalytically selective for biogenic species. Gold is relatively inert 
activity when in its bulk form; however, when distributed in the form of fine particles 
with sizes below 10 nm, its catalytic activity increases. This enhancement is associated 
with the high concentrations of low coordinated active sites on the small nanoparticles 
surface, allowing GNPs to efficiently facilitate the rate of electron transfer. The method 
we presently use to modify our electrodes involves the electropolymerization of chitosan, 
which is a biocompatible polymer with anti-interference character, around GNPs. 
Chitosan assists the formation of CS/GNPs film on the electrodes by acting as a metal-
complexing agent, encapsulating and homogeneously distributing the GNPs on the 
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electrode surface. Thus, we expected to observe an enriching effect and improved LODs 
by introducing CS/GNPs modification to the electrodes. However, PYO is a quasi-
reversible redox active molecule whose redox mechanism is not entirely dependent on an 
electron transfer step and involves a chemical intermediates.  Therefore the mechanistic 
ability of GNPs to provide catalytic enhancement as the overall response is limited by 
bimolecular chemical steps and not electron transfer rates. The CS acts as an insulating 
layer and the GNPs restore and facilitate the electron transfer to the electrode, but it does 
not influence the rate of the chemical step or rate-limiting step.  Upon modification, the 
residual electroactive area of the electrode is further decreased to a point at which the rate 
of electrochemical conversion for PYO is not fast enough to compete with the flux of 
PYO to the electrode (CS/GNP surface), saturating the electrode and effectively 
decreasing the linear range. It should be noted that T-CUA geometry does not show the 
expected improved analytical response and thus a lower LOD compared to the T-Macro. 
We have previously characterized and determined the critical scan rate of T-CUA using 
Electrochemical Impedance Spectroscopy (ESI),30 to be 22 Hz, below which semi-infinite 
linear diffusion regimes are observed identical to that of T-Macro electrodes. Here, we 
used a scan rate below the T-CUA critical scan rate, thus T-CUAs do not demonstrate 
pure ultramicroelectrode behavior. As a result, the LOD of T-CUA is marginally higher 
compared to T-Macro. It should also be mentioned that the benefit of T-CUA relative to 
T-Macro also depends on the resistive and capacitive effects introduced by the alumina 













Electrochemical detection of cellularly derived PYO from P. aeruginosa strains while 
concurrently imaging bacterial cells through T-CUA electrodes. 
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Figure 2.7: Electrochemical detection of cellular PYO from clinical and laboratory 
bacterial strains while simultaneously imaging cells on T-CUAs. 
 
 
Background corrected square wave voltammetric responses for cellular PYO from two P. 
aeruginosa strains PA11 and PA14 in (a) 1:3 (v/v) lysogeny broth (LB) to sodium 
phosphate buffer (SPB) and (b) 1:1 (v/v) LB:SPB. The quantitatively determined PYO 
concentrations are displayed in Table 2.2. Optical bright-field images of (c) PA14 
bacterial strain and (d) PA11 bacterial strain obtained through T-CUA electrodes. 
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Table 2.3 compares the present work’s figures of merit to the previous reported 
values in the literature.  The current LODs and LDRs are compare favorable to those 
reported using previous PYO detection schemes. T-CUAs have the greatest LDR of all 
current electrochemical detection schemes. In addition, the electrochemical platform 
reported here represents a low-cost alternative compared to the other electrochemical 
methods referenced in Table 2.3, in particular platinum and boron-doped diamond 
electrodes. Finally, the electrode sensors for PYO here are transparent and planar, 
enabling concurrent optical studies of cells that will be key to acquiring contextual 





Bacterial Strain PA11 PA14 
Pyocyanin concentration in 1:3 (v/v) 
LB:SPB (µM) 45 ± 5 3 ± 2 
Pyocyanin concentration in 1:3 (v/v) 
LB:SPB (µM) 50 ± 4 6 ± 6 
Table 2.2: Concentrations of pyocyanin secreted from P. aeruginosa PA11 and PA14 







Working Electrode Electrochemical Technique LDR (µM) LODs (µM) Ref. 
T-Macroδ, φ SWV 0.75–25 0.75 ± 0.09  
This Work T-CUAδ, φ SWV 1–250 1.0 ± 0.3 
CS/GNP T-CUAδ, φ SWV 1–100 1.6 ± 0.2  
AuΨ,φ SWV 1–100 0.597 22 
Carbon Fibre tow laminate 
¥, φ SWV 1–100 0.03 
24 
Boron Doped Diamond ¥,φ DPV 2–100 0.05 25 
Disposable screen printed 
electrode, Auψ,Ϯ CV 0–100 2 
23 
Disposable screen printed 
electrode, Auψ,Ϯ Amperometry 0–90 0.125 
27 
 
¥ - Ag/AgCl reference electrode, ψ - Ag quasi-reference electrode,  
φ - Pt counter electrode, Ϯ - Au counter electrode,  
Ψ- palladium hydride (PdH) reference electrode, δ- SCE reference electrode 
 
Table 2.3: Comparison of limits of detection (LODs) and linear dynamic ranges 
(LDRs) of PYO using T-CUAs in comparison to other electrochemical tools 









The possibility of using transparent carbon ultramicroelectrode arrays (T-CUAs) 
as an electroanalytical sensing platform for the electrochemical detection of PYO was 
investigated. The redox activity of PYO at T-Macro and T-CUA electrodes was 
examined using CV. Using SWV, the detection of PYO at these electrodes was evaluated 
and LODs and LDRs were determined at each electrode type. The LOD for the T-Macro 
was determined to be 0.75 ± 0.09 µM with a linear range of 0.75–25 µM.  The LOD for 
the CS/GNP modified T-CUA was 1.6 ± 0.2 µM with a LDR of 1–100 µM, while the 
LOD for the T-CUA electrode was 1.0 ± 0.3 µM with a LDR of 1–250 µM. Additionally, 
the determined LDR at the T-CUA electrode was larger than previously reported linear 
ranges, allowing for detection of higher PYO concentrations. Although our LODs are 
comparable to other electrodes previously used for the detection of PYO,22,23,27 they fall 
within the low- to mid-micromolar range for PYO detection from P. aeruginosa 
organized within individual biofilm aggregates and from infected cystic fibrosis sputum 
samples.22-24,26 Thus, this work presents an electrochemical sensing platform that could 
be useful for monitoring PYO concentrations in in vitro and in vivo environments, a 
subject of further investigation. Finally, our method has an additional benefit compared to 
other electrochemical detection techniques; the T-CUA electrodes transparency provides 
a means to optically analyze P. aeruginosa cell modulation in tandem with 
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Chapter 3:  Real-time Electrochemical Detection of Pseudomonas 
aeruginosa Phenazine Metabolites using Transparent Carbon 
Ultramicroelectrode Arrays3 
3.1 INTRODUCTION 
The detection, identification, and monitoring of severe infectious diseases in host 
organisms by pathogenic bacteria remains a major challenge1-3 as infections spread 
through specific entities (e.g., hospitals) when the hosts (e.g., patients) make contact with 
bacterial communities. One microorganism responsible for the majority of hospital-
acquired infections is the opportunistic human pathogen Pseudomonas aeruginosa, which 
causes a significant increase in morbidity and mortality rates.4-6 Although this pathogen is 
rarely the source of microbial diseases in healthy individuals, it successfully establishes 
infections in patients with compromised immune systems and suffering from conditions 
such as cystic fibrosis, severe burns, and chronic wounds.7-11  
In hospital diagnosis, to confirm presence of P. aeruginosa in samples from 
patients, specimens are typically grown on agar plates with selective growth components 
to specifically target the bacterial strain, however, this process requires several days. As a 
result, patients with symptoms are treated with broad-spectrum antibiotics, which leads to 
increased antibiotic resistance,12 making P. aeruginosa infections difficult to treat. 
Therefore, understanding early stages of infection is necessary as it could point to more 
effective treatments. To avoid time-consuming diagnostics, a variety of electrochemical 
sensing techniques have recently been established as popular alternatives to standard 
                                                
3Adapted with permission from Simoska, O.; Sans, M.; Fitzpatrick, M. D.; Crittenden, C. M.; Eberlin, L. 
S.; Shear, J. B.; Stevenson, K. J. Real-time Electrochemical Detection of Pseudomonas aeruginosa 
Phenazine Metabolites using Transparent Ultramicroelectrode Arrays. ACS Sensors 2019, 4, 170–179. 
Copyright © 2019 American Chemical Society. Simoska, O. acquired the data, wrote the manuscript, and 
performed electrochemical measurements/characterization. Simoska, O., Crittenden. C. M., and Sans, M. 
performed mass spectrometry experiments. Simoska, O. and Stevenson, K. J. designed studies, planned 
experiments, and analyzed all data. All authors contributed in editing the manuscript. 
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spectrophotometric and molecular pathogen detection approaches due to their enhanced 
sensitivity, rapid response times, and simplicity of operation.5,13 In addition to 
electrochemical sensors, several optical sensing methods have been developed for 
analysis of P. aeruginosa. Both optical and electrochemical sensors are relatively non-
invasive with biological systems. While optical sensors can provide a means for spatial 
analysis of cells, they have several limitations. In particular, they involve the use of 
expressed fluorescent protein reporters,14,15 which have time delays associated with 
production of detectable signal, and are limited by nonspecific reactivity. On the other 
hand, electrochemical sensors can directly detect and rapidly quantify critical 
components, including cellular signaling species and metabolites, with high sensitivity. 
As a result, various electrochemical methods have successfully used voltammetry16-19 and 
amperometry4 for detection and quantification of P. aeruginosa toxins. However, none of 
these methods have demonstrated in situ, real-time detection of biogenic species from 
true, unperturbed P. aeruginosa cell cultures in simulated cell growth media. In addition, 
spatially resolved detection of phenazine metabolites from P. aeruginosa biofilm surfaces 
has been performed by very specialized techniques such as scanning electrochemical 
microscopy20,21 and integrated-circuit based electrochemical chips.22,23 However, these 
approaches involve quite costly and highly specialized equipment and expertise to 
perform quantitative studies.  
Our group has recently reported a low-cost, facile and versatile method to design 
transparent carbon ultramicroelectrode arrays (T-CUAs),24 which offer several 
advantages to other electrochemical detection methods. T-CUAs provide the benefits of 
microelectrodes, but have an additional advantage of amplified currents due to the 
individual electrodes in the array functioning in a parallel circuit.24 Their nanometer sizes 
permit measurements on smaller samples in biological environments with fast response 
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times.24,25 Furthermore, their small electroactive area allows for lower background 
currents to be achieved, thus resulting in higher signal-to-noise (S/N) ratios and lower 
limits of detection (LODs) with large linear dynamic ranges (LDRs).24 Since T-CUAs are 
constructed of primarily glassified carbon, they are chemically stable, very conductive, 
and highly biocompatible.  
In a previous study, we characterized T-CUAs analytical responses to hydrogen 
peroxide (H2O2),26 a biogenic metabolite produced by pathogenic bacterium 
Streptococcus gordonii. Additionally, we have previously presented successful 
modification of T-CUAs for the detection of cellularly derived nitric oxide (NO•), a 
biogenic signaling molecule produced by host cells like macrophages.25 Moreover, we 
have recently used T-CUAs to determine the figures of merit for pyocyanin (PYO),27 a 
redox-active bacterial toxin, which engages in chemical warfare with the immune system 
(Chapter 2). PYO is secreted by 96-98% P. aeruginosa strains28,29 and its redox state has 
important implications about its biological activity.20,30-34 Using square wave 
voltammetry (SWV), the LOD was determined to be 1.0 ± 0.3 µM with the largest 
reported linear dynamic range (LDR) of 1–250 µM, which allows detection of higher 
concentrations of cellular PYO.27 Importantly, these fall within the reported range of 
PYO concentrations (1–130 µM)35 from sputa isolated from lungs of cystic fibrosis 
patients.27 Additionally, we successfully used T-CUAs to detect PYO from laboratory 
and clinical P. aeruginosa strains (Chapter 2).27 
P. aeruginosa produces biotoxins as virulence factors,36 including various 
phenazine metabolites. Although phenazines play significant roles in cellular functions 
and P. aeruginosa virulence mechanisms, little is known about how their concentrations 
vary and direct cellular behavior over time. Here, we demonstrate use of T-CUAs for the 
sensitive, continual, real-time, electrochemical monitoring of phenazine metabolites 
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secreted from wild type P. aeruginosa strain (PA14), over a 48-hour period. Our results 
show an increase in electrochemical current responses for PYO in the first 21 h, after 
which the cells secrete similar levels of PYO. At intermediate stages of growth, we also 
observe an increase in production of 5-MCA, an extremely reactive phenazine species37 
and a precursor to PYO.38 Additionally, the metabolism dynamics in different growth 
media are quite distinct, which is reflective of the heavy influence of various broth 
components. Therefore, distinctive PYO concentration fluctuations at different time 
points are observed. In addition to changes in current responses of PYO, we observed 
dynamic changes in the detection of 5-MCA. While the electrochemical signature of 5-
MCA has been previously detected from wild type and mutant PA14 strains, its identity 
has only been speculated due to its reactive nature.22,23,39 Here, we used nano-electrospray 
ionization tandem mass spectrometry (nano-ESI MS/MS) to confirm its detection and 
identity. Additionally, we performed desorption electrospray ionization mass 
spectrometry imaging (DESI-MSI) in tandem with electrochemical measurements at 
various time points, which show correlations between levels of cellular PYO. 
3.2 EXPERIMENTAL METHODS 
3.2.1 General 
All chemicals were used as received. Photoresist AZ 1518 was purchased from 
Microchemicals.  Polystyrene spheres (Polybead®) with a diameter of 1.54 µm were 
purchased from Polysciences, Inc. Pyocyanin (PYO) was purchased from Cayman 
Chemical Company. Ethanol and Lysogeny Broth (LB) Lennox were purchased from 
Thermo Fisher Scientific Inc. Acetone, 2-Propanol, and Carbenicillin Sodium Salt, were 
acquired from Sigma-Aldrich Co.  Bacto Tryptic Soy Broth (TSB) and Tryptic Soy Agar 
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(TSA) were purchased from Becton, Dickinson, and Company and from Remel, 
respectively. 
3.2.2 Cell Culture and Optical Density 
Wild-type Pseudomonas aeruginosa strain PA14 was used, carrying pMRP9-1, a 
constitutive green fluorescent protein (GFP) expressing plasmid. PA14 was cultured from 
a freezer stock on TSA plates containing 10 µg/mL carbenicillin sodium salt (carb10) to 
maintain the plasmid. Using PA14 cells initially grown on TSA agar plates, overnight 
liquid cultures were prepared by inoculating 75 cm2 tissue culture flasks with vented caps 
filled to a volume of 75 mL with LB and TSB, respectively, using sterile wooden dowels. 
These samples were left to shake in a 37 °C incubator for 18 h at 150 rpm. The optical 
densities (ODs) of these solutions were then determined using an Agilent Instrument 
8453 UV–vis–NIR spectrophotometer by recording the absorbance at 600 nm.  These 
samples were subsequently diluted into 250 mL Erlenmeyer flasks to achieve an OD of 
0.15 at 600 nm with a volume of 125 mL with TSB and LB, respectively. Cell cultures 
were shaken for another 2 h at 37 °C to achieve exponential phase, which is indicated as 
t=0 h. OD measurements were performed alongside electrochemical square wave 
voltammetry (SWV) measurements for 48 h starting at 0 h. All ODs were set to standard 
method at 600 nm. Blanks were taken using either TSB or LB and for each of the two 
cultures, three cuvettes were sampled from the main flask at each time point against the 
appropriate blank. Flasks were removed from the 37 °C shaker for only the brief time 
needed to transfer liquid culture into the cuvettes to minimize disruption of cell growth. 
Finally, pH measurements were taken at each time point using a pH electrode connected 
to a portable pH meter (VWR Scientific pH Meter Model 8005). 
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3.2.3 Fabrication of T-CUA Electrodes 
Preparation of transparent carbon ultramicroelectrode arrays (T-CUAs) follows 
previously described procedures.24–27 Quartz microscopic slides (6.45 cm2 and 1 mm 
thick, Technical Glass Products) were treated with piranha (3:1 H2SO4: 30% H2O2) to 
remove any organic contaminants. A 1:3 dilution of AZ 1518 photoresist with PGMEA 
(1-methoxy-1-propanol acetate) was spun onto the piranha cleaned quartz slides at 6000 
rpm for 60 s. Following spin coating, the photoresist slides were soft baked at 90 °C for 
10 min and then transferred to a tube furnace. After 15 min of purging with 5% H2: 95% 
N2 (~100 mL/min), the photoresist slides were pyrolized by heating to 1000 °C at 5 
°C/min and holding at that temp for 1 h before allowing them to cool slowly back to 
room temperature at 5°C/min. The pyrolized photoresist film (PPF) slides were then 
removed from the furnace and stored for 3 days prior to use to allow for the oxide layer to 
stabilize. T-CUAs fabrication involved a lithography method using polystyrene 
microspheres (PSS) with a diameter of 1.54 µm, which were drop cast from a 5.4 wt % 
methanol suspension onto the conductive PPF electrodes. The organization of the spheres 
is that of a hexagonal close-packed two-dimensional ordered network. After this 
microsphere lithography step, 10 nm of Al2O3 layer was deposited via atomic layer 
deposition (ALD) technique at 80 °C. The ALD process was calibrated by the 
manufacturer (Cambridge Nanotech Savannah 100) to deposit 0.089 nm conformal Al2O3 
layer per cycle. Thus, cycling this process for 112 times formed a 10 nm ALD layer. This 
ALD step is then followed by removal of PSS via sonication with methanol, acetone, 
isopropanol and water. Disk-shaped carbon areas remained where the PSS made contact 
with the PPF, thus forming a carbon ultramicroelectrode array. Details on 
characterization of T-CUA electrodes have been reported in previous research studies 
from our group.24–27  
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3.2.4 Preparation of Standard Pyocyanin Solutions 
For calibration curves of PYO in TSB and LB, a 2 mM PYO stock solution was 
prepared in ethanol and was then diluted to make a 500 µM stock solution in either TSB 
or LB broth.  From the 500 µM stock solution respective PYO standard solutions were 
prepared to have the following concentrations: 1 µM, 5 µM, 10 µM, 25 µM, 50 µM, 75 
µM, 100 µM, 150 µM and 250 µM, in either LB or TSB. 
3.2.5 Electrochemical Measurements 
Electrochemical measurements were performed using a three-electrode cell 
system. Electrochemical experiments including square wave voltammetry (SWV) and 
cyclic voltammetry (CV) were performed using an Autolab PGSTAT30 potentiostat. T-
CUA was used as the working electrode with a total geometric area of 0.495 cm2, defined 
by the electrode area exposed to a solution in a homemade Teflon electrochemical well. 
A gold wire electrode was used as the counter electrode and saturated calomel electrode 
(SCE) was used as the reference electrode. SWV measurements were performed using a 
current sensitivity of 5 µA, 3 mV step potential and a frequency of 15 Hz.  The potential 
window ranged from –0.7 to 0.0 V vs SCE. CVs were carried at scan rates of 25, 50 and 
100 mV s-1 to check for PYO polymerization on T-CUA.  The background solutions used 
were TSB and LB. After a background SWV or CV curve was collected using a total of 
20 scans, subsequent PYO measurements were obtained. For the real-time 
electrochemical detection of PYO from PA14 in LB and TSB growth media, all liquid-
batch cell samples were incubated at 37 °C and shaken at 150 rpm for the duration of the 
experiments (48 h). For each electrochemical measurement, 800 µL of each liquid culture 
were placed onto T-CUA electrodes to immediately perform SWV measurement, 
detecting PYO from P. aeruginosa at different time points. For the first 12 h of 
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experiments, SWV measurements were taken every hour, followed by every three hours 
until 24 h, and finally followed by every six hours until 48 h of bacterial growth. 
3.2.6 Mass Spectrometry for Identification of 5-methylphenazine-1-cabocylic acid 
(5-MCA) 
Mass spectrometry (MS) analysis was used to confirm identity of 5-MCA 
phenazine species. Samples were prepared from PA14 cell cultures in LB and TSB grown 
to 6 hr. At 6 h, 1 mL of each cell culture, in LB and TSB, was placed in a centrifuge tube 
equipped with 0.2 µm pore filters to separate cells from growth media. Electrochemical 
measurements, as described previously, were carried using the growth media separated 
from cells to confirm the presence of PYO and 5-MCA in samples before MS analysis. 
Samples were then infused into a Thermo Scientific Velos Pro dual linear ion trap mass 
spectrometer (San Jose, CA) via a pulled borosilicate glass emitter coated in Au/Pd with 
an outer diameter of 1.2 mm and a tip of less than 1 µm in diameter. A source voltage of 
1.2 kV (both in the positive and negative polarity) was applied and the capillary 
temperature was held at 275 °C for optimal spray stability. To further characterize the 
sample, tandem mass spectrometry (MS/MS) was performed on the precursor ion to 
confidently assign structure. Collisional-induced dissociation (CID) was performed with 
normalized collision energy (NCE) of 20-30% with a q-value of 0.25 and an isolation 
width of 1.5 m/z. A maximum ion injection time of 100 ms was utilized and the 
automated gain control (AGC) target for the MS2 experiments was held at 1 x 104. 
3.2.7 Desorption Ionization Mass Spectrometry Imaging (DESI-MSI) 
For DESI-MSI experiments, a 20 µL drop of bacterial growth broth was allowed 
to dry on air for about an hour. Media and cell aliquots (10-20 µL) were deposited onto 
well microscope slides and allowed to dry for 50 to 90 minutes in the fume hood prior to 
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analysis. Note that drying time was dependent on sample volume. Cells grown in LB and 
TSB media were analyzed at various different growth times. A 2D Omni Spray (Prosolia 
Inc.) coupled to an LTQ-Orbitrap Elite was utilized for the DESI-MS imaging 
experiments. Both negative and positive ion modes were used from m/z 100 to 400, using 
a hybrid mass spectrometer that allows for tandem MS experiments using both CID and 
HCD methods, high mass accuracy (<5 ppm mass error), and high mass resolution 
(60,000 resolving power) measurements. A spatial resolution of 200 µm was used and ion 
images were assembled using Biomap software. A 1:1 (v/v) mixture of acetonitrile 
(ACN) and dimethylformamide (DMF) was used for negative ion mode analysis, at a 
flow rate of 2 µL/min. For positive ion mode analysis, pure ACN was used, at a flow rate 
of 5 µL/min. The N2 pressure was set to 185 psi. 
3.3 RESULTS AND DISCUSSION 
3.3.1 Biosynthetic Route of Phenazine Metabolites in P. aeruginosa  
The opportunistic human pathogen P. aeruginosa secretes small redox-active 
metabolites known as phenazines, which are nitrogen−containing heterocyclic 
pigments.38,40,41 These metabolites are known for their ability to engage in redox cycling 
processes in the presence of molecular oxygen and reducing agents, such as NADH and 
NADPH, causing generation of reactive oxygen species (ROS), including toxic hydrogen 
peroxide and superoxide in host organisms and tissue.38,41 Due to their small sizes and 
similar physiological properties, phenazine species facilitate electron transfer and cross 
cell membranes, transferring content from inside the cell to the extracellular 
environment.42 In addition, phenazines act as signals that regulate gene expression, 
contributing to survival of pathogenic species. In P. aeruginosa, the core biosynthetic 
genes encode various terminal-modifying enzymes, resulting in production of phenazine 
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derivatives.41 Wild type P. aeruginosa PA14 produces various phenazine derivatives, 
including phenazine-1-carboxylic acid (PCA), pyocyanin (PYO) and 5-methylphenazine-
1-carboxylic acid (5-MCA).38 Among these species, cellular PYO is essential for 
generation of disease symptoms,43 therefore, previous studies have explored its 
biosynthetic pathway.38 As shown in Figure 3.1a, the synthetic pathway begins with 
chorismic acid, which yields PCA via the phenazine biosynthetic enzymes PhzA-G. The 
following step involves the N-methylation of enzyme PhzM, which then converts PCA to 
5-MCA, a highly reactive and unstable intermediate.37 Finally, 5-MCA is converted to 
PYO by monooxygenase PhzS. The minor differences between functional groups 
surrounding the core phenazine structure have an effect on chemical properties and redox 
activity of each species (Figure 3.1b). Previous studies have made efforts in examining 
steps of this biosynthetic route, however little is known about the dynamics of the 
conversion process from PCA to PYO.44 In this study, we show the use of T-CUAs for 
simultaneous electrochemical detection of two phenazine species, 5-MCA and PYO, 
from wild type P. aeruginosa PA14 liquid-batch cultures and provide temporal evidence 













Figure 3.1: Representation of the biosynthetic P. aeruginosa phenazine pathway.  
 
(a) Biosynthesis and signaling pathway of PYO. The arrows are marked with the 
enzymes acting as catalysts for the shown conversion reactions.  (b) Redox reactions for 
PYO and 5-MCA. 
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3.3.2 T-CUAs for the Electrochemical Detection of PYO in Biologically Relevant 
Media 
Previously, we have reported T-CUAs analytical figures of merit and for PYO,27 
however, these studies were performed in a simple buffer with no growth media. While 
the direct detection of PYO in buffer solutions is significant, detection of cellular PYO in 
biologically relevant growth media is key as bacterial species are exposed to a plethora of 
compounds (e.g., sugars and proteins) that could adsorb onto the working electrode 
surface and possibly hinder the detection, identification, and quantification of certain 
metabolites of P. aeruginosa. In order to quantify secreted PYO levels from wild type 
PA14 on T-CUAs, we constructed calibration curves using square wave voltammetry and 
various PYO concentrations in two biological growth media, tryptic soy broth (TSB) and 
lysogeny broth (LB). TSB and LB are both nutritionally rich liquid media, which support 
the growth of various microbial species, in particular, common aerobic bacteria such as 
P. aeruginosa. Figure 3.2 shows background subtracted square wave current-potential 
curves for biological concentrations of PYO in TSB and LB (Figure 3.2a,b) and 
corresponding calibration curves (Figure 3.2c,d). Using standard approach 1 (SA1),45 
LODs were determined as 3σ/slope from calibration curves to be 1.0 ± 0.8 µM and 1.0 ± 
0.3 µM for PYO in TSB and LB, respectively. The LODs (Table 3.1) determined in these 
biologically relevant environments are in agreement with our previously reported LODs 
in sodium phosphate buffer,27 indicating good sensitivity and resistance to biofouling on 
T-CUA electrode surfaces that can significantly affect quantification. Additionally, our 
previously reported linear dynamic range (LDR) remains the same,27 ranging from 1–250 
µM, in both LB and TBS. This LDR is the largest compared to those of other 
electrochemical sensing platforms reported to date27 and falls within the determined 
micromolar range for PYO concentrations from in vitro cellular environments.46  
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Figure 3.2: Square wave voltammetric responses and calibration curves for PYO in TSB 





Square wave voltammetric studies (background corrected) for various concentrations of 
PYO in (a) TSB growth media, and (b) LB growth media. Corresponding calibration 
curves, shown in (c) and (d), are used to quantify concentrations of PYO secreted from P. 
aeruginosa cell cultures. 
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Biological Sample Sensitivity (nA/µM) LOD (µM) 
Tryptic soy broth (TSB) 39 ± 2 1.0 ± 0.8 
Lysogeny broth (LB) 46 ± 4 1.0 ± 0.3 
Table 3.1: PYO detection in biological growth media using T-CUAs. 
 
Different from our previous study (Chapter 2), here, we extended the potential 
window (−0.7 to 0.0 V vs SCE) for PYO detection in order to observe changes in other 
phenazine derivatives from P. aeruginosa. PYO is known to undergo a non-reversible 
phenolic oxidation, forming a polymerization product that can influence the detection and 
quantification of PYO. We have previously shown that this polymerization process can 
be avoided by reducing the potential window to −0.4 to −0.1 V vs SCE.27 Using cyclic 
voltammetry, we performed tests in both TSB and LB and successfully confirmed that no 
PYO polymerization reaction takes place in this new potential window (Figure A1.4), and 
the redox couple detected is entirely due to conversions between soluble, monomeric 
species of PYO. Additionally, we determined that it takes a total of 20 background scans, 
in both TSB and LB, to establish a consistent double layer capacitance on T-CUAs 
(Figure A1.5). Moreover, T-CUA electrode surfaces are comparable to glass, thus they 
are extremely biocompatible (Figure A1.6) and are not prone to biofouling. These results 
indicate that PYO production can be quantitatively detected, in real time, with T-CUAs in 
complex growth media of biological significance.  
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3.3.3 Real-time Electrochemical Monitoring of P. aeruginosa 
The major aim of this study was to use T-CUAs as bioanalytical sensing 
platforms for the time-based, continual electrochemical detection of cellularly derived 
phenazine metabolites from P. aeruginosa in TSB and LB growth media, monitored over 
a 48-hour period. Among these phenazine species is PYO, which is exclusively secreted 
by P. aeruginosa during early stages of infection,40 and as such it has been considered an 
effective diagnostic biomarker for infections caused by this microorganism.30 
Consequently, there has been a significant amount of research dedicated to designing 
sensors for the detection of this biogenic species of interest,4,16,17,27,47-49 however, no 
studies to date have explored how the relative concentrations of cellular PYO change at 
numerous points during a longer time-frame. The real-time, in vitro detection of PYO 
enables us to monitor P. aeruginosa virulence, thus providing fundamental information 
about pathogenic responses to environmental factors, such as levels of molecular oxygen.  
A major concern with use of electrochemical sensors is the working electrode’s 
ability to differentiate phenazine species from interferents. In this application, 
components in the growth media and cellularly derived species (e.g., glucose, NAD, 
NADH, NADP, NADPH, pyoverdine) could interfere with the sensor’s response in 
potential window where phenazine redox peaks are observed. Previous research showed 
that these common interferents have positive redox potentials,4 which fall outside of the 
potential window used. Additionally we tested 100 µM solutions of glucose, gluconic 
acid, NADH, NAD, NADP, NADPH, and H2O2 in LB, which confirmed that these 
interferents do not show redox activity in potential range (−0.7 to 0.0 V vs SCE). Our 
results in Figure 3.3 demonstrate that the notable electroactive peaks result from 
phenazine metabolites, which we confirm with mass spectrometry analyses.  
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Figure 3.3: Time-dependent square wave voltammetric studies conducted for 0–48 h in 
(a) LB growth media and (b) TSB growth media. The peak at −0.256 V vs 
SCE is due to PYO oxidation, while the emerging peak at a more positive 
potential (−0.115 V vs SCE) is due to 5-MCA phenazine oxidation. 
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Liquid-batch cultures of wild type P. aeruginosa PA14 in TSB and LB were 
grown at 37 °C and 150 rpm over the course of two days, during which concentrations of 
cellular PYO were monitored (Figure 3.3). Using square wave voltammetry, the 
production of PYO was monitored directly from bacterial cultures every hour during the 
first 12 h of bacterial growth, then every three hours for the next 12 h, followed by every 
six hours until 48 h. The data were analyzed using background-subtraction (background 
was either TSB or LB) to determine the concentration of PYO in each growth media 
(Figure 3.2b, Table S1) using the respective calibration curves (Figure 3.2). The redox-
active peak around −0.256 V vs SCE identifies the presence of PYO (Figure 3.3, Figure 
3.1). To demonstrate reproducibility, real-time electrochemical measurements of 
cellularly derived PYO were made a total of nine times in each growth media, thus error 
bars reported represent standard deviation between nine samples (Figure 3.4). Contrary to 
other carbon electrodes, which require the use of a fresh electrode for each measurement, 
T-CUAs can be reused for numerous measurements. Note that for each 48-hour 
electrochemical measurement, the same T-CUA sensor was used to constantly monitor 
cellular PYO for the entire duration of each experiment. Additionally, T-CUAs utilized in 
48-hour tests can be successfully used again because the SWV background current 
responses are nearly identical pre- and post-48-hr studies (Figure A1.5). 
While performing electrochemical detection, we also acquired optical density 
measurements (absorbance at 600 nm) of samples to monitor growth stages of bacteria in 
TSB and LB. Figure 3.4a shows the bacterial growth curves during the 48-h period, 
which have a fairly sigmoidal character. Briefly, during the first 4 hours (0–3 h), bacteria 
are in exponential phase, followed by the stationary phase where the curves start to 
plateau. During the stationary phase, the number of viable bacteria remains unchanged, 
which means that the rate of bacterial growth equals the rate of bacterial death. Bacteria 
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grown in LB media show marginally higher optical densities compared to those in TSB 
for the first 12 h, after which optical densities of cells in TSB are higher than those in LB. 
Figure 3.3 displays resulting square wave voltammetry current–potential 
responses as a function of time. The determined PYO concentrations at different time 
points in both TSB and LB are summarized in Table A1.1. During the exponential phase 
of bacterial growth (0–3 h), the concentrations of PYO remain fairly constant. During this 
growth phase, concentrations secreted in LB media are almost twice as high compared to 
TSB. Once in stationary phase, PA14 start producing higher levels of PYO, which 
increase over time until 21 h, after which PYO levels slightly decrease and plateau in 
both media. At 21 h, PA14 strains produce maximum PYO concentrations of 190 ± 5 µM 
and 150 ± 1 µM in TSB and LB, respectively. Note that from 4–12 h, there is not a 
significant difference in PYO concentrations when comparing TSB and LB media. Yet 
after 15 h, PYO concentrations in TSB are approximately 1.3 times higher than those in 
LB (Figure 3.4b, Table A1.1). These differences are likely the result of distinctive 
composition of media (Figure A1.8, Table A1.3, Table A1.4) and changes in phenazine 
production dynamics, which is discussed in detail in the next sections. These results show 
an increase in PYO production rates in two media during the first 21 h, which is likely 
due to increased intercellular communication during the exponential phase of bacterial 
growth. After 21 h, PYO levels slightly decrease, indicating a decrease in virulence factor 
production after prolonged growth in the stationary phase.  
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Figure 3.4: Time-dependent optical densities, PYO concentrations, and 5-MCA/PYO 
Dynamics. 
(a) P. aeruginosa optical density at 600 nm (OD600) determined over time in TSB and 
LB media. (b) PYO concentrations secreted from cells P. aeruginosa over time in TSB 
and LB media. (c) Phenazine synthesis kinetics between PYO and 5-MCA as a function 
of time in TSB and LB. Error bars are plotted to represent standard deviation between 
nine samples. 
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PYO from P. aeruginosa liquid cultures shows its electrochemical fingerprint 
around −0.256 V vs SCE, but when bacteria enter stationary phase, we observe the 
appearance of an additional redox peak at a more positive potential of −0.115 V vs SCE 
(Figure 3.3).  A few previous studies22,23,39 have attributed redox activity at this potential 
to production of 5-MCA (Figure 3.1), a highly reactive phenazine that is a precursor to 
PYO in the biosynthetic pathway (Figure 3.1). While a previous electrochemical study 
has speculated on the detection of 5-MCA,22 that earlier study was not able to confirm its 
identity due to its extremely unstable nature. In these studies, nano-ESI MS/MS was used 
to corroborate the identity of this P. aeruginosa reactive intermediate, which is further 
elaborated on in a subsequent subsection.  
Square wave voltammograms in Figure 3.3 at later time points show that the PYO 
redox peak shifts slightly to more negative potentials (Figure A1.3a), likely due to 
increasing pH values in growth media.50 To demonstrate this, time-based pH readings 
were recorded, showing an increase in pH over time (Figure A1.3). The resulting peak 
potential shifts were plotted as a function of pH, showing that the pH dependence of PYO 
is almost completely Nernstian (Figure A1.3) and shift by ~60 mV per pH unit change.   
3.3.4 Biosynthetic Route of Phenazine Metabolites in P. aeruginosa  
In addition to quantifying the concentration of cellular PYO, the dynamics of 
phenazine biosynthesis was monitored in a time-based fashion, which enabled the 
detection of reactive intermediates. The results shown in Figure 3.3 demonstrate 
noteworthy differences in 5-MCA production, suggesting variations in the dynamics of 
biosynthesis processes, which appear to be dependent on growth media that has not 
heretofore been observed nor reported in quantitative detail. Initially, when P. aeruginosa 
are in exponential phase (0–3 h), 5-MCA cannot be detected in either media. Yet once the 
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cells enter stationary phase, the production of 5-MCA increases, then decreases after 12 
h. 5-MCA is no longer detected after 21 h, indicating that PA14 no longer produces this 
metabolite or that some other process leads to rapid diminishment such as cross reaction 
with oxygen. These data show that initially there is a build-up of 5-MCA, which later 
decreases. This is likely associated with environmental factors, suggesting that cells 
might be O2-starved.   
The square wave voltammetric currents for 5-MCA in TSB are higher compared 
to LB (Figure 3.3). Additionally, at various time points (5–11 h), 5-MCA concentrations 
are higher than those of PYO in TSB, which is not the case in LB. To better illustrate 
differences between the two media, a plot of the ratio of peak currents between 5-MCA to 
PYO was constructed as a function of time, which assuming equal diffusion coefficients 
(Table A1.2), is equal to the ratio of concentrations (Figure 3.4c). The ratio of currents of 
5-MCA to PYO is an important parameter, relating to kinetics, as the standard 
heterogeneous electron transfer rate constant is a function of current ratio and frequency 
in square wave voltammetry.51,52 The ratio of 5-MCA to PYO peak currents in TSB is 
significantly higher relative to LB, which suggests that the media composition influences 
the dynamics of phenazine synthesis. Consequently, the difference in dynamics between 
two growth environments likely contributes to the variance in PYO production rates and 
determined concentrations (Figure 3.4b, Table A1.1).   
The two growth media used in this study are known to be composed of different 
peptides, casein peptones, various vitamins, minerals and trace elements such as N, S, 
and Mg. To better understand the differences in media composition, DESI MS/MS 
analyses were performed. A detailed summary of identified species from acquired mass 
spectra is provided in supporting information (Figure A1.8, Table A1.3, A1.4), which 
shows the presence of small species such as peptides and amino acids. In the positive ion 
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mode, choline (m/z 104.107) was detected at a higher relative abundance in TSB 
compared to LB. Choline is a water-soluble vitamin, which bacteria consume as a 
nutrient to produce toxins. In the negative ion mode, a higher relative abundance of 
deprotonated and chlorinated hexose species (simple six-carbon sugars, such as glucose) 
was detected in TSB compared to LB. These differences in media composition, such as 
the higher abundance of choline and hexose species in TSB relative to LB, might be 
catalyzing the production of higher levels of 5-MCA, and consequently higher amounts 
of PYO at later stages of bacterial growth. A previous research study has shown that the 
nutrient sources, in particular, carbon sources, have a significant effect on PYO 
production rates.28,53 Supplementary DESI-MS experiments performed at various time 
points of cell growth (3, 21 and 48 h) in TSB media provided the detection of hexose 
(glucose), hexonic acid (gluconic acid) and keto-hexonic acid (keto-gluconic acid). These 
results suggest that P. aeruginosa metabolizes glucose to gluconic and keto-gluconic 
acids. Interestingly, these species were also detected in LB media, but at lower relative 
abundances. Figure A1.7 shows that as growth time increases, the abundance of hexose 
species and ratios of gluconic acid to keto-gluconic acid decrease over time. These 
differences in media composition observed from DESI-MS data can aid in understanding 
the distinct dynamics of 5-MCA and PYO in LB and TSB. Finally, PYO levels secreted 
from P. aeruginosa cultures appear to depend on several parameters, such as nutrient 
availability, temperature, and oxygenation of cultures. 
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Figure 3.5: Stability and identification of 5-MCA phenazine species.  
 
 
Square wave voltammograms showing 5-MCA’s highly reactive nature after 1 hour of air 
(O2) exposure in (a) LB and (b) TSB, media. (c) nano-ESI MS/MS spectra of 5-MCA 
species in the positive ion mode (top) and negative ion mode (bottom).  
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The conversion of 5-MCA to PYO (Figure 3.1), involves NADH and molecular 
O2, thus this reaction will proceed as long as there is molecular oxygen present. To 
confirm this and examine the reactive nature of 5-MCA, we performed electroanalytical 
tests using square wave voltammetry (Figure 3.5a,b). At 5 h of bacterial growth, liquid 
cultures were centrifuged and the media supernatant was separated from P. aeruginosa 
cells. Immediately after separation, square wave voltammograms were recorded using LB 
and TSB supernatants (Figure 3.5b), both showing the presence of PYO and 5-MCA. The 
supernatant samples were then exposed to air (O2) for one hour, after which current 
responses were recorded again. The current-potential curves shown in red (Figure 3.5a,b) 
revealed that the 5-MCA peak current decreases and almost completely diminishes, while 
the PYO peaks increase. These results demonstrate that the conversion of 5-MCA to PYO 
is highly oxygen-dependent, indicating that environmental parameters comparatively 
regulate phenazine synthesis. In future studies, we plan to investigate the effects on 
phenazine dynamics with cells grown under anaerobic (O2-free) conditions, which are 
very difficult to achieve.  
Previously, Bellin and co-workers explored the effects of anaerobic conditions on 
P. aeruginosa PA14 biofilms by growing cells on nitrate, which confirmed that 
conversion of 5-MCA to PYO depends on the availability of molecular oxygen.23 
However, their reported results indicate that 5-MCA is concentrated at the edges of P. 
aeruginosa biofilm colonies, where the O2 levels would be highest,23 which contradicts 
our evidence of 5-MCA reacting quickly in presence of oxygen to generate PYO. In their 
study, researchers used an electrochemical chip with integrated electrodes arrays to detect 
phenazine metabolites,23 which may bias the time dependent analysis of spatially 
resolved results. While Bellin et al. can image phenazine signals at specific time points 
we note that this method takes on the order of approximately 5 minutes to obtain a 
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readout of all electrodes in the array.23 In contrast, our sensing platform using T-CUAs 
provides high sensitivity and very rapid response times, thus allowing us to obtain 
responses in roughly 15 seconds from all ultramicroelectrodes in the array. Additionally, 
as part of Bellin and co-workers’ sensor design, bacterial colonies are grown on agar 
membranes placed directly on top of the integrated chip,23 which raises a question about 
measuring real-time concentrations of phenazine production since transport parameters 
are not quantified. Contrary to other approaches, our method does not require the use of a 
“permselective” membrane and is demonstrated to be biologically compatible which 
should not interfere with quantitative measurements (Figure A1.5, Figure A1.6). Finally, 
compared to other carbon-based, macro-sized electrodes,4,16,39,48 T-CUAs have enhanced 
sensitivity due to their nano-scale features.24 This allows for simultaneous monitoring and 
quantification of dynamics of multiple phenazine species (Figure 3.2), which has not 
been previously demonstrated with carbon electrodes. 
3.3.5 Detection and Characterization of P. aeruginosa Phenazines 
Various mass spectrometry (MS) techniques were used to confirm the identity of 
the 5-MCA metabolite. Originally, DESI-MS at various time points was used when 5-
MCA was electrochemically observed. Since 5-MCA rapidly converts to PYO in the 
presence of O2 (Figure 3.5a,b), DESI-MSI was not a suitable technique for this analysis. 
Additionally, LC-MS with supernatant samples at 5 h of growth was employed. 
However, with this method, neither 5-MCA nor PYO was detected possibly due to the 
presence of many other interfering species in media (Figure A1.8). 
The best approach relied upon nano-ESI MS/MS by directly injecting separated 
supernatant samples into the mass spectrometer. The identity of 5-MCA was confirmed 
(Figure 3.5c) based on the observed collision-induced fragmentation pattern in both the 
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positive and negative ion modes. The mass spectrum in the negative ion mode shows the 
precursor ion of m/z 239.09; the resulting fragment ions of m/z 224.00, m/z 221.09, m/z 
195.09, and m/z 180.09 correspond to the loss of CH3, H2O, COOH, and (COOH+CH3) 
groups, respectively, thus confirming the identity of 5-MCA phenazine. To the best of 
our knowledge, for the first time, the identity of this reactive metabolite was confirmed 
directly from bacterial populations since prior electrochemistry studies were only able to 
speculate the identity of 5-MCA.22 
As previously discussed, the observed shifts in PYO peak potentials in square 
wave voltammograms with increasing pH over time follow the predicted Nerstian 
dependence upon pH. To further investigate that observed peak shift is not due to 
presence of other phenazine derivatives, in tandem with electrochemical measurements, 
DESI-MSI analyses were preformed at a number of different time points, which 
confirmed that PYO is the phenazine species present (Figure 3.6). Figure 3.6a illustrates 
mass spectrometry (MS) ion images of PYO in LB and TSB at different time stages of 
bacterial growth, showing an increase in ion abundance of m/z 211.086, identified as 
PYO, over time. During initial hours of growth, qualitative MS ion images show higher 
amounts of PYO in LB relative to TSB, which is in agreement with trends in the 
electrochemical results (Figure 3.4b). Figure 3.6b includes a DESI MS/MS spectrum of 
PYO. Fragment ions at m/z 196.063, m/z 183.092, and m/z 168.068 correspond to loss of 
CH3, CO and (CH3+CO) groups, respectively. Figure 3.6c displays representative mass 
spectra of LB and TSB media only compared to LB and TSB media with cells present. 
The mass spectra obtained from cell samples were mostly characterized by high relative 
abundance of PYO, which was not detected (S/N<3) in the mass spectra of media alone. 
Other signaling molecules from P. aeruginosa detected using DESI-MS, such as 4-
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hydroxy-2-heptylquinoline (HHQ) and 2-nonyl-4-hydroxy-quinoline (NHQ), (Figure 
3.6c) are detailed in Table A1.5. 
In addition, the only other phenazine species detected, using DESI-MS, in trace 
amounts at late time points (21 h) was 1-hydroxyphenazine (OHPHZ) (Figure A1.9). 
OHPHZ is a redox-active phenazine metabolite, which is a degradation product of PYO, 
where PYO coverts to OHPHZ under basic conditions.18 Previous research has shown 
that OHPHZ oxidizes at more negative potentials than PYO.18 Note that at later time 
points (21 h) in square wave voltammograms (Figure 3.3), a small shoulder peak around 
–0.512 V vs SCE is observed, in particular in LB media, which is likely due to OHPHZ. 
However, this OHPHZ redox potential needs to be confirmed in the future using a 
commercially available OHPHZ standard. Additionally, at later stages of bacterial 
growth, the detection of a new species at a more positive potential (–0.0122 V vs SCE) is 
seen that has previously not been detected and identified. Although there are various 
species that oxidize at higher potentials, speculatively this may be a short-lived derivative 
of 5-MCA due to its high reactivity. Studies have shown that 5-MCA can undergo 
extracellular modification by free amine-compounds.54 Presently, however, the 
identification of this species remains elusive. Future work will focus on enhancing MS 
methods to enable the identification of this new metabolite or degradation species. 
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Figure 3.6: DESI-MSI of PYO at different time points – the relative abundance 
increases over time in accordance with electrochemical data.  
 
 
(a) DESI-MSI ion images at various time points from PA14 cell cultures in LB and TSB 
growth media. Initially, relative abundance of PYO is lower in TSB compared to LB, 
which is in agreement with electrochemical quantitative data. (b) DESI MS/MS spectra 
of PYO (positive ion mode). (c) DESI-MS spectra of cells + media compared to media 
only. Note that cells are secreting PYO. No other phenazine species were identified using 
this method. NL directly correlates to ion current (ion abundance). 
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Our electrochemical method comprising T-CUAs is capable of simultaneously 
sensing several redox-active phenazine metabolites from P. aeruginosa in liquid-batch 
cultures thereby enabling the in situ detection of cellular metabolites from undisturbed 
bacterial populations. Furthermore, this method is capable of quantifying the 
concentration of these species, which is presently not achievable with most MS 
techniques.55 Because our platform allows for continual, in situ sensing of cellular 
phenazine metabolites, it provides fundamental information about the metabolic 
dynamics of P. aeruginosa phenazines biosynthesis. In follow-on work T-CUAs will be 
used to characterize redox phenazines in microbial cultures and monitor their interactions 
in realistic environments. Furthermore, T-CUAs offer great promise as electrochemical 
devices in diagnostics and real-time monitoring of P. aeruginosa in healthcare settings. 
This platform provides impetus for the elucidation of the metabolite dynamics including 
detection, identification, and monitoring of infection state and quorum sensing variables 
such as oxygen availability, antibiotics and presence of additional pathogenic bacteria 
and/or host cells. 
3.4 CONCLUSIONS 
In summary, we demonstrated a quantitative, real-time sensing platform using T-
CUAs as electrochemical sensors, to detect, identify and monitor the production of 
phenazine metabolites from wild type P. aeruginosa PA14 liquid cultures in two different 
media. This study shows continual monitoring of the dynamics of P. aeruginosa 
phenazine biosynthesis by sensing not only PYO but also its highly reactive precursor, 5-
MCA. The real-time quantitative analyses show an increase of cellular concentrations of 
PYO during the first 21 h of bacterial growth, which then plateau. Using square wave 
voltammetry, we determined the maximum concentrations of cellularly secreted PYO to 
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be 190 ± 5 µM and 150 ± 1 µM TSB and LB, respectively.  Additionally, the media type 
has an effect not only on rates of PYO production but also on amount of secondary 
phenazine derivatives, which directly correlate to presence of different nutrients, media 
concentrations, and components. Furthermore, MS analysis, including nano-ESI and 
DESI-MSI, confirmed the identity of phenazine species observed in our electrochemical 
measurements. 
While previous research has focused on developing an electrochemical sensing 
device to monitor PYO, this is the first time that this approach has been used to detect, 
identify and monitor the dynamics of phenazine biosynthesis. Future work will focus on 
performing real-time electrochemical studies using P. aeruginosa strains of clinical 
relevance. Additionally, the effects on PYO production rates and phenazine dynamics in 
the presence of polymicrobial communities need to be investigated. Finally, effects on 
phenazine biosynthetic dynamics and PYO concentrations should be examined in other 
media (e.g., buffered yeast extract broth, nutrient broth, Mueller-Hinton broth, MOPS)53 
and growth environments, such as artificial cystic fibrosis sputum,56 that resemble key 
attributes of in vivo environments. 
3.5 ADDITIONAL INFROMATION 
Details on additional experimental methods, quantitatively determined pyocyanin 
concentrations from real-time electrochemical data, time-dependent square wave 
voltammograms for pyocyanin detection on T-CUAs in LB and TSB, pH and peak 
potential changes as a function of time, PYO polymerization tests, T-CUA 
biocompatibility data and images, pyocyanin diffusion coefficients, DESI-MS/MS mass 
spectra of TSB and LB media contents, DESI-MS data of cellular species detected from 
P. aeruginosa, Tables A1.1–A1.5, and Figures A1.1–A1.10 are provided in Appendix 1. 
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Chapter 4: Electrochemical Monitoring of the Impact of Polymicrobial 
Infections on Pseudomonas aeruginosa and Growth Dependent Medium4 
4.1 INTRODUCTION 
The development of severe microbial infections remains a challenge1,2 in 
healthcare facilities as immune-compromised hosts are exposed to communities of 
pathogenic bacteria.3-5 Prompt detection, identification and real-time monitoring of early 
stages of infectious diseases, such as pneumonia, invasive wounds, and bloodstream 
infections,6,7 are essential in disease prevention and determining effective treatment 
strategies. Typically, these hospital-contracted infections are populated by multiple 
microbial species, including Pseudomonas aeruginosa (Pa), Staphylococcus aureus (Sa), 
Escherichia coli (Ec), Enterococcus faecalis, and Staphylococcus epidermidis.8,9 Current 
hospital diagnosis methods involve use of cell-culturing platforms, which classify 
specimens based on growth patterns observed in different media with selective growth 
components and/or antibiotics. These approaches, however, often require several days 
before pathogen identity is known, resulting in an increased antibiotic resistance as 
patients undergo treatments with broad-spectrum antibiotics.10 As an alternative to the 
standard techniques, various electrochemical sensor platforms have been developed, 
which offer rapid identification, direct detection, and quantification of pathogenic 
signaling metabolites and byproducts.  
In previous studies, our group has reported an inexpensive, facile and adaptable 
electrochemical platform using transparent carbon ultramicroelectrode arrays (T-
                                                
4Adapted with permission from Simoska, O.; Sans, M.; Eberlin, L. S.; Shear, J. B.; Stevenson, K. J. 
Electrochemical Monitoring of the Impact of Polymicrobial Infections on Pseudomonas aeruginosa and 
Growth Dependent Medium. Biosens. Bioelectron. 2019, 142, 111538. Copyright © 2019 Elsevier. 
Simoska O. acquired the data, wrote the manuscript, and performed electrochemical 
measurements/characterization. Simoska, O. and Sans, M. performed mass spectrometry experiments. 
Simoska, O. and Stevenson, K. J. designed studies, planned experiments, and analyzed all data. All authors 
contributed in editing the manuscript. 
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CUAs).11,12 These sensors provide advantages in contrast to other electrochemical 
sensing devices, including amplified current responses, fast response times, large linear 
dynamic ranges (LDRs), high signal-to-noise (S/N) ratios and lower limits of detection 
(LODs).11-15 As their electroactive material is comparable to glassy carbon, T-CUAs are 
inert, highly conductive and extremely biocompatible. This electroanalytical platform has 
been used to rapidly detect the common opportunistic human pathogen Pa.14,15 Similar to 
other pathogens, Pa readily establishes infections in hosts with compromised immune 
systems and in those suffering from conditions, such as chronic wounds, lung infections, 
and severe burns.16-19 Using electrochemical sensors, Pa can be easily detected via the 
production of redox-active pyocyanin (PYO),14,15,20-23 which is a bacterial warfare toxin 
secreted as a secondary metabolite.23 Because it is produced uniquely by Pa during early 
infection stages,24 PYO is considered a useful electroactive biomarker indicative of 
infections caused by this pathogen.25 
Although a significant amount of research has focused on developing 
electrochemical platforms for the detection of PYO,14,20,21,26-28 this is only the end product 
of Pa phenazine biosynthetic pathway.24,29,30 PYO is synthesized through a cascade of 
complex metabolic reactions involving various genes. In addition to PYO, Pa produces 
several phenazine derivatives in this biosynthetic route, including a side product, 1-
hydroxyphenazine (OHPHZ), and a short-lived, reactive precursor, 5-methylphenazine-1-
carboxylic acid (5-MCA).30 Phenazines are small, redox-active, nitrogen-containing 
heterocyclic molecules, which engage in reduction and oxidation processes in the 
presence of molecular oxygen. Thus, they play key roles in altering metabolism, modify 
immune responses and damage host tissue.29-32 Additionally, a recent study reported that 
phenazines interact with antibiotics, thus influencing treatment of Pa infections.33 
Detection and examination of their relative quantities produced during various growth 
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stages could provide a better understanding of phenazine functions in Pa virulence 
mechanisms. 
In a recent study, described in Chapter 3 herein, we have demonstrated use of T-
CUAs for the real-time monitoring of phenazine production and metabolism dynamics 
from Pa cell cultures in simulated growth media.15 Our previous work increased 
knowledge about phenazine biosynthesis in Pa monocultures, yet a follow-on study is 
necessary to understand the impact of polymicrobial cultures on phenazine production 
and dynamics, in particular when Pa is cultured alongside other bacterial pathogens in the 
same growth environments. Microorganisms seldom live in isolation as in almost all 
environments, multiple bacterial species inhabit diverse microbial communities in which 
interactions between species shape biological activities of cellular populations.34-37 
During polymicrobial infections, cellular communication within complex cellular 
communities can alter virulence and/or host responses.8,36,38 As a prominent pathogen in 
polymicrobial infections, Pa often displays either synergistic or adversarial relationships 
with other bacteria, thus increasing disease severity.39 Therefore, Pa phenazine 
production and biosynthesis dynamics in polymicrobial environments need to be 
examined, as they represent a clinically relevant problem. Although various fluorescence 
microscopy-based methods have been employed,38,40,41 additional analytical tools are 
necessary to quantitatively study the dynamic microbe-microbe interactions, in real 
time.39,42,43 
Herein, we demonstrate use of T-CUAs for the quantitative, real-time 
electrochemical monitoring of the impact of polymicrobial communities on Pa phenazine 
production where Pa is co-cultured with other clinical pathogens, Sa and Ec, in two 
different growth media that are predominately used for such bacterial-based cell culture 
studies. Our results, during 48 h bacterial growth, show distinct differences in amounts of 
 98 
phenazine products and intermediates secreted by Pa in mono- and polymicrobial 
communities. Specifically, when Pa was co-cultured with Ec, the concentrations of 
cellular PYO were significantly reduced compared to amounts produced in monoculture 
samples, in both media. Yet when Pa was cultured alongside Sa, PYO concentrations 
were lower in only one media. These results show that the amounts of phenazine 
derivatives produced during growth depend on both various environmental factors in the 
media and presence of other microbes. These electrochemical results were confirmed by 
desorption electrospray ionization mass spectrometry (DESI-MS) imaging studies to 
determine differences in relative abundances of key growth media components and 
nutrients, and to identify other cellular metabolites produced in polymicrobial cultures.  
4.2 EXPERIMENTAL METHODS 
4.2.1 General 
All chemicals were used as received. Photoresist AZ 1518 was purchased from 
Microchemicals.  Polystyrene spheres (diameter of 1.54 µm) were purchased from 
Polysciences, Inc (Polybead®).  Lysogeny Broth (LB) Lennox and Bacto Tryptic Soy 
Broth (TSB) were acquired from Thermo Fisher Scientific Inc. and from Becton, 
Dickinson, and Company, respectively. Tryptic Soy Agar (TSA) was obtained from 
Remel. Ethanol, Acetone, 2-Propanol, Methanol, Carbenicillin Sodium Salt, and Kovac’s 
reagent for indoles were purchased from Sigma-Aldrich Co. Erythromycin was acquired 
from MP Biomedicals. 
4.2.2 Cell Culture  
The bacterial strains used for this works were the following: (1) wild-type 
Pseudomonas aeruginosa (Pa) PA14 strain carrying pMRP9-1 plasmid, constitutively 
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expressing green fluorescent protein (gfp), (2) wild-type Staphylococcus aureus (Sa) 
MN8 strain, carrying a pJY209 reported plasmid with expressing yellow fluorescent 
protein (yfp10B), and (3) wild-type Escherichia coli (Ec) MC4100 strain expressing gfp. 
Pa and Ec strains were cultured separately from freezer stock on TSA plates containing 
10 µg/mL carbenicillin sodium salt (carb10) to maintain the plasmids. Sa strain was 
cultured from freezer stock on TSA plates containing 0.5 µg/mL erythromycin to 
preserve the plasmid. Using Pa, Sa, and Ec cells initially grown on distinct TSA agar 
plates with either carb10 or erythromycin, overnight liquid-batch cultures of the three 
separate bacteria were prepared by inoculating 75 cm2 tissue culture flasks with vented 
caps filled to a volume of 75 mL with either LB or TSB media, respectively, using sterile 
wooden dowels. Prior to co-culturing, the three separate bacterial cell cultures in either 
LB or TSB were left to shake in a 37 °C incubator for 16-18 hours at 150 rpm. LB and 
TSB media contained 10 µg/mL carb10 for overnight Pa and Ec cultures and 0.5 µg/mL 
erythromycin for overnight Sa cultures. The optical densities (ODs) of overnight cell 
culture solutions were then determined using an Agilent Instrument 8453 UV–vis–NIR 
spectrophotometer by recording the absorbance at 600 nm. The three separate cell culture 
samples, in either TSB or LB, were subsequently diluted into 250 mL Erlenmeyer flasks 
with fresh growth media to achieve the same staring optical densities of 0.1 at 600 nm for 
all three liquid cultures with a volume of 125 mL with TSB and LB (without carb10 or 
erythromycin antibiotics), respectively. Separate cell cultures in fresh media were shaken 
for another 2 h at 37 °C to achieve exponential phase, which is designated as 0 h. At 0 h, 
equal volume amounts of same initial cell densities were combined in 250 mL 
Erlenmeyer flasks to obtain differing polymicrobial combinations in either LB or TSB 
media. Cell cultures of individually grown Pa in both media were tested in a previous 
study.1 For the two bacterial combination studies, Pa strain was co-cultured with either 
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Sa or Ec, in LB and TSB media. For the three bacterial combination studies, Pa was 
cultured alongside both Sa and Ec in either LB or TSB. 
4.2.3 Optical Density Measurements 
Optical density measurements at 600 nm (OD600) were determined using an 
Agilent Instrument 8453 UV–vis–NIR spectrophotometer. OD600 readings were 
performed alongside with electrochemical square wave voltammetry (SWV) 
measurements for 48 h starting at 0 h. All ODs were set to a standard method at 600 nm. 
Blank measurements were taken using either TSB or LB media and for each of the 
polymicrobial combination samples, three cuvettes were sampled from the main flask at 
each time point against the appropriate blank. Flasks were removed from the 37 °C 
shaker for only the brief time needed to transfer 1 mL liquid culture into the cuvettes to 
minimize disruption of cell growth. 
4.2.4 Fabrication of T-CUA Electrodes 
Preparation of electrode platform using transparent carbon ultramicroelectrode 
arrays (T-CUAs) follows detailed procedures described in our previous studies.11-15 
Quartz microscopic slides (6.45 cm2 and 1 mm thick, Technical Glass Products) were 
treated with piranha (3:1 H2SO4: 30% H2O2) to remove any organic contaminants. A 1:3 
dilution of AZ 1518 photoresist with PGMEA (1-methoxy-1-propanol acetate) was spun 
onto the piranha cleaned quartz slides at 6000 rpm for 60 s. Following spin coating, the 
photoresist slides were soft baked at 90 °C for 10 min and then transferred to a tube 
furnace. After 15 min of purging with 5% H2: 95% N2 (~100 mL/min), the photoresist 
slides were pyrolized by heating to 1000 °C at 5 °C/min and holding at that temp for 1 h 
before allowing them to cool slowly back to room temperature at 5°C/min. The pyrolized 
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photoresist film (PPF) slides were then removed from the furnace and stored for 3 days 
prior to use to allow for the oxide layer to stabilize. T-CUAs fabrication involved a 
lithography method using polystyrene microspheres (PSS) with a diameter of 1.54 µm, 
which were drop cast from a 5.4 wt % methanol suspension onto the conductive PPF 
electrodes. The organization of the spheres is that of a hexagonal close-packed two-
dimensional ordered network. After this microsphere lithography step, 10 nm of Al2O3 
layer was deposited via atomic layer deposition (ALD) technique at 80 °C. The ALD 
process was calibrated by the manufacturer (Cambridge Nanotech Savannah 100) to 
deposit 0.089 nm conformal Al2O3 layer per cycle. Thus, cycling this process for 112 
times formed a 10 nm ALD layer. This ALD step is then followed by removal of PSS via 
sonication with methanol, acetone, isopropanol and water. Disk-shaped carbon areas 
remained where the PSS made contact with the PPF, thus forming a carbon 
ultramicroelectrode array. Details on characterization of T-CUA electrodes have been 
reported in previous research studies from our group.11-15 
4.2.5 Pyocyanin Calibration Curves 
To quantify phenazine concentrations from Pa cells in polymicrobial 
environments, calibration curves for pyocyanin (PYO) in TSB and LB media were used, 
reported in our previous study in Chapter 3.15 
4.2.6 Electrochemical Measurements 
All electrochemical measurements were performed using an Autolab PGSTAT30 
potentiostat. Square wave voltammetry (SWV) experiments were done using a three-
electrode cell system where T-CUA was used as the working electrode, saturated calomel 
electrode (SCE) was used as the reference electrode, and a gold wire electrode was used 
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as the counter electrode. T-CUA working electrode had a 0.495 cm2 total geometric area, 
defined by the electrode area exposed to a solution in homemade Teflon or 
Polydimethylsiloxane (PDMS) electrochemical wells. SWV measurements were 
performed in a potential window ranging from –0.7 to 0.0 V vs SCE. A current sensitivity 
of 5 µA, a frequency of 15 Hz and a step potential of 3 mV were used. The background 
current responses were obtained using TSB and LB media (without bacteria) as 
background solutions. After collecting a background SWV curves with a total of 20 
scans, subsequent real-time electrochemical detection measurements of polymicrobial 
samples in LB and TSB growth media were performed. All liquid-batch polymicrobial 
samples were incubated at 37 °C and shaken at 150 rpm for the entire 48-h duration of 
the experiments. For each electrochemical measurement, 800 µL aliquots of each 
polymicrobial liquid-batch culture were placed onto T-CUA electrodes to instantly 
perform SWV tests, detecting PYO and other phenazines from Pa at different time points 
of growth. For the first 12 h of the real-time experiments, SWV measurements were taken 
every hour, followed by SWV measurements every three hours until 24 h, and lastly 
followed by every six hours until 48 h of cell growth. A single SWV measurement took 
approximately 15 s to acquire 
4.2.7 Desorption Ionization Mass Spectrometry (DESI-MS) Imaging of Metabolites 
in Polymicrobial Cultures 
For DESI-MS experiments, 20 µL aliquots of bacterial growth media (with and 
without bacteria) were placed onto well microscope slides and allowed to dry for 60 
minutes in a fume hood prior to mass spectrometry analysis. Polymicrobial cell samples 
grown in LB and TSB media were analyzed at 5 h or bacterial growth. For DESI-MS 
imaging tests, a 2D Omni Spray (Prosolia Inc.), coupled to an LTQ-Orbitrap Elite, was 
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used. Tests in both the negative and positive ion modes from m/z 100 to 400 were 
utilized, using a hybrid mass spectrometer that allows for tandem MS experiments using 
both collision-induced dissociation (CID) and high-energy collisional dissociation (HCD) 
methods, high mass accuracy (<5 ppm mass error), and high mass resolution (60,000 
resolving power) measurements. The spatial resolution used was 200 µm and ion images 
were constructed using Biomap software. For the negative ion mode analysis, a 1:1 (v/v) 
mixture of acetonitrile (ACN) and dimethylformamide (DMF) was used, at a flow rate of 
2 µL/min. Pure ACN was used for the positive ion mode analysis, at a flow rate of 5 
µL/min. The N2 pressure for analysis was set to 185 psi. 
4.2.8 Kovac’s Test for Indoles in Polymicrobial Cultures 
To qualitatively investigate the presence of indoles in polymicrobial samples 
containing Ec in LB and TSB, Kovac’s reagent was used. After 24 h growth in 37 °C 
incubator, polymicrobial samples in each media were examined by adding five drops of 
Kovac’s reagent (~0.5 mL). Polymicrobial cultures in test tubes were then gently shaken. 
Samples containing Ec in both LB and TSB media resulted in the appearance of a red-
violet-pink top layer in the cell culture tubes, thus qualitatively confirming the presence 
of indoles produced by Ec. 
4.3 RESULTS AND DISCUSSION 
4.3.1 Pa Phenazine Biosynthetic Pathway in Polymicrobial Environments 
During stationary phase, Pa strains actively produce phenazines, including 
phenazine-1-carboxylic acid (PCA), OHPHZ, 5-MCA, and PYO,44 which are 
biomolecules with key functions in microbial virulence.45,46 Due to their small sizes and 
minor structural variations,40 these highly diffusible species are extremely challenging to 
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study and identify as they undergo redox changes.25 The influence of polymicrobial 
communities on Pa phenazine production remains unclear,44 thus research addressing 
distinct quantities and ratios of phenazine products and intermediates is necessary to 
understand interactions of Pa with other co-infecting species (here, Sa and Ec).29 
Phenazines are derived from shikimic acid pathways, where PYO production begins with 
the conversion of chorismic acid to PCA. Enzyme PhzM then converts PCA to highly 
reactive 5-MCA. In the final step, monooxygenase PhzS converts 5-MCA to PYO.47 
4.3.2 Phenazines and Interferents in Polymicrobial Cultures 
A general concern with the use of electrode-based sensors for biological 
applications is the device selectivity, particularly the ability of the working electrode to 
distinguish phenazine targets from potential interferents. As they grow in distinct multi-
species environments, pathogens produce a variety of redox-active, small molecules as 
secondary metabolites.48 In this specific application, species secreted by other bacteria 
could potentially interfere with T-CUA responses in the potential window where redox 
peaks of Pa phenazines are observed. To test potential interferences, the two bacterial 
pathogens used in this study, Sa and Ec, were electrochemically examined after 24 h of 
cell growth in lysogeny broth (LB) and tryptic soy broth (TSB). The square wave 
voltammograms (SWVs) in Figure 4.1 demonstrate that the distinguishable electroactive 
peaks are due to Pa phenazine species only. Specifically, redox-active metabolites, PYO, 
5-MCA, and OHPHZ are produced by Pa in LB and TSB media at 24 h. The identities of 
these metabolites were confirmed using mass spectrometry methods in our previous study 
in Chapter 3.15 The SWVs for Sa and Ec display nearly identical current responses 
compared to background currents (LB or TSB). These results confirm that Sa and Ec do 
not produce electrochemically active species in the potential window (−0.7 to 0.0 V vs 
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SCE) used. Furthermore, current responses for Sa and Ec co-cultures in TSB and LB 
were also recorded at 24 h growth, which demonstrate that the interaction between Sa and 
Ec does not produce redox-active metabolites in the potential window used here. In 
addition to the presence of other pathogens, several growth media components (e.g., 
glucose, gluconic acid, uric acid, ascorbic acid, NADH, NADPH, NAD, NADP, H2O2) 
could have interference effects, impacting electrode responses. Previous research has 
shown that biologically relevant concentration of these common biological interferents 
have redox signatures at more positive potentials, which are outside of the potential 
widow in this study.15,21 Among phenazine metabolites, Pa secretes various other 
biological metabolites, including non-electrochemically active N-Acyl homoserine 
lactones, as well as electrochemically active species such as pyoverdine, 2-heptyl-3-
hydroxy-4-quinolone (PQS) and its immediate precursor, 2-heptyl-4-hydroxyquinoline 
(HHQ). Previous research has shown that pyoverdine, PQS and HHQ have 
electrochemical signatures at more positive potentials, which fall outside of the potential 
window used herein.49,50 Therefore, the redox peaks observed in Figure 4.1 are due to Pa 
phenazine metabolites, which were identified with mass spectrometry methods in our 
recent study.15 Thus, using an electrochemical potential window specific to Pa 
phenazines, their production rates in polymicrobial samples were monitored on T-CUAs, 
in real time. 
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Figure 4.1: Phenazine metabolites and interferences in polymicrobial samples. 
 
Square wave voltammograms of bacterial cultures at 24 h of growth in (a) LB and (b) 
TSB. The redox peaks around –0.256 V vs SCE result from PYO present in Pa liquid-
batch cultures. No interfering redox active peaks are observed from Sa and Ec cultures in 
the working potential window. 
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4.3.3 Real-time Electrochemical Detection and Quantification of Pa Phenazines in 
Polymicrobial Cultures 
Real-time, continual electrochemical monitoring, over 48 h, was performed to 
study the effect of polymicrobial communities’ dynamics on phenazine production in two 
different media. Combinations of Pa co-cultured together with (1) Sa, (2) Ec or (3) both 
Sa and Ec, were prepared in either LB or TSB media to examine how other bacteria 
impact phenazine biosynthesis production in polymicrobial cultures. To start cell growth, 
individually grown liquid-batch cultures of Pa, Sa and Ec were diluted into fresh media 
to achieve identical initial optical densities. Polymicrobial samples were incubated at 37 
°C and shaken at 150 rpm for a 48-h period, during which optical density (absorbance at 
600 nm) measurements were performed to monitor growth stages in LB and TSB. Figure 
4.2 shows fairly sigmoidal growth curves for mono- and poly-microbial samples in LB 
and TSB. The initial 4 h (0-3 h) represent the exponential phase, after which bacteria 
enter the stationary stage, as indicated by the resulting plateau in the growth curves. 
During the stationary phase, population size remains the same since the rate of cell 
growth equals the rate of cell death. When grown individually, Pa cells initially show 
higher optical densities in LB media than TSB, however, after 12 h, optical 
measurements are higher in TSB relative to LB. When Pa was co-cultured with Sa in LB, 
the time-dependent optical densities are marginally higher compared to Pa monoculture 
sample (Figure 4.2a), indicating the presence of another bacterial species. Similarly, the 
polymicrobial combination samples with Ec in LB show optical densities higher than 
those for Pa only and Sa sample. These higher doubling rates in combination samples 
containing Ec are likely a result of Ec growing faster than Sa and Pa.43 On the other 
hand, all three polymicrobial combinations in TSB display higher optical densities than 
the control Pa monoculture at nearly all time points. These results suggest that media also 
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has an effect on bacterial growth rates as some bacteria might outgrow others in 
competing for resources and nutrients.51 Although these optical density measurements 
show differences between mono- and poly-microbial samples in two media, this method 
provides no information about quantities of phenazine metabolites produced during 
different growth stages.   
Therefore, in tandem with optical density, electrochemical measurements, using 
SWV, were performed in a time-based fashion to simultaneously detect various 
phenazines, including PYO, 5-MCA, OHPHZ, and an unknown derivative, in 
polymicrobial environments (Figure 4.3). Specifically, phenazine production was 
monitored directly from different polymicrobial samples every hour during the initial 12 
h, followed by every three hours until 24 h, then every six hours till 48 h. To quantify 
concentrations of cellular metabolites in polymicrobial samples in LB and TSB, the data 
were analyzed using background current subtraction and previously constructed 
calibration curves.15 In this study, real-time electrochemical measurements of cellular 
PYO and 5-MCA in polymicrobial cell cultures were performed six times in each media 
to validate high reproducibility. Thus, error bars (Figure 4.4) represent the standard 
deviation between the six replicates.  Figure 4.3 shows the resulting SWVs for different 
cell combination samples in LB and TSB, where the current-potential responses are 
plotted as a function of time. In previous research, mass spectrometry methods, including 
DESI-MS and nano-electrospray ionization (nano-ESI), were used to confirm the 
identities of phenazine metabolites observed in our electrochemical data.15 Specifically, 
cellular PYO has a redox-active peak at −0.256 V vs SCE while highly reactive 5-MCA 
shows its electrochemical fingerprint at −0.115 V vs SCE (Figure 4.3). Additionally, the 
shoulder peak observed at a more negative potential (−0.512 V vs SCE) after 21 h, is 
corroborated by OHPHZ, a degradation, side product of PYO.15,52 Finally, in certain 
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samples, an unknown species is detected at a more positive potential of −0.0112 V vs 
SCE at later stages of growth. Unfortunately, the identity of this species remains elusive, 
but it is suspected to be a highly unstable 5-MCA derivative or a degradation species. 
Presently, this metabolite can only be detected using our electrochemical T-CUA 
platform, however, MS methods need optimization to enable its identification. The 
marginal shifts in PYO redox peaks in SWVs (Figure 4.3) are due to increasing pH 
values in liquid-batch cultures in the two media.15,53 
The SWV responses in Figure 4.3 show the temporal changes in phenazine 
dynamics in the different microbial samples in LB and TSB. When Pa is individually 
cultured, concentrations of cellular PYO do not change significantly in both broths during 
the exponential growth phase (0–3 h). Initially, PYO concentrations in LB are 
approximately two times higher compared to those in TSB for Pa cultures. In the 
stationary phase, Pa cells produce increasing amounts of PYO until 21 h, after which 
PYO concentrations decrease and plateau in LB and TSB as observed in the resulting 
current responses. While PYO levels do not significantly differ between LB and TSB 
during 4–12 h, PYO amounts in TSB are 1.3 times higher than in LB broth after 15 h 
(Figure 4.3a–b, Table A2.1–A2.2). During 21 h growth, increasing PYO production rates 
correlate to increased intercellular communication.15,33 Extended growth in the stationary 
stage results in a decrease in production of virulence factors. The time-dependent SWVs 
show different current responses when additional pathogens are cultured with Pa in LB 
and TSB. When co-cultured with Sa in LB, Pa produces PYO amounts that are twice 
lower than those in Pa sample during 0–12 h. After 15 h, levels of cellular PYO in Pa 
and Sa combination sample in LB are similar to those in Pa alone (Figure 4.3b). On the 
other hand, when grown with Ec, Pa produces PYO concentrations that are two times 
lower compared to Pa only, at all time points of growth (Figure 4.3c). For samples 
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comprised of all three microorganisms in LB, PYO concentrations are approximately 
five-fold lower, on average, relative to individual Pa culture (Figure 4.3d). These results, 
summarized in Figure 4.4a, show the determined PYO concentrations as a function of 
growth time in polymicrobial samples in LB. Similarly to LB, the presence of Sa and Ec 
changes phenazine production rates in TSB. PYO concentrations decrease nearly four 
times when Pa is co-cultured with Sa in TBS (Figure 4.3f). The presence of Ec in TBS 
significantly reduces phenazine production (Figure 4.3g–h) resulting in notably smaller 
quantities of PYO. These quantitative results, summarized in Figure 4.4b, illustrate PYO 
concentrations at different time points of growth for polymicrobial combinations in TSB. 
The concentrations of PYO produced by Pa in polymicrobial samples in LB and TSB are 
outlined in Tables A2.1–A2.2 in the supplementary information. For individual Pa 
cultures, the maximum PYO concentrations were determined to be 150 ± 1 µM and 190 ± 
5 µM in LB and TSB, respectively, at 21 h. For polymicrobial samples in LB, Pa 
produces maximum PYO concentrations of 150 ± 1 µM in Pa and Sa, 72 ± 1 µM in Pa 
and Ec, and 28 ± 1 µM in Pa, Sa and Ec sample at 21 h growth. When cultured together 
with Sa in TSB, Pa produces 78 ± 2 µM as the highest PYO concentration (at 21 h). The 
maximum concentration of PYO for Pa and Ec sample in TSB was 9.3 ± 0.2 µM at 21 h. 
At 48 h, Pa produced a maximum PYO concentration of 8.2 ± 0.5 µM in the 







Figure 4.2: Optical density of polymicrobial co-cultures at various time points of 
growth in LB and TSB broth. 
Optical density measurements at 600 nm (OD600) of polymicrobial co-cultures 
determined at various time points of growth in (a) LB and (b) TSB broth. Error bars 
represent the standard deviation between six samples. 
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These results demonstrate that in addition to other bacterial pathogens, the media 
composition largely impacts phenazine production rates. Briefly, the presence of Sa does 
not have a large effect on Pa phenazine production in LB (Figure 4.4a). The ability of 
PYO to inhibit Sa growth has been reported,54 which might result in preferential growth 
of Pa. A previous study has shown that Sa promotes growth and increased aggregation of 
Pa, thus suggesting that these two pathogens can co-exist and interact in a beneficial 
manner.55 Additionally, research has demonstrated Pa to be the dominant growing 
species when co-cultured with Sa.34 These reports on microbial interactions potentially 
explain why PYO concentrations are marginally higher when Pa is grown with Sa in LB. 
However, this is not observed for Pa and Sa sample in TSB, suggesting the phenazine 
production rates greatly depend on media composition. When Pa is co-cultured together 
with Sa in TSB, a decrease in PYO concentrations of approximately 60% is observed 
(Figure 4.4b). Unlike in LB, Pa and Sa likely engage in competitive behaviors for various 
nutrients in TSB. The presence of Ec influences phenazine production in both media. 
Specifically, PYO amounts are approximately 50% lower in Pa and Ec sample compared 
to Pa sample in LB (Figure 4.4a). Furthermore, Ec considerably slows down phenazine 
production in TSB, as noted by approximately 95% lower PYO concentrations compared 
to amounts produced in Pa monocultures (Figure 4.4b).  A previous study has shown Ec 
to not only dominate co-cultures but also hinder Pa growth in both nutrient-limited and 
enriched conditions,56 resulting in smaller amounts of Pa cells compared to 
monocultures. Additionally, research has shown Ec to dominate multi-species 
environments, in particular, when co-cultured with either Pa or Sa,34 suggesting that Ec 
consumes nutrients at a fast pace. In addition, Ec might produce unique cellular signaling 
molecules that can directly impact Pa phenazine production, which is discussed in 
subsequent discussion sections.  
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Figure 4.3: Real-time electrochemical monitoring of Pa phenazine production in 
polymicrobial environments  
Time-dependent square wave voltammograms recorded for 0–48 h for (a) Pa, (b) Pa and 
Sa, (c) Pa and Ec, and (d) Pa, Sa and Ec in LB media, and (e) Pa, (f) Pa and Sa, (g) Pa 
and Ec, and (h) Pa, Sa and Ec in TSB media. The redox peak at –0.256 V vs SCE 
corresponds to PYO, while the emerging peak at a more positive potential (–0.115 V vs 
SCE) is due to  5-MCA.  The identity of electroactive peaks at a more positive potential 
than 5-MCA observed in some bacterial cultures remains elusive, however, it might be a 
reactive derivative species of 5-MCA. Shoulder peaks observed at –0.5 V vs SCE are 
related to PYO side product, 1-hydroxyphenazine. 
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Previously, Santiveri and co-workers studied PYO production in various 
polymicrobial cultures in different media using another electrochemical approach.57 Their 
reported results showed that the presence of additional pathogens in growth media did not 
affect the relative rates of PYO produced by Pa,57 which contradicts our evidence. In 
their study, to detect and quantify PYO concentrations, researchers used a carbon, macro-
size working electrode (3 mm diameter), which might not have the sensitivity, large 
linear dynamic ranges, and rapid response times necessary to appropriately distinguish 
differences in production rates not only for PYO, but also for intermediate species in 
polymicrobial environments. In contrast to their electrochemical platform, requiring the 
use of a fresh electrode for each new time-based measurement, we have shown that T-
CUAs are continually used for measurements for the entire duration of 48-h 
experiments.15  
4.3.4 Dynamics of Phenazine Production in Polymicrobial Environments 
Along with electrochemical quantification of PYO concentrations in 
polymicrobial co-cultures, dynamics of the phenazine biosynthetic pathway was 
monitored. The current-potential responses in Figure 4.3 display remarkable distinctions 
in production rates of 5-MCA in polymicrobial samples in LB and TSB. These data 
demonstrate dissimilarities in dynamics of phenazine biosynthesis processes, suggesting a 
dependence on environmental factors, including other pathogens and media type, which 
have to date not been observed nor reported in a quantitative manner.  
In LB, highly reactive 5-MCA cannot be detected during the exponential phase in 
any of the cell cultures (Figure 4.3a–d). During intermediate growth stages, 5-MCA 
production increases corroborated by increasing current responses. The time points where 
5-MCA is no longer detected differ between mono- and poly-microbial combination 
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samples in LB. At later stages of growth, Pa no longer produces 5-MCA, likely due to a 
process leading to fast diminishment (e.g., reaction with oxygen). While there is an initial 
buildup of 5-MCA, current responses for this intermediate later decrease, which might be 
associated with factors in growth environments. Comparing polymicrobial samples in 
LB, the lowest 5-MCA current responses are observed in Pa and Ec sample (Figure 4.3c). 
Similar to these results in LB, 5-MCA does not display redox peaks during the first 4 h of 
growth in TSB (Figure 4.3e–h). Yet, once bacteria enter stationary growth phase, 5-MCA 
production rates increase in some cell cultures. In TSB-grown samples containing Ec, 5-
MCA current responses are extremely small, particularly in the combinatorial sample 
containing all three pathogens (Figure 4.3h). Furthermore, the SWV responses for 5-
MCA differ based on media type, where in some cases 5-MCA amounts are higher in 
TSB compared to LB. Additionally, OHPHZ responses are significantly higher in various 
polymicrobial samples, specifically those with Ec, suggesting increased rates of PYO 
decomposition in these environmental conditions. Thus, these data illustrate that both the 
dynamics of polymicrobial co-cultures and media composition influence the rates of 
phenazine production.  
To illustrate the dynamics of phenazine production between polymicrobial 
samples in two media, the ratios of peak currents of 5-MCA to PYO were plotted as a 
function of time (Figure 4.5). Theoretically, assuming both metabolites have equal 
diffusion coefficients, the peak current ratio should be in proportion to the concentration 
ratio of 5-MCA to PYO. The 5-MCA/PYO current ratio is a significant parameter that 
reflects the standard rate constant of heterogeneous electron transfer.58,59 For Pa samples, 
5-MCA to PYO peak current ratio is higher in TSB relative to LB, indicating that media 
components impact phenazine biosynthesis. Comparing co-culture samples in LB, 5-
MCA to PYO current ratio is approximately two and one half times lower when Pa is co-
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cultured with Ec (Figure 4.5a). On the other hand, polymicrobial samples in TSB display 
5-MCA/PYO peak current ratios that are nearly three times lower in polymicrobial 
samples with Ec (Figure 4.5b). Thus, variations in phenazine dynamics between 
polymicrobial samples in LB and TSB are observed, which contribute to different 
production rates (Figure 4.4). 
Using 5-MCA to PYO peak current ratios, the concentrations of 5-MCA were 
determined for mono- and poly-microbial samples in LB and TSB, which are 
summarized in Tables A2.3–A2.4 in the supplementary information. When grown 
individually, Pa produces a maximum 5-MCA concentration of 78 ± 5 µM and 220 ± 2 
µM in LB and TSB (at 9 h), respectively. For polymicrobial combinations in LB, Pa 
produces the greatest 5-MCA concentration of 56 ± 3 µM in Pa and Sa (at 12 h), 9.9 ± 
0.4 µM in Pa and Ec (at 11 h), and 12 ± 2 µM in Pa, Sa and Ec sample (at 11 h). When 
cultured with Sa in TSB, Pa produces 38 ± 2 µM as the highest 5-MCA concentration, at 
21 h. For Pa co-cultured with Ec in TSB, the highest amount of 5-MCA was 2.8 ± 0.5 
µM at 21 h. Pa produces 3.3 ± 0.9 µM as the maximum concentration of 5-MCA when 
all three pathogens were co-cultured together in TSB. The quantified 5-MCA 
concentrations were plotted as a function of growth time for two media (Figure 4.4c-d). 
The maximum 5-MCA concentration in TSB is higher by a factor of 3 compared to LB 
for Pa samples. Yet, when cultured with Sa, Pa produces slightly higher amounts of 5-
MCA in LB compared to TSB. The amounts of 5-MCA in Pa and Sa sample are 
marginally lower than in Pa culture, in LB. In contrast, 5-MCA concentrations in Pa and 
Sa co-culture are lower by a factor of 6 relative to the Pa monoculture in TSB. In both 
media, the presence of Ec results in more significant differences with notably small 
concentrations of 5-MCA produced. 
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Figure 4.4: PYO and 5-MCA concentrations determined from Pa in different 





PYO concentrations determined from Pa in different microbial co-cultures in (a) LB and 
(b) TSB growth media, as a function of time. 5-MCA concentrations secreted from Pa in 
(c) LB and (d) TSB media, were determined from 5-MCA/PYO current peak ratios, 
relating to phenazine kinetics. Error bars show the standard deviation between six 
samples. PYO and 5-MCA concentrations are outlined in Tables A2.1–A2.4. 
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We note that as a highly reactive intermediate15,60-62 5-MCA might serve as a 
signaling molecule in redox balancing. The conversion of PCA to 5-MCA, and to PYO, 
involves additional functional groups derived from S-adenosylmethionine and molecular 
oxygen, respectively. The methylase PhzM is responsible for the conversion of PCA to 5-
MCA. However, there is an unknown parameter that affects 5-MCA production, which 
needs to be examined in a future study. While 5-MCA production acts as a sink for PCA, 
a research study has shown that additional steps, requiring molecular oxygen, might have 
a significant influence on 5-MCA production.63 As a result, 5-MCA production might not 
directly correlate with available PCA. This observation further suggests that 
environmental factors may differentially regulate synthesis of this intermediate. Our 
distinct results in LB and TSB further illustrate the effect of environmental factors on 5-
MCA concentrations produced in polymicrobial cultures. A recent study has shown that 
PYO production is activated only in the presence of NADH in addition to a required 
interaction between PhzM and PhzS enzymes.47 Pa phenazine production is growth phase 
dependent as metabolites are produced in the stationary phase. During this stage, oxygen 
is limiting, resulting in NADH accumulation and an increased intercellular NADH/NAD+ 
ratio,64 which is relieved by PYO redox balancing. Additionally, the growth conditions, 
such as nutrients, carbon and nitrogen sources, have significant effects on PYO 
production rates.15,65,66 
Figure 4.4 shows distinct phenazine concentrations of PYO and 5-MCA in 
polymicrobial communities in each media. The presence of Sa in LB does not largely 
impact phenazine production, however, the concentrations of PYO and 5-MCA are lower 
by a factor of 2.5 and 4, respectively, in TSB. These results suggest that Sa and Pa 
compete for nutrients in TSB media, leaving far fewer nutrients available for Pa, which 
consequently decreases phenazine production. The presence of Ec in polymicrobial 
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samples in each media significantly diminishes the rates of phenazine production. In 
particular, large differences are observed in polymicrobial co-cultures in TSB, where 
extremely small amounts of both PYO and 5-MCA are produced. A previous biological 
study has shown initial evidence of the ability of indole produced by Ec to quench PYO 
production and facilitate growth of Ec in mixed cultures.67 Produced as a signal molecule 
from the amino acid tryptophan by tryptophanase during stationary phase,36,68 indole  
inhibits cell division, thus allowing Ec to thrive over other bacteria in multispecies 
communities. Other research has suggested that indole has the capability to decrease 
virulence induced production in Pa by altering gene expression and interfering with 
quorum sensing mechanisms.36 To test for indole presence in polymicrobial samples with 
Ec, Kovac’s test was performed. This qualitative procedure, which determines bacteria’s 
ability to produce indole by deamination of tryptophan, yielded a red-violet-pink top 
layer in cell cultures with Ec in each media at various growth times (6, 18, and 24 h), 
confirming the presence of indole in the polymicrobial combinations.  
Although a previous study has shown the Ec can secrete indole concentrations up 
to 600 µM,36 indole production might be critically affected by several environmental 
factors, such as cell population, carbon sources, pH, and temperature. Therefore, indole 
amounts produced likely diverge in different environmental conditions thus impacting 
phenazine production dynamics in various ways. These results highlight the importance 
of identifying environmental parameters that influence metabolism dynamics in diverse 
microbial communities, particularly in the context of polymicrobial infections. Phenazine 
production rates are likely regulated on multiple environmental levels, which have to be 
standardized with regard to growth media to understand phenazine production dynamics. 
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Figure 4.5: Phenazine metabolites kinetics in polymicrobial samples.  
5-MCA/PYO peak currents ratios determined from Pa in different co-cultures in (a) LB 
and (b) TSB, shown as a function of time. Error bars plotted denote standard deviation 
between six samples. 
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4.3.5 Influence of Growth Media on Phenazine Production in Polymicrobial 
Environments 
The quantitative results, shown in previous sections of this study, address how the 
relative phenazines production (Figure 4.4) and ratio to other intermediates  (Figure 4.5) 
change during growth in response to various environmental factors. Most importantly 
changes in the dynamics are observed in the presence of other microbes, pH, and media 
composition. In this study, both LB and TSB liquid broths were used, which are rich with 
nutrients essential in supporting the growth of various microorganisms. Although there 
are many options when choosing growth media (e.g., phosphate buffered saline, buffered 
year extract broth, Mueller-Hinton broth, nutrient broth),66 these two complex media are 
the most predominant in studies with Pa reported in the literature (Table A2.5 in 
Appendix 2). In particular, LB and TSB contain different casein peptones, peptides, 
minerals, several vitamins and trace elements (e.g., S, Mg, N). Given their complexity 
and richness in nutrients, TSB and LB are reasonable choices of growth media herein. In 
prior research,15 described in Chapter 3, DESI-MS methods were employed to analyze 
differences in the composition of these media. Briefly, these results showed noteworthy 
distinctions between LB and TSB: (1) the relative abundance of choline (a water-soluble 
vitamin consumed by cells for production of toxins) at m/z 104.107 in the positive ion 
mode, and (2) the relative abundance of protonated and chlorinated hexose species (six-
carbon sugars) at m/z 179.056 and m/z 215.032, respectively. Higher relative abundances 
for both choline and hexose species were detected in TSB relative to LB, which resulted 
in higher amounts of PYO produced in TSB for Pa monoculture.15 
To better understand how components of each media might be contributing to 
observed variations in phenazine production, qualitative DESI-MS analyses were 
performed to compare relative abundances of choline and hexose species in 
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polymicrobial combinations at 5 h growth. In the positive ion mode, the relative 
abundances of choline at m/z 104.107 for three different polymicrobial cultures in LB did 
not notably differ between samples (Figure A2.1b), with the lowest abundance observed 
for the Pa and Ec sample (Figure A2.1a, A2.2). Similarly, the relative abundances of this 
species were comparable between the three combination samples in TSB (Figure A2.1a, 
A2.1c, A2.3). Higher relative abundances for choline were detected in samples in TSB 
compared to LB as depicted in the ion images in Figure A2.1a. When Pa was cultured 
separately in LB or TSB, significantly lower abundances of choline were detected (Figure 
A2.2b, A2.3b) in comparison to polymicrobial samples, suggesting high consumption of 
choline by individually grown Pa. Yet this is not observed in the polymicrobial samples, 
indicating that the presence of other pathogens changes choline consumption rates. In the 
negative ion mode, the relative abundances of hexose species did not considerably vary 
between three different polymicrobial combinations in LB and TSB (Figure A2.4–S2.5). 
For Pa monocultures in TSB and LB, the hexose relative abundances are qualitatively 
higher compared to polymicrobial samples (Figure A2.6–A2.7). Variation in the 
abundance of deprotonated and chlorinated hexose species are observed, likely due to 
possible changes occurring dependent on adduct type. These data suggest that pathogenic 
bacteria in these environments might compete for hexose and most likely numerous other 
nutrients in growth media. Consequently, growth media composition highly impacts 
phenazine production and dynamics in several ways as observed in our electrochemical 
results. 
In addition to qualitatively comparing relative abundances of choline and hexose, 
DESI-MS analysis was performed to detect PYO and other cellular metabolites in 
polymicrobial samples in both growth media. Figure 4.6 provides representative mass 
spectra and ion images (in the positive ion mode) for cellular PYO detected at m/z 
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211.086 in polymicrobial environments in LB and TSB. Higher relative abundances of 
PYO were observed in polymicrobial samples in LB than in TSB (Figure 4.6a). A small 
decrease in PYO abundance was observed when all three pathogens were cultured 
together in LB (Figure 4.6b). For polymicrobial combination tests in TSB, the highest 
PYO abundance was detected in Pa and Sa sample while the lowest PYO abundance was 
found in the sample containing all three bacterial types (Figure 4.6c). Yet PYO was not 
detectable (S/N<3) in the mass spectra for Pa and Ec co-culture in TSB. These qualitative 
mass spectrometry results are in agreement with PYO trends in quantitative 
electrochemical data. In addition to PYO, other metabolites and enzymatic products from 
different polymicrobial cultures in each media were detected using DESI-MS (Figure 
A2.4–A2.6). Multiple changes in metabolites abundances were observed: (1) succinate at 
m/z 117.019 was less abundant in Pa and Sa samples in LB and TSB, (2) disaccharide at 
m/z 377.085 was detected in lower abundances in polymicrobial samples with Sa present, 
and (3) abundances of citrate at m/z 191.019 and gluconate at m/z 195.051 were lower in 
samples containing Ec. As summarized in Figure A2.6, metabolite distribution differs 
between growth media. While DESI-MS results provide useful information about media 
composition and additional cellular species produced in polymicrobial co-cultures, these 
results are only qualitative. Unlike our electrochemical method providing means for in 
situ quantitative analysis, DESI-MS measurements are associated with biases present in 
sampling times and sample drying effects, causing exposure to oxygen and cell death 
prior to analysis. Moreover, enhanced matrix and susceptibility to ion suppression 
associated with ambient ionization mass spectrometry methods lead to additional 




Figure 4.6: DESI-MS data of PYO at m/z 211.086 obtained at 5 h of growth in different 
polymicrobial samples in LB and TSB.  
 
(a) DESI-MS ion images in Pa and Sa, Pa and Ec, and Pa, Sa, and Ec in each media. 
Relative abundances of PYO produced by Pa are higher in LB relative to TSB. Highest 
PYO relative abundances are observed in samples containing Sa. PYO relative 
abundances are lower in polymicrobial samples containing Ec, especially in TSB. These 
qualitative data are in agreement with electrochemical quantification of PYO. (b) DESI-
MS spectra of PYO (positive ion mode) for polymicrobial samples in LB. (c) DESI-MS 
spectra of PYO (positive ion mode) for polymicrobial samples in TSB. PYO, secreted 
from Pa, is not detected in the DESI-MS spectra for LB and TSB only. NL represents ion 
abundance (ion current). 
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In these complex polymicrobial environments, bacteria might be feeding and 
competing for nutrients, and/or producing additional cellular metabolites dependent on 
the media type. Our results clearly demonstrate that in polymicrobial communities, the 
onset of infection changes drastically with respect to phenazine production rates. The 
presence of other bacteria significantly influences phenazine production in different 
ways, which is also heavily dependent on growth media. Our results call for the 
standardization for cell culture experiments, largely with respect to growth media 
components and quantities, as it is necessary to appropriately study the onset of 
polymicrobial infections. As summarized in Table A2.5 in Appendix 2, there are 
countless possibilities of growth media for culturing Pa, including nonstandard methods, 
such as synthetic cystic fibrosis sputum69 and wound-like media.70 Yet, with standard 
growth media, such as LB and TSB, the real analytical concentrations of components 
likely vary between batches. Future research needs to focus on optimization, 
standardization, and certification of growth environment standards mainly because 
quantitative analytical chemistry is missing from standardization of assays. Specifically, 
it is necessary to understand particular media components and quantities to adequately 
assess which contribute to differences in phenazine dynamics. To understand how 
complex media influences development of infections, design of certified media standards 
that simulate environments for cystic fibrosis, biofilms and/or wound infections is 
essential, which is beyond the scope of this study. Therefore, the state of polymicrobial 
infections needs to be reexamined for biodiagnosis of Pa phenazine dynamics.  
Our results, showing distinct dynamics of phenazine production with regard to 
growth in multispecies samples, point to the need for standard methods of growth media, 
which have great implications towards understanding the onset of bacterial infections, 
antibiotic resistance, and treatments. More extensive environmental factors need to be 
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examined, however, our electrochemical approach provides the basis set as to the relative 
differences in phenazine production rates that can be quantified with high sensitivity. In 
follow-up work, the influence of additional factors (oxygen availability, host genetics, 
and antibiotics) on redox phenazine production will be monitored using T-CUAs.  
3.4 CONCLUSIONS 
In summary, this study shows quantitative electrochemical monitoring of the 
impact of polymicrobial communities on production rates of Pa phenazine metabolites in 
different growth media. Using T-CUAs as electrochemical sensors, the dynamics of 
phenazine biosynthesis were continually observed via detection of redox-active 
metabolites PYO, 5-MCA, OHPHZ, and an unknown species. These quantitative results 
demonstrate distinct electrochemical current responses for phenazines produced between 
Pa grown: (1) individually, and (2) in polymicrobial samples. In LB, the maximum 
concentrations of PYO were 150 ± 1 µM for Pa, 150 ± 1 µM for Pa and Sa, 72 ± 1 µM 
for Pa and Ec, and 28 ± 1 µM in Pa, Sa and Ec sample (at 21 h). In TSB, the highest 
PYO concentrations were 190 ± 5 µM for Pa (at 21 h), 78 ± 2 µM for Pa and Sa (at 21 h), 
9.3 ± 0.2 µM for Pa and Ec (at 21 h), and 8.2 ± 0.5 µM in Pa, Sa and Ec sample (at 48 h). 
Additionally, the concentrations of highly reactive 5-MCA were determined. The 
presence of Sa caused a notable decrease in phenazine concentrations only in TSB while 
the presence of Ec in polymicrobial samples drastically quenched phenazine production 
rates in both media. These disparities likely correlate to (1) differences in nutrient 
consumption, and (2) other cellular metabolites produced, in polymicrobial environments. 
These results clearly demonstrate that presence of other bacteria dramatically impacts 
phenazine production rates, which also directly depends on the media type. The media 
type strongly influences phenazine product distribution, especially in polymicrobial co-
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cultures. Therefore, these data imply the need for analytical standardization of simulation 
media, which represent key attributes of in vivo environments (e.g., wounds, cystic 
fibrosis lungs). Our T-CUAs electroanalytical method has the sensitivity to distinguish 
differences based on correlative measurements in media not only on phenazine 
production but also on intermediates produced in polymicrobial samples. Thus, these data 
support use of T-CUAs in biodiagnosis and monitoring of Pa infections colonized by 
multiple bacteria. 
Future work will focus on electrochemical monitoring of Pa phenazine production 
in the presence of other relevant pathogens, such as Enterococcus faecalis and 
Staphylococcus epidermidis, as well as in the presence of eukaryotic, host cells (e.g., 
macrophages). Moreover, studies need to be performed with additional, increased co-
cultures comprising of more than three pathogens. Additionally, phenazine production 
and dynamics need to be examined on T-CUAs with clinically relevant Pa strains 
isolated from patients, as clinical strains grow at different rates dependent on 
environmental conditions and composition.71 Finally, the state of infection in these 
polymicrobial populations needs to be reexamined for diagnosis, specifically with respect 
to standardization of simulated growth media. 
4.5 ADDITIONAL INFROMATION 
Details on the quantitatively determined PYO and 5-MCA concentrations in 
polymicrobial samples in LB and TSB media from real-time electrochemical data, DESI-
MS spectra in the positive and negative ion modes at 5 h of bacterial growth in 
polymicrobial samples TSB and LB media contents, DESI-MS data of cellular 
metabolites detected in polymicrobial combinations samples, summary of most 
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commonly used growth media for P. aeruginosa, Tables A2.1–A2.5, and Figures A2.1–
A2.7 are provided in Appendix 2. 
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Chapter 5: Future Directions5 
5.1 INTRODUCTION 
5.1.1 Synthetic Cystic Fibrosis Sputum as Growth Medium for P. aeruginosa   
Cystic fibrosis is a genetic disorder associated with colonization of bacterial 
pathogens and accumulation of large amounts of mucus secretions (here, referred to as 
sputum) within the lungs, which diminishes the ability of the host to clear bacterial 
diseases.1-4 The gram-negative pathogen Pseudomonas aeruginosa is a major bacterium 
causing chronic airways infections in people with cystic fibrosis (CF), causing an 
increase in morbidity and mortality rates.5-9 While multicellular aggregates colonize the 
CF sputum during infections, P. aeruginosa is a major species often growing to high cell 
densities of 109 cells/mL of sputum.2,10 Once established, P. aeruginosa infections in the 
CF lung are resistant to effective antibiotic and antimicrobial treatments as therapies fail 
to fully eliminate the pathogen.9 Although the mechanisms for P. aeruginosa high 
persistence to antibiotics are not completely understood, recent studies have shown that 
P. aeruginosa adopts physiological states and evolve traits that enhance their capability 
to evade host responses in the CF sputum.8,11-13 A recent study showed that airway P. 
aeruginosa strains produced higher levels of specific proteins involved in the production 
and transport of alginate (an exopolysaccharide involved in the formation of aggregates). 
The study concluded that P. aeruginosa grows more slowly in the CF sputum13,14 and 
exhibits different metabolic provides from in vitro grown bacteria,1,15-17 highlighting how 
                                                
5Portions of this chapter were published in Darch, S. E; Simoska, O.; Fitzpatrick, M. D.; Barraza, J. P.; 
Stevenson, K. J.; Bonnecaze, R. T.; Shear, J. B.; Whiteley, M. Spatial Determinants of Quorum Signaling 
in a Pseudomonas aeruginosa infection model. Proc. Natl. Acad. Sci. U.S.A. 2018, 5, 4779-4789. 
Copyright © 2018 National Academy of Sciences. For some data and results presented in first part of this 
chapter, Simoska, O. performed research; Simoska, O. and Stevenson, K. J. designed the viscosity and 
electrochemistry studies and analyzed the data.  
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standard culturing methods can provide poor models for how bacteria persist in the 
host.13 
In studying bacterial infections, it is important to understand the composition of 
the in vivo growth environments (e.g., carbon source, energy from host).1 While Garber 
proposed the host system as a growth medium over 50 years ago,18 the nutritional 
composition of most infection sites, such as the CF lung, is not well defined and often 
inadequately modeled by standardized growth media used in laboratory settings. The 
results presented in Chapters 3 and 4 in this dissertation point to the need for analytical 
standard methods of simulated growth media to adequately study bacterial infections and 
antibiotic resistance.19 The lack of standard methods of growth media that closely mimic 
in vivo growth environments provides significant challenges in studying the onset of P. 
aeruginosa infections. Thereby, it is critical to define the growth environment 
components and concentrations of infection sites (e.g., CF airway) to study the effects of 
environmental conditions on the production of P. aeruginosa virulence factors.1 
Towards these goals, the Whiteley laboratory has previously developed a defined 
synthetic CF medium to closely represent key attributes of the human CF sputum 
(SCFM),1,2 which has been used to study how nutritional composition impacts P. 
aeruginosa growth rates and virulence production.20,21 In a follow-up study, the Whiteley 
lab further modified this growth medium via the addition of relevant levels of 
macromolecules found in CF sputum (mucin, DNA and lipids) to develop a second-
generation CF medium (SCFM2). SCFM2 has genetic requirements similar to human 
sputum and closely mimics the physical properties of expectorated CF sputum.20 Previous 
research has shown that SCFM2 promotes the formation of P. aeruginosa aggregates 
similar to those found in the lungs of CF patients.3 While this growth medium is not a 
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standardized method of growth, it provides a relevant growth media model to study P. 
aeruginosa CF infections.3 
In this dissertation chapter, research studies performed using SCFM2 sputum 
media are presented. Specifically, analyses were performed to characterize the 
viscoelastic properties of SCFM2 as well as to electrochemically determine the diffusion 
coefficients of pyocyanin (PYO) in SCFM2.22 Additionally, we present preliminary 
results from time-dependent studies using transparent carbon ultramicroelectrode arrays 
(T-CUAs) to electrochemically monitor PYO production by P. aeruginosa cells grown in 
SCFM2 sputum in tandem with confocal microscopy imaging through T-CUAs to 
observe the formation of bacterial aggregates. For these studies, mutant P. aeruginosa 
strains were used, which were modified by the Whiteley laboratory to constitutively 
express mCherry as well as express green fluorescent protein (GFP) when quorum 
sensing molecules are produced. Our initial results indicate that P. aeruginosa grows 
differently in SCFM2, associated with the lower rates PYO production compared to those 
from P. aeruginosa grown in standard laboratory growth media (Chapters 3 and 4). 
Additionally, these preliminary results show slight correlations between electrochemical 
measurements of PYO concentration and data obtained confocal microscopy images of P. 
aeruginosa aggregates. 
5.1.2 Pyocyanin and Nitric Oxide Interaction 
The complex environments in which cells interact typically have diverse cellular 
populations and are susceptible to changes that influence cellular survival, division, 
differentiation, death, and virulence. Such dynamic responses are often mediated, at least 
in part, by changes in the concentrations of cellularly derived biogenic signaling 
molecules. Hence, the in vitro detection of these cellular species is pivotal to 
 138 
understanding cellular communication in immunological-bacterial interactions. Microbial 
pathogenicity occurs in a susceptible host, which houses its microbiota while interacting 
with pathogenic microorganisms. Recent research findings have provided insight on how 
the cell signaling mechanisms are activated in host immune responses,23 however, there is 
a significant lack of knowledge in understanding the interactions of signaling biogenic 
molecules in host-pathogen environments as infections develop.  
As highly adoptable microorganism that causes infections in humans, bacteria 
evade host defense responses as well as antibiotic resistance mechanism. Thereby, it is 
important to identify and characterize complex mechanisms in which microorganisms 
cause chronic and persistent infections.24 Specifically, an important strategy in 
developing pathogenicity and antibiotic resistance is the formation of bacterial 
biofilms,24-26 which are associated with 80% of human infections and often present in the 
CF lungs.27 Biofilm formation is a complex and highly regulated process, which is often 
an adaptation response to environmental factors, including changes in temperature, pH, 
nutrient limitations, and/or oxygen levels.26 Consequently, eukaryotic, host organisms 
develop sophisticated defense mechanisms in response to developing antibiotic-resistant 
biofilms.27 Various research studies have shown that the biogenic signaling molecule 
nitric oxide (NO•) to induce biofilm dispersal in many bacterial species, including P. 
aeruginosa.28,29 NO• is involved not only in biofilm regulation but also in mediating QS 
responses,30,31 which are interconnected with biofilm formation.32 The complex 
interactions between the immune system and microbes involve signaling molecules that 
largely vary in size, ranging from large molecules (e.g., cytokines, hormones, 
neurotransmitters, sugars) to very small molecules (e.g., hydrogen peroxide, PYO, nitric 
oxide).27 Small molecules are most abundant and their functions include serving as 
intermediate metabolites, nutrients, virulence factors, and electron acceptors.27 Therefore, 
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understanding the role of NO• in P. aeruginosa biofilm dispersal could be fundamental in 
developing effective strategies in prevention and treatment of antibiotic-resistant biofilm 
infections. Thus, this chapter presents preliminary studies on the electrochemical 
monitoring of the interaction of two biogenic signaling molecules, NO• and PYO, 
secreted by macrophages and P. aeruginosa cells, respectively. Insight into how and 
when P. aeruginosa encounter NO• during infection progress has both clinical and 
physiological relevance.  
As described in previous chapters in this dissertation, gram-negative, facilitative 
anaerobe P. aeruginosa is an opportunistic human pathogen responsible for a high 
number of hospital-acquired biofilm infections. It is the prevalent species isolated from 
patients with immune-compromised systems and chronic wounds as well as from the 
lungs of those suffering from cystic fibrosis. As part of its virulence mechanisms, P. 
aeruginosa secretes virulence factors that cause infections in host organisms to thrive.33,34 
Among these virulence factors is the blue pigment, redox-active phenazine compound, 
PYO.35-37 As a highly diffusible signal, PYO is involved in quorum sensing (QS), a 
population-dependent cell-to-cell communication process allowing bacteria to regulate 
gene expression based on the effective cellular density.38,39 Since it is uniquely produced 
by P. aeruginosa cells, PYO serves as an effective diagnostic molecule marker for 
identifying developing P. aeruginosa infections.38 Previous studies have shown that PYO 
concentrations isolated and detected from various in vivo environments, fall in the low- to 
mid-micromolar range. PYO readily reacts with cellular metabolites to generate reactive 
oxygen species (ROS), causing damage to host tissue and surrounding microorganisms.35 
Additionally, it has a variety of pharmacological effects on both prokaryotic and 
eukaryotic cells.40 PYO engages in chemical warfare with the immune system, thereby its 
detection could provide a better understanding of P. aeruginosa virulence mechanisms. 
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Another cellular biogenic species of interest is diatomic, cell-permeable, free 
radical NO• and significant attention is garnered around its detection in biological 
environments.41,42 As a major biogenic ROS, NO• plays multiple roles in complex 
organisms. First, NO• serves as a messenger molecule in neuronal communication and 
vasodilation, the endothelium-derived relaxing factor (EDRF), which is released by the 
endothelium to relax smooth muscle.41,43-47 Second, NO• is secreted in high concentration 
by immunological (eukaryotic) cells as an immunological defense mechanism in response 
to bacterial infections.43,48 Three different kinds of nitric oxide synthases (NOS) are 
responsible for generating NO•, namely (1) endothelial nitric oxide synthase (eNOS), 
neuronal nitric oxide synthase (nNOS), and immunological nitric oxide synthase 
(iNOS),49 where NOS converts L-arginine and oxygen (O2) to L-citrulline and NO•. In 
biological organisms under physiological conditions, NO• is present in low-micromolar 
concentrations.50 NO• is a very reactive and highly diffuse molecule, the former 
particularly true within complex biological systems. In the presence of oxygen, NO• 
converts to reactive nitrogen species, which induce damage to biological macromolecules 
such as DNA, lipids, and proteins. This signaling molecule is known to regulate various 
physiological processes including virulence, biofilm regulation and gene expression. For 
instance, low, nontoxic levels of NO• have been shown to induce biofilm dispersal in P. 
aeruginosa.29 These biofilm dispersal mechanisms involve NO•-mediated pathways, 
which trigger responses based on changes in the modulation of QS.24 While NO• is an 
effective molecule in biofilm dispersal, bacterial pathogens have developed defense 
mechanisms against immune responses. In particular, P. aeruginosa initiates crosstalk to 
regulate not only biofilm formation and virulence, but also host immune responses.51 
Previous research has shown the ability of PYO to inhibit ciliary functions of 
respiratory epithelial cells and to block EDRF NO• release and vasorelaxation. In its 
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mechanism of action, PYO inhibits NO• synthases, blocking the relaxation of smooth 
muscle induced by nitric oxide.40,52 Additionally, immune cells (e.g., macrophages) 
produce high concentrations of NO• in response to pathogenic infections.43 Yet there is a 
lack of knowledge in understanding the in vivo and/or in vitro mechanisms in which PYO 
interacts with NO•. A 1990 study by Warren et al. examined the reaction between PYO 
and NO•.53 The authors observed a rapid change from initial blue to pink color when NO• 
was passed in a deoxygenated aqueous solution of PYO and mass spectrometry (MS) 
analyses of the products indicated conversion of PYO to nitrosylated species.53 
Specifically, fast atom bombardment MS showed that PYO was not present and 
desorption electron-impact ionization showed the presence of minor amounts of 1-
methoxyphenazine and 1-hydroxyphenazine in addition to major ions at m/z 211 and m/z 
193. The authors suggested that the latter ions are due to nitrosylation of PYO by nitric 
oxide, followed by generation of substituted oxazoline by dehydration, which was 
suspected to have occurred during MS analysis.53 These results provided speculation that 
the interaction between PYO and NO• could occur in patients infected with P. 
aeruginosa, thus this reaction deserves further examination. 
While standard analytical methods, including fluorescence, chemiluminescence, 
spectrophotometry, and MS are typically used to detect both PYO and NO•,54-58 they are 
either costly or time-consuming. Electrochemical detection methods have been 
recognized as popular alternatives for these two species as they provide low-cost, highly 
sensitive, responsive, robust, and direct detection methods.19,41,57,59-66 In Chapter 2 of this 
dissertation, we showed the characterization of T-CUA analytical responses to PYO and 
the successful use of this electrode platform to detect cellular PYO from P. 
aeruginosa.19,59,60 Additionally, the Stevenson research group has previously 
demonstrated promising adaptation of T-CUAs for the detection of biogenic NO•. 
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Specifically, two modifications were introduced to T-CUAs for detection of NO•, 
including (1) the addition of a cellulose acetate gas permeable membrane selective to 
NO•, and (2) the introduction of chitosan-gold nanoparticles (CS/GNPs) to enhance the 
limit of detection to NO•.56 
Herein, we demonstrate initial experimental results on the chemical interaction 
between PYO and NO• on T-CUA electrodes. To the best of our knowledge, this 
interaction has not been previously studied using electrochemical methods. Our 
preliminary electrochemical measurements performed in tandem with UV-Vis 
spectroscopic studies show no evidence of an interaction between PYO and NO• at 
biologically relevant conditions and physiological pH 7.0. These primary observations 
may be important in studying other potential mechanisms in which the chemical reaction 
between PYO and NO• occurs. 
5.2 EXPERIMENTAL METHODS 
5.2.1 General 
All chemicals were used as received. Photoresist AZ 1518 was purchased from 
Microchemicals.  Polystyrene spheres (diameter of 1.54 µm) were purchased from 
Polysciences, Inc (Polybead®).  All chemicals were used as received. Potassium chloride, 
acetic acid, cyclohexanone, isopropanol, ferrocenemethanol, nitric acid, and MOPS 
buffer were acquired from Sigma-Aldrich Co. Pyocyanin was purchased from Cayman 
Chemical Company. Ethanol, Monosodium phosphate, disodium phosphate were 
purchased from Thermo Fisher Scientific Inc. Carbenicillin disodium salt was purchased 
from Fisher BioReagents. Tryptic soy broth (TSB) was purchased from Thermo 
Scientific and Tryptic soy agar (TSA) was acquired from Remel. 
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5.2.2 Preparation of SCFM2 
Parts of the studies presented in this chapter use an in vitro model based on 
chronic P. aeruginosa infection of the CF lung. Specifically, the studies utilize synthetic 
SCFM2 sputum, previously designed by the Whiteley lab,1,2,20 to mimic the lung 
secretions of individuals with CF, which importantly promotes natural formation of P. 
aeruginosa aggregates.3 
5.2.3 Viscosity Measurements of SCFM2 
Viscosity measurements were performed using a Sine-wave Vibro Viscometer 
SV-10 and Haake temperature-controlled water bath. The SV-10 viscometer consists of 
two thin gold sensor plates that vibrate at a constant frequency. The electromagnetic force 
influencing the vibration of the sensor plates maintains constant amplitude. The 
magnitude of viscosity is detected as electric current necessary to resonate gold electrode 
plates at a selected frequency and magnitude. After performing calibration of the 
instrument, the viscosity of the following samples was measured with increasing 
temperature in 1.0°C increments ranging from 20.0 °C to 37.0 °C: (1) water, (2) SCFM, 
(3) SCFM2, (4) SCFM2 (mucin removed), (5) SCFM2 (DNA removed), and (6) 
expectorated CF sputum. 
5.2.4 Electrochemical Determination of Diffusion Coefficients of Pyocyanin in 
SCFM2 
The electrochemical measurements were done using a three-electrode cell system. 
All electrochemical experiments were performed at room temperature (25 °C). 
Electrochemical experiments including cyclic voltammetry (CV) and 
chronoamperometry were performed using an Autolab PGSTAT30 potentiostat. A 
platinum (Pt) electrode with a diameter of 5 mm (Metrohm Autolab) was used as the 
 144 
working electrode. A gold mesh was used as the counter electrode and a saturated 
calomel electrode (SCE) was used as the reference electrode. The working electrode was 
polished between each run using aluminum oxide colloidal suspension with a particle size 
of 0.05 microns. The background solutions used were SCFM, SCFM2, SCFM2 (mucin 
removed), and SCFM2 (DNA removed). After collecting a background cyclic 
voltammogram or chronoamperogram, a 2 mM PYO stock solution (dissolved in ethanol) 
was added to each respective background solution to give a final concentration of 90 µM 
PYO. For PYO, CVs with a potential window ranging from –0.4 V to –0.1 V vs SCE at a 
scan rate of 50 mV s-1 were recorded before each chronoamperometry experiment. For 
ferrocene methanol (FcMeOH), CVs with a potential window ranging from –0.2 V to 
0.45 V vs SCE (scan rate of 50 mV s-1) were recorded before chronoamperometry 
experiments. The diffusion coefficients of PYO in each of the separate synthetic sputum 
solutions were determined via chronoamperometry by initially holding the potential at –
0.20 V vs SCE for 0.5 s, then stepping the potential to –0.32 V vs SCE for 60 s in the 
aforementioned solutions. The diffusion coefficient of FcMeOH in synthetic SCFM2 
sputum solutions was determined via chronoamperometry by holding an initial potential 
of 0.35 V vs SCE for 0.5 s, then stepping the potential to 0.10 V vs SCE for 60 s. Using 
the obtained chronoamperograms, Cottrell curves were plotted, from which the 
corresponding diffusion coefficients for PYO and FcMeOH were determined. For 
comparison studies with FcMeOH, the background solutions used were: (1) MOPS 
buffer, (2) SCFM2 sputum, and (3) 1:1 (v/v) MOPS:SCFM2. 
5.2.5 Bacterial Strains, Plasmids, and Cell Culture Conditions 
Bacterial strains used in these experiments were provided and prepared by Dr. 
Sophie Darch of the Whiteley lab. Specifically, P. aeruginosa PA14 ΔlasIΔrhlI 
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“responder” strain, containing either plasmid pSEDQS (PA14 QS) or pSEDQS2 (PA14 
QS2), was used. PA14 ΔlasIΔrhlI pSEDQS strain constitutively expresses mCherry, and 
a transcriptional fusion of rsaL:gfp, allowing for the production of green fluorescent 
protein (GFP). All strains were grown from TSA plate culture and prior to use were 
shaken overnight at 37 °C at 200 rpm in TSB. All washing steps were performed using 
phosphate buffer saline (PBS, 7.0 pH).  
5.2.6 Concurrent Confocal Imaging and Electrochemical Measurements 
Confocal images were acquired on a Zeiss LSM 700 CLSM utilizing Zen image-
capture software. Bacterial cells were pictured via mCherry with an excitation 
wavelength of 587 nm and an emission wavelength of 610 nm. Detection of GFP-
expressing cells was performed using an excitation wavelength of 488 nm and an 
emission wavelength of 509 nm. Confocal images were acquired using a 63× oil-
immersion objective. All data were saved as 512- by 512-pixel (0.45- by 0.45-µm pixel 
size) 8-bit z-stack images. Control confocal images of SCFM2 without any bacterial cells 
were acquired using identical settings to determine the background for image analysis. 
For this study, electrochemical measurements were performed using a three-electrode cell 
system including square wave voltammetry (SWV) and an Autolab PGSTAT30 
potentiostat. T-CUA was used as the working electrode with a total geometric area of 
0.495 cm2, defined by the electrode area exposed to a solution in a homemade 
polydimethylsiloxane (PDMS) electrochemical well. A gold wire electrode was used as 
the counter electrode and SCE was used as the reference electrode. SWV measurements 
were performed using a current sensitivity of 5 µA, 3 mV step potential, and a frequency 
of 15 Hz.  The potential window ranged from –0.4 to –0.1 V vs SCE. The background 
solution used was 1:1 (v/v) SCFM2:TSB. After a background SWV was collected using a 
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total of 20 scans, subsequent PYO measurements were obtained. For the real-time 
electrochemical detection of PYO from P. aeruginosa in 1:1 (v/v) SCFM2:TSB, liquid-
batch cell samples were placed on T-CUA electrodes to perform SWV measurements 
while performing confocal microscopy imaging. PYO production was monitored during 
the initial 8.5 h of bacterial growth. Note that experiments were performed at room 
temperature due to the lack of a 37 °C chamber on the confocal microscope. Additionally, 
all confocal images were captured 30 min after each SWV measurement due to time 
delays associated with the expression of fluorescent protein reporters. 
5.2.7 Pyocyanin Calibration Curves 
For combined electrochemistry and confocal microscopy imagining studies, to 
quantify PYO concentrations from P. aeruginosa cells, calibration curves for PYO in 
TSB were used reported in our previous studies in Chapter 3.19  
5.2.8 Pyocyanin Standard Solutions 
For studies on the interaction between PYO and NO•, 100 µM of PYO in sodium 
phosphate buffer solution (SPB, 7.0 pH) was prepared. Initially, a 2 mM PYO stock 
solution was prepared in ethanol and was diluted to make a 500 µM stock solution in 
SPB. From the 500 µM stock solution, the respective PYO standard solution was 
prepared to have a concentration of 100 µM in SPB. 
5.2.9 Preparation of Stock Standard NO• Solutions 
The stock NO• solution was prepared according to a previously reported 
procedure with modifications.41 6 M sulfuric acid (H2SO4) was slowly added drop wise 
into a saturated sodium nitrate (NaNO2) solution, which generated sodium sulfate and 
nitrous acid. Nitrous acid decomposed into nitrogen dioxide (NO2) and NO• gases. The 
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generated gases were passed through a 30% sodium hydroxide (NaOH) solution to trap 
the NO2 gas, while the remaining NO• gas was bubbled through 10 mL of 0.1 M SPB (7.0 
pH) for 40 min. The NO• concentration saturates at 2 mM at 22°C.56,67 The entire 
procedure must be performed very carefully because the NO• gas is toxic and it easily 
reacts with O2 in the air. Thus, the saturated NaNO2, the 30% NaOH and the SPB 
solutions were purified with nitrogen gas for 3 h to remove any oxygen before adding 6 
M H2SO4 acid to generate NO• gas. The 2 mM NO• stock solution was used immediately 
upon preparation to make the standard NO• solutions. For PYO/NO• interaction studies, a 
20 mL standard NO• solution was prepared to have a concentration of 50 µM in SPB, by 
diluting from the 2 mM NO• stock solution. Since the NO• gas reacts highly with oxygen, 
the standard SPB solutions were purified with nitrogen gas for 2 h before adding any of 
the NO• stock solutions. 
5.2.10 Preparation of PYO/NO• Solutions 
For studies on the interaction between PYO and NO•, the solutions used were 50 
µM NO•, 100 µM PYO, 1:1 (v/v) 100 µM PYO: 50 µM NO•, and 3:1 (v/v) 100 µM PYO: 
50 µM NO• in SPB (7.0 pH).  
5.2.11 Fabrication of T-CUA Electrodes 
Preparation of the electrode platform using transparent carbon ultramicroelectrode 
arrays (T-CUAs) follows detailed procedures described in our previous studies.19,48,56,60,68 
Quartz microscopic slides (6.45 cm2 and 1 mm thick, Technical Glass Products) were 
treated with piranha (3:1 H2SO4: 30% H2O2) to remove any organic contaminants. A 1:3 
dilution of AZ 1518 photoresist with PGMEA (1-methoxy-1-propanol acetate) was spun 
onto the piranha cleaned quartz slides at 6000 rpm for 60 s. Following spin coating, the 
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photoresist slides were soft baked at 90 °C for 10 min and then transferred to a tube 
furnace. After 15 min of purging with 5% H2: 95% N2 (~100 mL/min), the photoresist 
slides were pyrolized by heating to 1000 °C at 5 °C/min and holding at that temp for 1 h 
before allowing them to cool slowly back to room temperature at 5°C/min. The pyrolized 
photoresist film (PPF) slides were then removed from the furnace and stored for 3 days 
prior to use to allow for the oxide layer to stabilize. T-CUAs fabrication involved a 
lithography method using polystyrene microspheres (PSS) with a diameter of 1.54 µm, 
which were drop cast from a 5.4 wt % methanol suspension onto the conductive PPF 
electrodes. The organization of the spheres is that of a hexagonal close-packed two-
dimensional ordered network. After this microsphere lithography step, 10 nm of Al2O3 
layer was deposited via atomic layer deposition (ALD) technique at 80 °C. The ALD 
process was calibrated by the manufacturer (Cambridge Nanotech Savannah 100) to 
deposit 0.089 nm conformal Al2O3 layer per cycle. Thus, cycling this process for 112 
times formed a 10 nm ALD layer. This ALD step is then followed by removal of PSS via 
sonication with methanol, acetone, isopropanol, and water. Disk-shaped carbon areas 
remained where the PSS made contact with the PPF, thus forming a carbon 
ultramicroelectrode array. Details on the characterization of T-CUA electrodes have been 
reported in previous research studies from our group.19,48,56,60,68  
5.2.12 Concurrent Electrochemical and UV-Vis Measurements of PYO/NO• 
Reaction 
The electrochemical measurements were performed using a three-electrode cell 
system. Electrochemical experiments including SWV were performed using a CHI 700 
potentiostat (CH Instruments Inc). The T-CUA was used as the working electrode, a steel 
electrode was used as the counter and a gold (Au) electrode was the reference. The T-
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CUA working electrode had a total exposed geometric area of 0.495 cm2. SWV was 
performed using a current of 5 A, 3 mV step potential, and a frequency of 15 Hz.  The 
potential ranged from –0.8 V to 0.8 V vs Au. The background solution was SPB (7.0 pH), 
purged with argon gas for 20 min.  After a background SWV curve was collected, 
subsequent PYO/NO• measurements were obtained. In tandem with electrochemistry 
experiments, UV-Vis measurements (Agilent Instrument 8453 UV−vis−NIR 
spectrometer) were recorded to examine the interaction of PYO and NO• using the 
solutions described in section 5.2.10. For these measurements, a homemade Teflon 
spectroelectrochemical well was used and contact to the working electrode was made 
using copper tape. To study the effects of molecular oxygen on PYO/NO• interaction, 










Viscosity is measured as the kinematic viscosity across a temperature range of 20–37 °C 
for SCFM2 (green) compared with SCFM (navy blue), SCFM2 with mucin removed 
(red), SCFM2 with DNA removed (blue), expectorated CF sputum (grey) and water 
(black). Statistical comparisons at 37 °C using a two tailed t test indicate that SCFM2 has 
a similar viscosity to expectorated CF sputum (P = 0.01), that the removal of mucin 
changes viscosity (P = 0.0001) and is more viscous than water (P = 0.0001). Data 
represent the mean value of three replicates. Error bars are too small to be seen. 
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5.3 RESULTS AND DISCUSSION 
5.3.1 Characterization of SCFM2 Sputum 
Previous studies have attempted to determine components of CF sputum and have 
shown that the artificial SCFM2 sputum developed by the Whiteley lab can be used as a 
relevant model system to study P. aeruginosa chronic CF infections as it closely 
represents key attributes of CF sputum from patients.1-3 The Whiteley lab developed two 
modulations of this medium (SCFM and SCFM2).1,2 Originally, SCFM was designed to 
study how the nutritional composition of CF sputum influences the growth and virulence 
of P. aeruginosa.1,2 SCFM2 was developed, with the addition of relevant amounts of 
DNA, lipids, and mucin to SCFM, to more closely represent the physical properties of 
human CF sputum.3 The viscous properties of CF sputum are believed to play an 
important role in bacterial aggregate formation, as well as in the development of 
biofilms.22,69,70 However, it remains unclear which sputum components contribute to the 
increased viscosity of this growth medium.  
Herein, the average kinematic viscosity of four variations of SCFM2 sputum 
media (SCFM2, SCFM2 mucin removed, and SCFM2 DNA removed) was measured, 
quantified, and compared with authentic CF sputum isolated from patients, SCFM, and 
water (Figure 5.1). The data shows that SCFM2 and CF sputum have significantly higher 
average viscosities compared to SCFM and water across a range of temperatures (Figure 
5.1). At 37 °C, the determined average viscosity of SCFM2 was 3.2×10-6 m2/s, which was 
slightly more viscous than that of CF sputum with an average viscosity of 2.9×10-6 m2/s 
(P-value=0.01). This viscosity is similar to that of the commonly used 30–40% glycerol 
lab solution within this range of temperatures. To determine which SCFM2 polymer 
components contribute to viscosity, mucin (glycoprotein constituent of mucus) or DNA 
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were removed from the medium. Removing mucin from SCFM2 resulted in ~25% 
decrease in viscosity to 2.4×10-6 m2/s at 37 °C (P-value= 0.001, compared to SCFM2). 
These results indicate that the removal of mucin from SCFM2 gives a solution that is 
nearly identical to the original SCFM formulation (Figure 5.1). The data in Figure 5.1 
reveal that the viscosity of SCFM2 is more similar to that of authentic CF sputum than to 
SCFM and that the addition of the mucin is a significant contributor to the increased 
viscosity. On the other hand, removal of DNA from SCFM2 resulted in higher viscosity 
than neat SCFM2, though they are not statistically different at 37 °C (P-value=0.02, 
compared to SCFM2). This increase in viscosity might be attributed to variations in 
different batches of SCFM2 media used in these studies, which remains a subject of 
further investigation.  
To further characterize SCFM2 sputum and understand the significant viscosity 
changes observed in Figure 5.1, the apparent diffusion coefficients of PYO four variants 
of SCFM2 sputum (SCFM2, SCFM, SCFM2 mucin removed, and SCFM2 DNA 
removed) were determined using electrochemical methods (herein, chronoamperometry). 
Previous studies have reported the concentration levels of PYO in the sol phase (colloidal 
solution) of sputa from infected CF patients to fall within the range of 0.2−27.3 µg/mL 
(1−130 µM).62,71,72 Consequently, a biologically relevant PYO concentration of 90 µM 
was used as it falls within the aforementioned range for the diffusion coefficients studies. 
Initially, CV was used to determine the potential at which PYO redox occurs in 
each of the SCFM2 sputum solutions (Figure 5.2). Figure 5.2b displays clean, 
background-corrected CVs for PYO redox (Figure 5.2a) in SCFM2, SCFM, SCFM2 
(mucin removed), and SCFM2 (DNA removed). The provided CVs indicate the PYO 
redox peak relative to the reference electrode. The reduction peak is more sensitive and 
shows less reversibility, which is most likely associated with a reductive radical-induced, 
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proton-coupled dimerization process, which is often observed for redox molecules of 
similar structure. According to the Randles-Sevcik equation, the peak current should be 
proportional to the square root of the diffusion coefficient.73-75 However, this relationship 
holds true for purely reversible electron transfer processes. As demonstrated in Chapter 2, 
the redox reaction for PYO is a quasi-reversible outer-sphere mechanism as the redox 
reaction not only involves electron transfer but also slow, bimolecular steps (transfer of 
protons).60 Additionally, large errors are typically associated with determining diffusion 
coefficients using CV; errors are significantly reduced by using chronoamperometry as it 




Sputum Solution Diffusion coefficients (cm2/s) 
SCFM (6.6±0.5)×10-6 
SCFM2 (2.8±0.6)×10-7 
SCFM2 (mucin removed) (7.4±0.4)×10-6 
SCFM2 (DNA removed) (1.8±0.2)×10-7 
Table 5.1: Determined apparent diffusion coefficients of PYO in different sputum 














(a) Reduction mechanism of PYO. (b) Background subtracted cyclic voltammetry 
responses for 90 µM PYO in (1) SCFM2, (2) SCFM, (3) SCFM2 (mucin removed) and 
(4) SCFM2 (DNA removed). 
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To determine the diffusion coefficients of PYO in synthetic sputum media, 
chronoamperometry studies were performed, where the resultant current was monitored 
as a function of time in a controlled potential fashion. Figure 5.3a shows background-
corrected chronoamperograms for four different variations of sputum media: (1) SCFM2, 
(2) SCFM, (3) SCFM2 (mucin removed), and (4) SCFM2 (DNA removed). Using the 
obtained chronoamperometry data, corresponding Cottrell curves were plotted where the 
resulting current was plotted as a function of the inverse square root of time (Figure 
5.3b). Resultant Cottrell plot slopes (Figure 5.3b) were used to determine the apparent 
diffusion coefficients of PYO in SCFM2 media (Table 5.1). In the chronoamperometric 
measurement of diffusion coefficients for redox-active species (e.g., PYO) in solution, 
three distinct diffusional regimes are clearly discernable corresponding to ultrashort, 
short and long times. In the microsecond to second ultrashort time regime, the response is 
associated with instrumental responses and double layer charging of the electrochemical 
interface to reach the applied potential during the potential step, thus this early time is not 
considered. In the seconds time regime, this response is associated with semi-infinite 
linear diffusion associated with free diffusion of redox-active molecules to the electrode 
interface. This time regime is what was used to estimate apparent diffusion coefficients 
since they are a function of the media (pH, ionic strength, temperature, and activity 
effects).  
The apparent diffusion coefficient of PYO in SCFM2 (2.8×10-7 cm2/s) was lower 
compared with SCFM (6.6×10-6 cm2/s), indicating that the addition of polymers to SCFM 
slows diffusion of quorum sensing molecules. The removal of mucin from SCFM2 
resulted in a similar PYO diffusion coefficient to SCFM (7.4×10-6 cm2/s) while the 
removal of DNA had a small but statistically significant effect (1.8×10-7 cm2/s). 
Significant differences, using a two-tailed t-test, were determined for (1) SCFM and 
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SCFM2 (P = 0.0002), (2) SCFM2 and SCFM2 mucin removed (P < 0.0001), and (3) 
SCFM2 and SCFM2 DNA removed (P = 0.002). These data, in agreement with the 
viscosity results, indicate that mucin is likely the primary polymer impacting the 
diffusion of PYO in SCFM2 media. As a control, diffusion coefficients of FcMeOH and 
PYO were determined via chronoamperometry in (1) MOPS buffer, (2) 1:1 (v/v) 
MOPS:SCFM2, and (3) SCFM2. FcMeOH was chosen as a standard redox couple with a 
known diffusion coefficient due to its similar molecular weight to PYO. These 






Solution Diffusion coefficients 
(cm2/s) for FcMeOH 
Diffusion coefficients 
(cm2/s) for PYO 
MOPS (3.5±0.3)×10-5 (4.0±0.7)×10-5 
1:1 (v/v) MOPS:SCFM2 (1.7±0.6)×10-6 (2.7±0.6)×10-6 
SCFM2 (2.1±0.4)×10-7 (2.8±0.6)×10-7 
Table 5.2: Determined apparent diffusion coefficients of PYO and FcMeOH in 
different SCFM2 sputum/buffer media. Data represent the mean of three 





Figure 5.3: Determination of diffusion coefficients by chronoamperometry.   
 
(a) Chronoamperometry responses for 90 µM PYO in the four different synthetic sputum 
media, and (b) the corresponding Cottrell plots.  
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5.3.2 Detection of Pyocyanin Production in Tandem with Confocal Imaging of P. 
aeruginosa Aggregates in SCFM2 
In previous chapters of this dissertation, the successful application of the T-CUA 
platform was demonstrated for the detection and real-time monitoring of PYO and 
various other phenazine species from P. aeruginosa strains.19,59,60 Chapters 2, 3 and 4 
discussed the advantages of T-CUAs in comparison to other electrochemical sensing 
devices, including amplified currents, fast response times, enhanced sensitivity, large 
liner dynamic ranges and high degrees of biocompatibility.19,59,60 An additional advantage 
of T-CUA electrodes is their planar and transparent features, which allow for 
electrochemical analyses to be performed concurrently with optical imaging of the 
bacterial cells on T-CUAs (Chapter 2).60 As a follow-up study, herein experiments were 
performed, in a collaborative effort with Dr. Sophie Darch of the Whiteley lab, to 
electrochemically detect and quantify PYO using T-CUAs while simultaneously 
monitoring bacterial aggregate formation in SCFM2 via confocal microscopy. Our initial 
data demonstrates that we can successfully detect QS responses in developing bacterial 
aggregates using PA14 strains, expressing a QS reporter plasmid, in SCFM2 while also 
being able to detect PYO secreted from QS P. aeruginosa cells. These preliminary data 
also indicate that PYO production in SCFM2 medium differs from commonly used 







Figure 5.4: Confocal microscopy imaging of bacterial aggregates in tandem with 
electrochemical quantification of PYO secreted from P. aeruginosa in 
SCFM2 sputum.  
(a) Confocal image of bacterial aggregates at 7.5 h of cell growth (b) Responding 
biomass determined GFP expression of quorum sensing bacterial cells. The confocal 
microscopy images and data in (a) and (b) were obtained in collaboration with the 
Whiteley laboratory and are a courtesy of Dr. Sophie Darch. (c) Time-dependent SWV 
current-potential responses of PYO secreted from P. aeruginosa in SCFM2 media. The 
peak at −0.256 V vs SCE is due to PYO redox. Quantified PYO concentrations are 
summarized in Table 5.3. 
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Liquid-batch cultures of P. aeruginosa PA14 ΔlasIΔrhlI strain were initially 
grown overnight at 37 °C in TSB media before re-introducing the cells into fresh SCFM2 
media. Upon introducing cells to SCFM2 medium, concurrent electrochemical 
measurements and confocal imaging were performed during the initial 8.5 h of cellular 
growth. Figure 5.4a illustrates a representative confocal microscopy image at 7.5 h of 
bacterial growth, where GFP-expressing aggregates represent P. aeruginosa bacteria 
responding to QS signals and the mCherry-expressing species are P. aeruginosa cells that 
are not engaged in QS. Using obtained confocal images, the responding biomass (QS 
GFP-expressing cells) was determined at 3 h, 7.5 h, and 8.5 h of bacterial growth in 
SCFM2 (Figure 5.4b). In tandem with confocal imaging, PYO production was monitored 
from P. aeruginosa in SCFM2 using SWV. The confocal images data on QS bacterial 
aggregate formation show a certain correlation with the electrochemical quantification of 
PYO. The data were analyzed using background-subtraction (background was 1:1 (v/v) 
SCFM2:TSB) to determine PYO concentrations secreted by bacteria. Our results in 
Figure 5.4c demonstrate the notable electroactive PYO peak around –0.256 V vs SCE, 
where current-potential responses are plotted as a function of time at various time points 
of cell growth. The determined PYO concentrations at these time points in SCFM2 media 
are summarized in Table 5.3. Our results show increasing PYO concentrations during an 
8-hour period, where the amounts of PYO secreted show a significant increase after 7 h 
bacterial growth. The maximum concentration of PYO was determined to be 36 ± 4 µM 
at 8.5 h growth. It should be noted that after 7 h, PYO concentrations plateau and do not 
change upon addition of an external QS signal, 3-oxododecanoyl homoserine lactone 
(30C12-HSL). Additionally, it should be noted that P. aeruginosa cultures in this study 
were kept at 25 °C for the duration of the experiments, which differs from experiments 
presented in Chapters 3 and 4 where cultures were grown under a physiological 
 161 
temperature of 37 °C during the entire period of experiments. Compared to the findings 
in Chapters 3 and 4, here no other phenazine metabolites were observed when P. 
aeruginosa was grown in SCFM2, which is likely due to differences in growth media 
composition, as well as due to different PA14 strains used in these studies. Thereby, the 
quantified PYO concentrations in SCFM2 are significantly lower than those determined 
from cultures grown in common laboratory growth media (Chapters 3 and 4). This 
indicates that bacteria in SCFM2 grow at different rates that in laboratory growth media, 
which is in agreement with very recent discoveries.13 Comparable to our conclusions in 
Chapter 4,19 these results highlight that laboratory culturing methods can provide 
inadequate models of growth environments, thus making it challenging to understand 
how bacteria persist and develop infections in the body. Similarly, these results point to 
the need for analytical standardization of growth media, which could have great 
implications towards understanding the onset of bacterial infections, antibiotic resistance, 
and treatments.  
Both optical imaging and electrochemical methods are relatively noninvasive with 
the analysis of biological systems. While optical imaging techniques proved a means for 
spatial analysis of bacterial cells, they have certain limitations. Specifically, they rely on 
the use of expressed fluorescent protein reporters,76,77 which are linked to time delays in 
the production of detectable signals and are limited by nonspecific reactivity. Differently, 
electrochemical sensors, such as T-CUAs, provide a means to directly detect and rapidly 
quantify key metabolic components with high sensitivity. Our transparent 
electrochemical devices allow for real-time electrochemical detection of redox-active 
metabolites19,59,60 to be performed together with spatial imaging of QS bacterial 
aggregates. Further work is necessary to examine the correlation between data obtained 
from confocal imaging and electrochemical measurement results. 
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Time (h) PYO concentration (µM) 
4 5.3 ± 0.3 
5 8.1 ± 0.4 
6 9.6 ± 0.5 
7 11 ± 1 
7.5 35 ± 2 
8 + signal 33 ± 3 
8.5 + signal 36 ± 4 
Table 5.3: Determined concentrations of cellular PYO concentrations measured at 
various time points of cell growth in SCFM2 media (shown are average 
concentrations values from three replicas).  
In future studies, more extensive environmental factors (oxygen availability, host 
generics, and antibiotics) need to be examined. Yet our electrochemical approach using 
T-CUAs provides a basis set to sensitively quantify relative differences in PYO 
production rates dependent on growth media composition. In a follow-up study using 
SCFM2 as a model, real-time electrochemical measurements will be performed using 
multiple wild-type and mutant P. aeruginosa strains, including both laboratory and 
clinical isolates. Additionally, quantitative electrochemical analyses, monitoring PYO 
production, need to be performed in synthetic sputum media variations (e.g., SCFM, 
SCFM2 mucin removed, SCFM2 DNA removed), as well as in expectorated CF sputum 
isolated from patients. Additional experiments need to be performed, including the 
introduction of disturbances to the biological system, to study the effects on PYO 
production in the presence of antimicrobial agents, as well as in more complex multi-
species environments (similar to studies in Chapter 4). 
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5.3.3 Electrochemical Monitoring of Pyocyanin and Nitric Oxide Interaction 
PYO is a low-molecular-mass biogenic species present in high concentrations of 
infected secretions from patients colonized with P. aeruginosa, thereby its reaction with 
NO• could be of high importance especially in understanding host-pathogen response 
mechanisms. In the 1990s, evidence of the inactivation of PYO by NO• (or vice versa) 
was discovered.53 In this study, Warren and co-workers passed NO• in a deoxygenated, 
aqueous solution of PYO and noted a rapid change of initial blue-pigment color to pink. 
Mass spectrometry (MS) methods, including fast atom bombardment and desorption 
electron-impact ionization, indicated the presence of trace amounts of phenazine 
metabolites, 1-hydroxyphenazine and 1-methoxyphenazine. Additionally, authors 
observed major ions of m/z 211 and m/z 193, which they suggested are due to 
nitrosylation of PYO by NO•, followed by dehydration step during MS analysis to form a 
substituted oxazoline.53 With the exception of this study by Warren et al., no additional 
evidence has been reported on the interaction between the two biomolecules. 
Consequently, the mechanism of the reaction between NO• and PYO is electrochemically 
investigated on T-CUA sensors herein. The T-CUA analytical responses to both NO• and 










Figure 5.5: Electrochemical monitoring of PYO/NO• interaction using T-CUAs.  
 
(a) UV-Vis absorbance spectra and (b) square wave voltammograms for 50 µM NO•, 100 
µM PYO, 1:1 (v/v) PYO:NO•, and 3:1 (v/v) PYO:NO• recorded simultaneously. 
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To investigate this PYO/NO• interaction, physiologically relevant concentrations 
of PYO (100 µM)71,78,79  and NO• (50 µM)50,80 were simultaneously detected via UV-Vis 
spectroscopy and SWV. Figure 5.5a shows the UV-Vis spectrophotometric data of 100 
µM PYO, 3:1 (v/v) 100 µM PYO: 50 µM NO•, 1:1 (v/v) 100 µM PYO: 50 µM NO•, and 
50 µM NO•. The pure PYO spectrum shows characteristic peak maxima at wavelengths 
of 249 nm, 307 nm, 370 nm, and 697 nm, which have been observed previously.81,82 The 
pure NO• spectrum shows a distinct absorption peak at 220 nm, associated with sσ, pπ, σ, 
and dδ transitions.83,84 Accordingly, as the ratio of PYO to NO• increases, the absorbance 
of the 220 nm band disappears. Following the decrease in PYO to NO• ratio, the presence 
of characteristic PYO peak at 697 nm disappears, as well as an observed increase in the 
presence of NO• by the appearance of its absorbance maxima at 220 nm. SWV 
measurements were performed in parallel with UV-Vis on T-CUAs.  
Figure 5.5b shows the corresponding SWV current-potential responses of pure 
PYO with a peak at –0.365 V vs Au and pure NO• with a peak at 0.71 V vs Au, as well as 
of the differing PYO/NO• ratio solutions. MS analysis of PYO/NO• solutions in the study 
by Warren and co-workers53 pointed to the presence of minor amounts of two phenazine 
derivatives, 1-hydroxyphenazine and 1-methoxyphenazine, which have known potentials 
of –0.35 V and –0.42 V, respectively,85,86 Consequently, this could explain the slight shit 
on PYO peak observed in the SWV responses for PYO/NO• solutions, however, it is 
more likely that this shift occurrence is due to the quasi-reference electrode used here. 
The resultant SWV data is inconsistent with the observations described by Warren et al 
involving an irreversible reaction between PYO and NO•. It should also be noted that no 
change in color (from blue to pink) was observed when nitric oxide was introduced to 
aqueous PYO solutions. These results indicate that PYO likely does not react with NO• at 
physiological pH conditions to form a nitrosylated PYO-NO• complex. Moreover, NO• 
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likely reacts with other species, such as molecular oxygen.87 Specifically, NO• converts to 
reactive nitrogen species in the presence of O2 or superoxide radicals, which damage 
biological macromolecules (e.g., DNA, lipids, proteins).24 Additionally, P. aeruginosa 
biofilms and PYO production are linked with oxygen availability.24,59 Under low oxygen 
levels, P. aeruginosa switches from its aerobic to anaerobic respiratory growth to obtain 
energy from nitrate respiration; this denitrification pathway involves an 8-electron 
reduction to NO3- to nitrogen gas by four reductases,88 but can also be activated by NO•.89  
As a result, preliminary time-dependent studies were performed to examine the 
interaction between PYO and NO• in the presence (Figure 5.6) and in the absence (Figure 
5.7) of O2 using the PYO/NO• solutions. Figures 5.6 and 5.7 show SWV measurements in 
the presence and absence of molecular oxygen, respectively, for the two different 
PYO/NO• solutions recorded when NO• was passed into deoxygenated aqueous PYO 
solution at 0 h and 1 h after the solutions were allowed to react. In the presence of O2, the 
PYO redox peak observed in the SWV after 1 h is broader than at 0 h for the 1:1 (v/v) 
PYO:NO• solution (Figure 5.6a), which could be due to slight changes in solution pH. On 
the other hand, this was not observed in the O2-present SWV curves, however, a shoulder 
peak at a more positive potential (–0.15 vs Au) appears (Figure 5.6b). Similarly, SWV 
measurements were performed for 1:1 (v/v) PYO:NO• and 3:1 (v/v) PYO:NO• solutions 
in a nitrogen glove bag, free of O2. The resulting SWV current responses show distinct 
redox peaks in the region where PYO redox appears (Figure 5.7). Specifically, SWV 
peaks at –0.75 V and –0.46 V vs Au (Figure 5.7a) and redox peaks at –0.70 V and –0.50 
V vs Au (Figure 5.7b) are observed for 1:1 (v/v) PYO:NO• and 3:1 (v/v) PYO:NO• 
solutions, respectively. Additionally, the redox peaks for nitric oxide appear wider 
compared to those for experiments performed in the presence of oxygen.  
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To better understand our preliminary electrochemical results, nanoelectrospray 
ionization (nano-ESI) MS experiments were performed with Dr. Christopher Crittenden 
of the Brodbelt research group. However, the MS studies proved to be challenging due to 
the use of a physiologically relevant SPB buffer (pH 7.0). Specifically, the use of 
nonvolatile buffers, such as SPB, is typically incompatible with MS detection as it could 
heavily interfere with ion generation.90 The salt concentrations present in SPB buffers 
make ion formation less reproducible, thereby causing ion suppression or adduction.91 
The MS spectra in the positive ion mode for the 1:1 (v/v) PYO:NO• solutions at 0 h and 1 
h showed the characteristic precursor ion at m/z 211.17, indicating the presence of PYO 
in the solutions. On the other hand, the MS spectra in the positive ion mode for the 3:1 
(v/v) PYO:NO• solutions at 0 h and 1 h did not detect any PYO present in the solution;  














Figure 5.6: Electrochemical monitoring of PYO/NO• interaction using T-CUAs with O2 




Square wave voltammograms recorded in the presence of molecular O2 for (a) 1:1 (v/v) 
PYO:NO• solution and (b) 3:1 (v/v) PYO:NO• solution at 0 h and 1 h after 50 µM NO• 
was passed into 100 µM PYO aqueous solution. 
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At present, our results are inconclusive and inconsistent with the findings of 
Warren et al.53 No explanation can be offered for these differences currently, especially 
since no immediate color changes were observed in the PYO/NO• solutions. Future work 
is necessary to examine the effects of O2 and/or other species (e.g., NADPH) that could 
act as limiting reagents in biological systems, which could make the PYO/NO• interaction 
extremely complicated. The changes in color of PYO solutions have been observed 
previously with changes in pH,40,92,93 where the immediate change in color from blue to 
pink was associated with a decrease in pH as protonated PYO is present. Our current 
results indicate that PYO is stable at pH 7.0, showing essentially no strong evidence of its 
reaction and/or interaction with NO•. In follow-up studies, combining UV-Vis, 
electrochemical and MS methods, PYO/NO• interaction experiments need to be 
performed in acidic and basic buffer solutions to examine the effects of pH on this 
reaction mechanism. Additional research needs to address the mechanism by which nitric 
oxide is bubbled into aqueous buffer; in particular, studies have shown that NO• can 
rapidly react with O2 in water to generate H+ and nitrite (NO2-), which could interfere 
with the reaction between PYO and NO•.94-96 Finally, since redox processes are 
concentration-dependent, studies should be performed to examine the kinetics of this 
reaction. Specifically, NO• immune responses are known to have broad concentration-
dependent activity against microbes ranging from signaling molecule-like anti-biofilm to 
bacterial activity, 24 thereby concentration-dependent studies need to be performed.  
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Figure 5.7: Electrochemical monitoring of PYO/NO• interaction using T-CUAs without 
O2 present.   
Square wave voltammograms recorded in the absence of O2 for (a) 1:1 (v/v) PYO:NO• 
solution and (b) 3:1 (v/v) PYO:NO• solution at 0 h and 1 h after 50 µM NO• was passed 
into 100 µM PYO aqueous solution. 
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5.4 CONCLUSIONS 
5.4.1 Electrochemical Monitoring of P. aeruginosa Phenazine Production in Growth 
Media and Samples of Clinical Relevance 
The CF lung represents an immense biological landscape in which distinct 
multicellular populations of microbes can develop. Dynamic pathogenic responses and 
virulence mechanisms are highly dependent on the nutritional composition of growth 
environments, as demonstrated by findings in Chapters 3 and 4. Research studies 
presently depend on standard culturing methods and liquid-batch cultures, thus providing 
unsuitable models to study these pathogenic systems. Although a non-standardized 
method of growth media, SCFM2 sputum as media closely represents key attributes of in 
vivo environments (e.g., CF lungs). In the initial portions of this dissertation chapter, the 
viscosity and electrochemical apparent diffusion coefficients of PYO in SCFM2 and its 
variations were characterized and quantified. Specifically, the determined kinematic 
viscosity of SCFM2 was 3.2×10-6
 
m2/s, which was comparable to that of CF sputum 
isolated from the lungs of CF patients. Additionally, the diffusion coefficient of PYO in 
SCFM2 was determined to be 2.8×10-7
 
cm2/s. Removal of various key polymeric 
components from SCFM2 indicated that mucin is the primary polymer likely impacting 
both viscosity and diffusion in SCFM2 sputum. Following the characterization of 
SCFM2, preliminary studies were successfully performed to monitor P. aeruginosa PYO 
production while imaging the formation of bacterial aggregates in SCFM2 on T-CUA 
electrodes, showing a certain degree of correlation between the two methods. 
Importantly, the quantified PYO concentrations secreted from P. aeruginosa grown in 
SCFM2 are significantly lower than those concentrations from P. aeruginosa grown in 
typical laboratory growth media (Chapters 3 and 4). These results indicate that P. 
aeruginosa cells likely grow at slower rates in SCFM2 sputum. These findings highlight 
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that laboratory cell culturing methodologies provide inadequate representations of how 
bacteria persist in the human body. Our T-CUAs electroanalytical devices have the 
sensitivity to distinguish differences based on correlative measurements in SCFM2 
media, laboratory media as well as polymicrobial samples. Additionally, T-CUAs are 
transparent which allows for imaging of bacterial cells while electrochemically 
quantifying PYO production from P. aeruginosa. 
Future studies, involving both confocal imaging and electrochemical 
measurements, should focus on studying PYO production in SCFM2 in the presence of 
other clinically relevant pathogens (Staphylococcus aureus, Escherichia coli, 
Staphylococcus epidermidis, Enterococcus faecalis) as well as host cells. Additional 
research in the future should examine virulence factor production in P. aeruginosa 
strains and samples of clinical relevance. Finally, the state of infection needs to be 
reexamined for diagnosis, in particular with respect to the analytical standardization of 
simulated growth media. 
5.4.2 Future Directions: Interaction Between Pyocyanin and Nitric Oxide 
In the second part of this chapter, the interaction reaction between PYO and NO• 
was investigated using T-CUAs bioanalytical devices for UV-Vis spectroscopy and 
electrochemical studies. Our preliminary results showed no strong evidence of PYO 
reacting with NO• as no PYO-NO• complex formation was observed via UV-Vis, 
electrochemical and MS methods at physiological pH 7.0. Future work should examine 
the effects of oxygen and/or other biological species (e.g., NADPH) on PYO/NO• 
interaction. Additionally, pH- and concentration-dependent studies need to be conducted 
to further investigate the interaction between these two biological species. Understanding 
the interaction reaction between PYO and NO• is of importance to investigators 
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researching pathogen-host responses and NO• biological problems, especially to those 
who have attributed an effect of PYO to its chemical reaction with NO• as suggested by a 
single 1990s study. Other mechanisms by which PYO could interact with NO• include 
direct inhibition of NO synthase, as suggested by previous research.97 This and other 
potential mechanisms, along with reaction kinetics, have to be fully examined in future 
experiments combining electrochemical and MS techniques. 
Finally, a study showed that NO•-induced biofilm dispersal completely eliminated 
P. aeruginosa biofilms in vitro.29 Additional proof-of-concept studies have shown the 
effectiveness of NO•-induced biofilm dispersal strategies in the treatment of chronic P. 
aeruginosa infections in CF patients,98 where NO• treatments resulted in the reduction of 
biofilm biomass in CF lungs after 5-7 days. Therefore, future work in this area needs to 
focus on electrochemically monitoring the role of NO• on inducing P. aeruginosa biofilm 
dispersal. This mechanism needs to be further examined in order to understand and 
develop most effective treatments of chronic P. aeruginosa infections. 
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Appendix 1: Real-time Electrochemical Detection of Pseudomonas 
aeruginosa Phenazine Metabolites using Transparent Carbon 
Ultramicroelectrode Arrays6 
A1.1 EXPERIMENTAL METHODS 
A1.1.1 Electrochemical Determination of Diffusion Coefficients of Pyocyanin (PYO)  
Background solutions were tryptic soy broth (TSB) and lysogeny broth (LB) 
growth media, while solutions of 90 µM PYO in LB and TSB were used to determine 
diffusion coefficients of PYO. Using double step potential chronoamperometry by 
initially holding the potential at −0.32 V vs SCE for 1 s, then holding the potential at 
−0.15 V vs SCE for 25 s, followed by stepping the potential back to −0.22 V vs SCE for 
another 25 s, in the aforementioned solutions. Using the obtained chronoamperograms, 
Cottrell plots were made, from which the corresponding diffusion coefficients for PYO in 
each media were determined. 
A1.1.3 Cell Imaging 
Images presented in electronic supporting information were acquired with a 
Nikon A1R confocal microscope using Nikon image-capture software. Bacterial cells 
PA14 were visualized via green fluorescence protein (gfp) expression utilizing 
appropriate filter set and v-filtering function. Images were acquired using a 20× air 
objective to image cells through T-CUAs. 
 
                                                
6Adapted with permission from Simoska, O.; Sans, M.; Fitzpatrick, M. D.; Crittenden, C. M.; Eberlin, L. 
S.; Shear, J. B.; Stevenson, K. J. Real-time Electrochemical Detection of Pseudomonas aeruginosa 
Phenazine Metabolites using Transparent Ultramicroelectrode Arrays. ACS Sensors 2019, 4, 170–179. 
Copyright © 2019 American Chemical Society. Simoska, O. acquired the data, wrote the manuscript, and 
performed electrochemical measurements/characterization. Simoska, O., Crittenden. C. M., and Sans, M. 
performed mass spectrometry experiments. Simoska, O. and Stevenson, K. J. designed studies, planned 
experiments, and analyzed all data. All authors contributed in editing the manuscript. 
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A1.2 ADDITIONAL DATA 
 
Growth Media TSB LB 
Time (h) PYO Concentration (µM) 
0 7.2 ± 0.2 17.4 ± 0.5 
1 7.0 ± 0.3 18 ± 2 
2 8.2 ± 0.8 19 ± 2 
3 15.6 ± 0.3 22 ± 2 
4 25.3 ± 0.6 33.2 ± 0.6 
5 45.6 ± 0.9 41 ± 2 
6 58 ± 2 55 ± 2 
7 75 ± 2 71 ± 3 
8 84 ± 2 79 ± 1 
9 100 ± 4 84 ± 2 
10 110 ± 5 94 ± 3 
11 120 ± 4 110 ± 1 
12 130 ± 5 120 ± 3 
15 160 ± 5 130 ± 2 
18 180 ± 4 150 ± 1 
21 190 ± 5 150 ± 1 
24 180 ± 6 150 ± 4 
30 160 ± 6 141 ± 16 
36 170 ± 5 130 ± 8 
42 160 ± 6 130 ± 6 
48 140 ± 6 130 ± 5 
Table A1.1: Concentrations of PYO secreted from P. aeruginosa measured at each time 
point in both TSB and LB media (shown are average concentration values 







Growth Media Diffusion coefficients (cm2/s) 
TSB (3.4±0.8)×10-6 
LB  (5.1±0.1)×10-6 
Table A1.2: Determined diffusion coefficients of 90 µM PYO in TSB and LB media 
using double potential step chronoamperometry. 
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Figure A1.1: Square wave voltammograms taken over time of PA14 in LB growth media 
in time frames (a) 0–12 h, (b) 0–24 h, and (c) 0–48 h. 
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Figure A1.2: Square wave voltammograms taken over time of PA14 in TSB growth 
media in time frames (a) 0–12 h, (b) 0–24 h, and (c) 0–48 h. 
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Figure A1.3: Dependence of PYO peak potential on pH. 
 
(a) Peak potential of PYO plotted as a function of time using data shown in Figure 3.3 for 
TSB and LB. PYO peak potential shifts to more negative values over time, which is 
likely due to changes in pH of solutions. (b) Time-based measurements of pH of PA14 
cultures in TSB and LB. Peak potential shifts plotted as a function of pH for (c) TSB and 
(d) LB, showing almost a completely Nernstian behavior with slope values close to 59 
mV/pH unit. Values plotted are the mean from 3x replicated with error bars showing 
standard error of the mean. 
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Figure A1.4: Cyclic voltammograms at different scan rates to test PYO polymerization 




Using 100 µM PYO on T-CUA electrodes, and a scan rate of 100 mV s-1, CVs were 
performed in (a) LB and (b) TSB media. Note that there is no polymerization of PYO 
observed in this potential window. 
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Figure A1.5: Biocompatibility of T-CUA electrodes showing that it takes 20 scans to 
establish double layer capacitance in biologically relevant media.  
Background cyclic voltammograms at scan rate 50 mV s-1 using (a) LB and (b) TSB. 
Square wave voltammograms showing background scan 20 of T-CUAs before and after 
48-hour long experiments in (c) LB and (d) TSB. These square wave curves show that we 
can successfully re-establish double layer capacitance after using CUAs for 48-hour 
continuous monitoring of PYO. These data demonstrate that T-CUAs have excellent 
biocompatibility. 
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Figure A1.6: Biocompatibility of T-CUA electrode surfaces.  
 
GFP-expressing P. aeruginosa PA14 in TSB imaged through T-CUAs. Confocal images 
of (a) an edge of a droplet of PA14 liquid culture in LB on T-CUA and (b) zoom-in view 
of bacterial culture shown in (a). 
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Figure A1.7: DESI-MS spectra of at various time points with changes in the relative 
abundances of hexose, hexonic acid and keto-hexonic acid. 
DESI-MS spectra of (a) TSB and (c) LB growth media at various time points, showing 
changes in the relative abundances of hexose (m/z 215.032), hexonic acid (m/z 195.051) 
and keto-hexonic acid (m/z 193.035). MS spectra in the right column represent a zoomed 
in mass spectra from m/z 191 to m/z 199 for (b) TSB and (d) LB media. These species 
detected in LB media have lower the relative abundances to TSB. Data collected with the 
assistance of Marta Sans of the Eberlin research group. 
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DESI MS/MS spectra of LB and TSB growth media in (a) positive ion mode, and (b) 
negative ion mode. Note that there is a very high abundance of choline and hexose in 
TSB media compared to LB. Data collected with the assistance of Marta Sans of the 




m/z Attribution Ion Molecular formula 
Mass 
Error 
104.107 Choline [M+H]+ C5H14NO -4.8 
118.086 Valine [M+H]+ C5H12NO2 -4.2 
140.068 Valine [M+Na]+ C5H11NO2Na -2.1 
156.042 Valine [M+K]+ C5H11NO2K -1.9 
166.086 Penylalanine [M+H]+ C9H12NO2 -2.4 
210.050 Penylalanine [M+2Na-H]+ C9H10NO2Na2 -2.9 
241.997 Penylalanine [M+2K-H]+ C9H10NO2K2 -2.9 
227.079 LG, GL, IG, GI [M+K]+ C8H16N2O3K -3.5 
211.105 LG, GL, IG, GI [M+Na]+ C8H16N2O3Na -3.3 
265.034 LG, GL, IG, GI [M+2K-H]+ C8H15N2O3K2 -3.4 
203.138 AL, LA, AI, IA [M+H]+ C9H19N2O3 -3.0 
203.052 Hexose [M+Na]+ C6H12O6Na -2.5 
219.026 Hexose [M+K]+ C6H12O6K -2.7 
231.170 VL, LV, VI, IV [M+H]+ C11H23N2O3 -2.6 
245.078 Uridine [M+H]+ C9H13N2O6 3.7 
Table A1.3: Contents of TSB and LB media identified using high mass accuracy and 









Species identified (Figure A1.8a) have different relative abundances in each media. Data 
collected with the assistance of Marta Sans of the Eberlin research group. 
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Detected 





117.019 Succinate [M+H]- C4H5O4 -0.4 
128.035 Pyroglutamate [M+H]- C5H6NO3 -0.3 
133.014 Malate [M+H]- C4H5O5 -0.5 
146.046 Glutamate [M+H]- C5H8NO4 -0.3 
154.062 Histidine [M+H]- C6H8N3O2 -0.7 
179.056 Hexose [M+H]- C6H11O6 -1.1 
187.109 LG, GL, IG, GI [M+H]- C8H15N2O3 -1.5 
191.020 Citrate [M+H]- C6H7O7 -1.0 
201.124 AL, LA, AI, IA [M+H]- C9H17N2O3 -1.6 
203.103 V-S [M+H]- C8H15N2O4 -1.8 
215.032 Hexose [M+Cl]- C6H12O6Cl -1.5 
229.155 VL, LV, VI, IV [M+H]- C11H21N2O3 -2.0 
243.062 Uridine [M+H]- C9H11N2O6 -2.0 
244.130 LB, BL, IB, BI, VQ, QV [M+H]- C10H18N3O4 -2.0 
245.114 VE, EV, DL, LD, DI, ID [M+H]- C10H17N2O5 -1.9 
259.129 EL, LE, EI, IE [M+H]- C11H19N2O5 -1.9 
267.146 HL, LH, HI, IH [M+H]- C12H19N4O3 -1.9 
279.038 Uridine [M+Cl]- C9H12N2O6Cl -1.8 
377.086 Disaccharides (2Hexose) [M+Cl]- C12H22O11Cl 0.3 
Table A1.4: Contents of TSB and LB media identified using high mass accuracy and 
DESI MS/MS in the negative ion mode.  
 
 
Species identified (Figure A1.8b) have different relative abundances in each media. Data 
collected with the assistance of Marta Sans of the Eberlin research group. 
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Figure A1.9: DESI-MS ion images and spectra for 1-hydroxyphenazine (OHPHZ) at 
various time points in LB and TSB. 
 
 
DESI-MS ion images for 1-hydroxyphenazine (OHPHZ) at m/z 197.070 at various time 
points in (a) LB and (b) TSB with respective DESI-MS spectra in LB for OHPHZ shown 
in (c). The top DESI-MS spectra in (c) shows that species is present with highest 
abundance at 21 hours in LB, and the bottom shows in silico mass spectra. Note that m/z 
197.071 and m/z 198.074 represent the C12 and C13 isotopes, respectively. (d) Molecular 
structure, formula and exact mass of OHPHZ. Data collected with the assistance of Marta 
Sans of the Eberlin research group. 
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(ppm) Exact Mass  
PYO   C13H11O2N 211.0861 2.4 211.0866 
HHQ  C16H22ON 244.1691 2.0 244.1696 
PQS or HQNO  C16H22O2N 260.1638 2.7 260.1645 
C 9:1 - NHQ  C18H24ON 270.1848 1.5 270.1852 
NHQ  C18H26ON 272.2003 2.2 272.2009 
C9:1-NQNO  C18H24O2N 286.1798 1.4 286.1802 
C9-PQS or C9-NQNO  C18H26O2N 288.1953 1.7 288.1958 
C11:1-UHQ  C20H28ON 298.2160 1.7 298.2165 
Table A1.5: Phenazine and quinolone species from P. aeruginosa detected from DESI-
MS mass spectra using high mass accuracy and tandem MS measurements 










Phenazine (PYO) and quinolone species (i.e., HHQ, HQNO, NHQ, PQS) from P. 
aeruginosa detected from DESI-MS mass spectra using high mass accuracy and tandem 
MS measurements in the positive ion mode. Data collected with the assistance of Marta 
Sans of the Eberlin research group. 
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Figure A1.10: P. aeruginosa liquid-batch cultures in LB growth media at various time 






PYO is a blue-pigmented nitrogen-containing aromatic species, known to give a 
blue/green appearance to P. aeruginosa cultures. Due to its characteristic blue color, 
PYO is commonly detected using spectrophotometric approaches. While at 0 and 3 h, the 
bacterial cultures appear yellow and there is no blue/green color indication of presence of 
PYO (such as green liquid cultures in flasks at 9 and 15 h), levels of cellular PYO are 
electrochemically detected as demonstrated in Figure 3.4. 
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Appendix 2: Electrochemical Monitoring of the Impact of Polymicrobial 
Infections on Pseudomonas aeruginosa and Growth Dependent Medium7 
A2.1 ADDITIONAL DATA 
Microbial 
Environment Pa Pa and Sa Pa and Ec Pa, Sa and Ec 
Time (h) PYO Concentrations (µM) in LB  
0 17.4 ± 0.5 9.1 ± 0.5 7.5 ± 0.2 4.2 ± 0.3 
1 18 ± 2 9.0 ± 0.5 7.6 ± 0.1 4.6 ± 0.1 
2 19 ± 2 9.3 ± 0.3 7.9 ± 0.2 4.6 ± 0.1 
3 22 ± 2 8.2 ± 0.4 8.0 ± 0.4 4.5 ± 0.1 
4 33.2 ± 0.6 11 ± 1 10.5  ± 0.3 4.9 ± 0.1 
5 41 ± 2 17 ± 1 14.2 ± 0.6 5.7 ± 0.1 
6 55 ± 2 25 ± 2 18.3 ± 0.6 7.2 ± 0.4 
7 71 ± 3 34 ± 2 21.8 ± 0.8 8.8 ± 0.7 
8 79 ± 1 44 ± 3 28.1 ± 0.7 12 ± 1 
9 84 ± 2 55 ± 3 35.0 ± 0.9 13 ± 2 
10 94 ± 3 63 ± 3 42 ± 1 16 ± 2 
11 110 ± 1 75 ± 3 50 ± 2 19 ± 3 
12 120 ± 3 88 ± 3 58 ± 2 20 ± 3 
15 130 ± 2 120 ± 4 68 ± 2 23 ± 3 
18 150 ± 1 140 ± 3 70 ± 3 27 ± 3 
21 150 ± 1 150 ± 1 72 ± 1 28 ± 3 
24 150 ± 4 150 ± 8 71 ± 1 28 ± 4 
30 141 ± 16 150 ± 7 65 ± 1 25 ± 3 
36 130 ± 8 140 ± 8 60 ± 1 24 ± 3 
42 130 ± 6 140 ± 3 64 ± 1 25 ± 2 
48 130 ± 5 140 ± 5 63 ± 2 26 ± 2 
Table A2.1: Pyocyanin (PYO) concentrations determined at each time point in 
polymicrobial samples in LB media (shown are average concentrations from 
6x replicas). Pa for P. aeruginosa, Sa for S. aureus, and Ec for E. coli. 
 
                                                
7Adapted with permission from Simoska, O.; Sans, M.; Eberlin, L. S.; Shear, J. B.; Stevenson, K. J. 
Electrochemical Monitoring of the Impact of Polymicrobial Infections on Pseudomonas aeruginosa and 
Growth Dependent Medium. Biosens. Bioelectron. 2019, 142, 111538. Copyright © 2019 Elsevier. 
Simoska O. acquired the data, wrote the manuscript, and performed electrochemical 
measurements/characterization. All authors contributed in editing the manuscript. 
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Microbial 
Environment Pa Pa and Sa Pa and Ec Pa, Sa and Ec  
Time (h) PYO Concentrations (µM) in TSB  
0 7.2 ± 0.2 2.7 ± 0.2 1.0 ± 0.1 1.0 ± 0.1 
1 7.0 ± 0.3 2.3 ± 0.3 1.0 ± 0.1 1.0 ± 0.1 
2 8.2 ± 0.8 2.8 ± 0.2 1.0 ± 0.1 1.0 ± 0.1 
3 15.6 ± 0.3 4.1 ± 0.2 1.0 ± 0.1 1.0 ± 0.1 
4 25.3 ± 0.6 4.4 ± 0.7 1.0 ± 0.1 1.0 ± 0.2 
5 45.6 ± 0.9 4.8 ± 0.5 1.0  ± 0.2 1.0 ± 0.1 
6 58 ± 2 10 ± 1 1.0  ± 0.1 1.0 ± 0.1 
7 75 ± 2 16 ± 1 1.0  ± 0.1 1.0 ± 0.1 
8 84 ± 2 22 ± 1 1.0  ± 0.1 1.0 ± 0.2 
9 100 ± 4 26 ± 2 1.1 ± 0.2 1.0 ± 0.3 
10 110 ± 5 32 ± 1 2.1 ± 0.2 1.0 ± 0.2 
11 120 ± 4 38 ± 1 4.4 ± 0.2 1.0 ± 0.2 
12 130 ± 5 45 ± 1 6.4 ± 0.1 1.0 ± 0.1 
15 160 ± 5 60 ± 2 6.7 ± 0.3 1.0 ± 0.1 
18 180 ± 4 68 ± 2 8.3 ± 0.2 1.0 ± 0.2 
21 190 ± 5 78 ± 2 9.3 ± 0.2 1.1 ± 0.8 
24 180 ± 6 78 ± 3 5.4 ± 0.1 1.2 ± 0.1 
30 160 ± 6 74 ± 2 5.4 ± 0.1 1.8 ± 0.2 
36 170 ± 5 59 ± 1 3.8 ± 0.1 2.3 ± 0.2 
42 160 ± 6 53 ± 2 4.1 ± 0.3 4.1 ± 0.2 
48 140 ± 6 58 ± 2 4.2 ± 0.4 8.2 ± 0.5 
Table A2.2: PYO concentrations determined at each time point in polymicrobial 
environments in TSB media (shown are average concentrations from 6x 











Environment Pa Pa and Sa Pa and Ec Pa, Sa and Ec 
Time (h) 5-MCA Concentrations (µM) in LB 
0 1.1 ± 0.2 1.3 ± 0.1 0.6 ± 0.1 1.1 ± 0.1 
1 1.2 ± 0.2 1.5 ± 0.2 0.6 ± 0.1 1.5 ± 0.1 
2 1.3 ± 0.2 1.6 ± 0.4 0.7 ± 0.1 1.6 ± 0.2 
3 3.8 ± 0.9 1.3 ± 0.2 0.9 ± 0.2 2.2 ± 0.4 
4 16 ± 1 5.9 ± 0.4 3.3 ± 0.5 3.6 ± 0.5 
5 31 ± 3 16 ± 1 5.3 ± 0.3 5.9 ± 0.7 
6 43 ± 1 27 ± 2 6.3 ± 0.4 7.8 ± 0.9 
7 57 ± 2 32 ± 2 6.4 ± 0.4 7.9 ± 0.8 
8 68 ± 3 39 ± 2 6.7 ± 0.3 8.0 ± 0.8 
9 78 ± 5 47 ± 3 7.1 ± 0.2 10 ± 1 
10 75 ± 4 49 ± 2 8.6 ± 0.3 10 ± 1 
11 64 ± 3 53 ± 2 9.9 ± 0.4 12 ± 2 
12 51 ± 3 56 ± 3 9.8 ± 0.6 11 ± 2 
15 3.5 ± 0.9 52 ± 2 7.5 ± 0.6 11 ± 2 
18 2.8 ± 0.9 23 ± 1 5.9 ± 0.8 7.4 ± 0.9 
21 2.3 ± 0.6 10 ± 1 3.9 ± 0.6 4.1 ± 0.8 
24 5.4 ± 0.9 4.9 ± 0.5 2.4 ± 0.3 2.5 ± 0.9 
30 6.7 ± 0.8 3.5 ± 0.3 1.1 ± 0.1 1.5 ± 0.4 
36 5.9 ± 0.7 2.5 ± 0.2 0.5 ± 0.1 1.0 ± 0.2 
42 5.6 ± 0.4 2.9 ± 0.1 0.5 ± 0.1 1.0 ± 0.2 
48 6.2 ± 0.7 1.2 ± 0.2 0.5 ± 0.1 1.0 ± 0.1 
Table A2.3: 5-methylphenazine-1-carboxylic acid (5-MCA) concentrations determined 
at each time point in polymicrobial environments in LB media (shown are 
average concentrations from 6x replicas). Pa stands for P. aeruginosa, Sa 









Environment Pa Pa and Sa Pa and Ec Pa, Sa and Ec 
Time (h) 5-MCA Concentrations (µM) in TSB 
0 2.3 ± 0.7 1.0 ± 0.2 0.15 ± 0.04 0.39 ± 0.04 
1 2.6 ± 0.9 1.0 ± 0.3 0.15 ± 0.02 0.35 ± 0.05 
2 3.5 ± 0.9 1.0 ± 0.2 0.19 ± 0.02 0.28 ± 0.06 
3 10 ± 1 3.2 ± 0.5 0.20 ± 0.04 0.34 ± 0.07 
4 36 ± 1 5.3 ± 0.8 0.27 ± 0.02 0.31 ± 0.06 
5 83 ± 2 6.1 ± 0.2 0.34 ± 0.02 0.31 ± 0.05 
6 140 ± 4 12 ± 1 0.32 ± 0.03 0.31 ± 0.05 
7 201 ± 8 19 ± 1 0.31 ± 0.02 0.34 ± 0.04 
8 220 ± 2 24 ± 2 0.36 ± 0.02 0.40 ± 0.03 
9 210 ± 7  28 ± 2 0.34 ± 0.06 0.43 ± 0.03 
10 190 ± 6 33 ± 2 1.0 ± 0.3 0.51 ± 0.02 
11 170 ± 4 35 ± 2 1.8 ± 0.4 0.67 ± 0.05 
12 130 ± 9 38 ± 2 2.8 ± 0.5 0.61 ± 0.04 
15 48 ± 7 38 ± 4 1.9 ± 0.3 0.52 ± 0.02 
18 10 ± 2 34 ± 4 1.5 ± 0.1 0.53 ± 0.02 
21 1.5 ± 0.5 33 ± 4 1.5 ± 0.1 1.0 ± 0.1 
24 1.1 ± 0.5 22 ± 3  1.0 ± 0.1 1.0 ± 0.2 
30 1.6 ± 0.5 3.2 ± 0.3 0.33 ± 0.08 1.0 ± 0.4 
36 2.6 ± 0.7 2.1 ± 0.3 0.31 ± 0.07 1.0 ± 0.3 
42 1.1 ± 0.4 1.9 ± 0.2 0.39 ± 0.09 1.7 ± 0.3 
48 1.0 ± 0.2 1.4 ± 0.3 0.33 ± 0.08 3.3 ± 0.9 
Table A2.4: 5-MCA concentrations determined at each time point in polymicrobial 
environments in TSB media (shown are average concentrations from 6x 
replicas). Pa stands for P. aeruginosa, Sa for S. aureus, and Ec for E. coli. 
 203 
Figure A2.1: DESI-MS data of choline at m/z 104.107 obtained at 5 h of bacterial growth 
in three different polymicrobial co-cultures in LB and TSB.  
(a) DESI-MS ion images for choline in (i) Pa and Sa, (ii) Pa and Ec, and (iii) Pa, Sa, and 
Ec in LB (top) and TSB (bottom). Higher abundance of choline observed in TSB relative 
to LB media. In LB and TSB media samples only, choline abundances are higher 
compared to those of samples containing cells, indicating that cells are consuming 
choline species present in media. (b) DESI-MS spectra of choline (positive ion mode) for 
LB media compared to three polymicrobial samples in LB. Similar choline abundances 
observed in all three co-culture samples, with lowest choline abundance in Pa and Ec 
sample. (c) DESI-MS spectra of choline (positive ion mode) for TSB media compared to 
three polymicrobial samples in TSB. In all three polymicrobial samples in TSB analyzed, 
choline abundances are similar, with potentially higher abundance in Pa, Sa and Ec 
sample. NL corresponds to the ion abundance (ion current). Pa stands for P. aeruginosa, 
Sa for S. aureus, and Ec for E. coli. Data collected with the assistance of Marta Sans of 
the Eberlin research group. 
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 Figure A2.2: DESI-MS spectra obtained in LB media at 5 h cell growth.  
 
(a) DESI-MS spectra (positive ion mode) for LB, Pa and Sa in LB, Pa and Ec in LS, and 
Pa, Sa and Ec in LB, and for comparison (b) DESI-MS spectra (positive ion mode) for 
Pa only in LB media. Relatively higher abundance of PYO at m/z 211.086 and lower 
abundance of choline at m/z 104.107 for the sample containing Pa cells only in TSB 
shown in (b) compared to three co-cultured samples in (a). NL corresponds to the ion 
abundance (ion current). Pa stands for P. aeruginosa, Sa for S. aureus, and Ec for E. coli. 
Data collected with the assistance of Marta Sans of the Eberlin research group. 
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Figure A2.3: DESI-MS spectra obtained in TSB media at 5 h cell growth.  
(a) DESI-MS spectra (positive ion mode) for TSB, Pa and Sa in TSB, Pa and Ec in TBS, 
and Pa, Sa and Ec in TSB, and for comparison (b) DESI-MS spectra (positive ion mode) 
for Pa only in TSB media. Relatively higher abundance of PYO at m/z 211.086 and much 
lower abundance of choline at m/z 104.107 for the sample containing Pa cells only in 
TSB shown in (b) compared to three co-cultured samples in (a). NL corresponds to the 
ion abundance (ion current). Pa stands for P. aeruginosa, Sa for S. aureus, and Ec for E. 
coli. Data collected with the assistance of Marta Sans of the Eberlin research group. 
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Figure A2.4: DESI-MS spectra (negative ion mode) show different species in LB media 
at 5 h cell growth.  
Mass spectra for LB, Pa and Sa in LB, Pa and Ec in LB, and Pa, Sa and Ec in LB, shown 
top to bottom, respectively. Multiple species detected include succinate at m/z 117.019, 
pyroglutamate at m/z 128.035, glutamate at m/z 146.046, histidine at m/z 154.062, hexose 
[M-H]- at m/z 179.056, dipeptide at m/z 187.042, hexose [M+Cl]- at m/z 215.032, uridine 
at m/z 279.039, and disaccharide at m/z 377.085. Changes in metabolite abundances 
observed due to the presence of different bacterial species. Hexose abundance in LB 
media only is higher compared to hexose abundances in three co-cultured samples. NL 
represents the ion abundance (ion current). Pa stands for P. aeruginosa, Sa for S. aureus, 




Figure A2.5: DESI-MS spectra (negative ion mode) show different species in LB media 
at 5 h cell growth.  
  
Mass spectra for LB, Pa and Sa in LB, Pa and Ec in LB, and Pa, Sa and Ec in LB, shown 
top to bottom, respectively. Multiple species detected include succinate at m/z 117.019, 
pyroglutamate at m/z 128.035, glutamate at m/z 146.046, histidine at m/z 154.062, hexose 
[M-H]- at m/z 179.056, dipeptide at m/z 187.042, hexose [M+Cl]- at m/z 215.032, uridine 
at m/z 279.039, and disaccharide at m/z 377.085. Changes in metabolite abundances 
observed due to the presence of different bacterial species. Hexose abundance in LB 
media only is higher compared to hexose abundances in three co-cultured samples. NL 
represents the ion abundance (ion current). Pa stands for P. aeruginosa, Sa for S. aureus, 




Figure A2.6: DESI-MS ion images (negative ion mode) for polymicrobial samples in LB 






Overall higher abundance of metabolites observed in TSB compared to LB. Differences 
in metabolite abundances observed in samples containing bacterial species. Succinate at 
m/z 117.019 is less abundant in Pa and Sa samples in both LB and TSB. Citrate at m/z 
191.019 and gluconate at m/z 195.051, which are more abundant in TSB compared to LB, 
show lower abundances in Pa and Ec, and Pa, Sa and Ec polymicrobial samples. 
Disaccharide at m/z 377.085 is less abundant in samples containing Sa cells. Although the 
deprotonated and chlorinate hexose species should correspond to same species, the 
abundances of hexose [M-H]- and [M+Cl]- species are very different, likely due to 
changes occurring depending on the type of adduct. Abundance scale is set to the same 
value for species in both TSB and LB media for comparison. Corresponding DESI-MS 
spectra are shown in Figures A2.4 and A2.5. Pa stands for P. aeruginosa, Sa for S. 
aureus, and Ec for E. coli. Data collected with the assistance of Marta Sans of the Eberlin 
research group. 
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Figure A2.7: DESI-MS ion images (negative ion mode) for hexose at m/z 215.032 for Pa 














DESI-MS ion images (negative ion mode) for hexose at m/z 215.032 for Pa cells only in 
LB and TSB at 6 h cell growth for comparison to DESI-MS ion images shown in Figure 
A2.6. Qualitatively, the hexose abundance is higher in samples with Pa cells only 
compared to abundance observed in polymicrobial samples. Pa stands for P. aeruginosa. 
Data collected with the assistance of Marta Sans of the Eberlin research group. 
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Table A2.5: Table summary of commonly used growth media for P. aeruginosa reported 
in the literature. LB and TSB (in blue) are the most commonly used media. 
 
Growth Media P. aeruginosa strains and other pathogens 
Used to Study 
Phenazines? Ref. 





TSB broth,  (2) M63 minimal 
salts media 
	





(1) TSB media, (2) LB media 
*the study uses urine, 
bronchial lavages, 
heparinized blood, and 
sputum, but the cells are 
grown in TSB and LB media 
and then introduced to these 
biological samples prior to 
echem measurements 
 
P. aeruginosa PA14 Yes, PYO 3  
(1) TSB media 
 
Various P. aeruginosa 
clinical isolates: hospital, 
mucoidal, and cystic 
fibrosis strains 
 
Yes, PYO 4 
(1) TSB media 
 
NCTC 6749, NCTC 8060 
and NCTC 8602 P. 
aeruginosa strains 
 
Yes, PYO 5 
 
Mueller-Hinton broth (MHB), 
(2) TSB media, (3) LB media, 
(4) Sabouraud dextrose broth 
(SDB), (5) buffered yeast 
extract broth (BYEB),  (6) 
nutrient broth (NB)  
	
S. aureus ATCC29213, E. 
coli ATCC25922, P. 
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Table A2.5 (continued) 
 
Growth Media P. aeruginosa strains and other pathogens 
Used to Study 
Phenazines? Ref. 





LB media, (2) ABTG 
medium containing 15.1 
mM (NH4)2SO4, 33.7 mM 
Na2HPO4, 22.0 mM 
KH2PO4, 0.05 mM NaCl, 
1 mM MgCl2·6H2O, 100 
µM CaCl2, 1 µM FeCl3, 
and 28 mM glucose 
(C6H12O6) 
	
Wild-type P. aeruginosa 
PAO1 and ΔpqsC + sPqsE 
mutant strains 
Yes, PYO 8 
(1) LB media 
 
PA14 mutants producing 
different combinations of 
phenazines 
 
Yes, PYO, 5-MCA, 
PCA depending on 
mutant used 
9 
(1) LB media 
 
PA14 mutants producing 
different combinations of 
phenazines 
 
Yes, PYO, 5-MCA, 
PCA depending on 
mutant used 
10 
(1) LB media PA01 and various mutant strains 
Yes, PYO, PCN, PCA 














(1) LB media,  (2) MOPS 
Minimal Medium 
 
* LB medium used for routine 
culturing 
 
P. aeruginosa PA14 and 
PA01 Yes, PYO and PCA 14 
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Table A2.5 (continued) 
 
Growth Media P. aeruginosa strains and other pathogens 
Used to Study 
Phenazines? Ref. 
 
(1) TSB media, (2) Synthetic 
Cystic Fibrosis Sputum 
(SCFM2) 
*TSB used for overnight 
cultures; for experiments, 
TSB overnight cultures were 
diluted into SCFM2 
 
Wild-type P. aeruginosa 







(1) TSB media, (2) LB media 
 
 
P. aeruginosa PA14, PA01, 
and mutants, PA clinical 
strains, S. aureus wild type, 
S. aureus mutant strains, S. 






(1) LB media 
 
P. aeruginosa PA14 wild- 
type and DphzA-G mutant 
strains 
 
Yes, PYO 17 
(1) LB media 
 
PA01, P. aeruginosa and S. 





(1) Nutrient Broth 
 
 
P. aeruginosa ATCC 9027 
(NCIMB 8626) and S. 
aureus NCTC 13142  
 
No 19 
(1) Nutrient Broth 
 
S. aureus ATCC 25923; E. 
coli ATCC 25922, P. 
aeruginosa ATCC 2785 
 
No 20 
(1) TSB media 
 
Non-biofilm forming P. 
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Table A2.5 (continued) 
 
Growth Media P. aeruginosa strains and other pathogens 
Used to Study 
Phenazines? Ref. 
 
(1) Wound-like medium 
(WLM with 45% Bolton 
broth, 50% bovine plasma, 
5% laked horse red blood 
cells), (2) LB media 
 
P. aeruginosa PAO1 and 
JM2, P. aeruginosa algD 
deletion, S. aureus SA31 












P. aeruginosa PA14 and 
the isogenic PA0601 and 
nagE transposon insertion 
mutants, S. aureus strain 
Mu50, E. coli DH5α 
Yes, PYO 23 





(1) L broth (10% Bacto-
Tryptone, 5% bacto-yeast 
extract, and 5% NaCl 
supplemented with 0.5% 
glucose), (2) TSY broth – 3% 
TSB broth and 0.5% yeast 
extract, (3) Succinate minimal 
medium (20 mM sodium 
succinate, 40 mM NH3Cl, 
2mM K2SO4, 0.4 mM MgCl2, 
1 µM CaSO4, 1 µM ZnCl2, 1 
µM FeCl3, 10 mM 
morpholinepropanesulfonic 
acid (MOPS), (4) Low and 
high-phosphate succinate 
media with either 0.1 or 4.0 
mM potassium phosphate 
 
E. coli K-12 RR1 strain, P. 






(1) LB media 
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Table A2.5 (continued) 
 
Growth Media P. aeruginosa strains and other pathogens 
Used to Study 
Phenazines? Ref. 
(1) LB media, (2) Nutrient 
Yeast Broth 
 
P. aeruginosa PA01,  P. 
aeruginosa and E. coli 
clinical isolate strains 
 
No 27 
(1) LB media P. aeruginosa PA01 Yes, PYO and OHPHZ 28 
(1) TSB media 
 





(1) Yeast nitrogen base 
synthetic medium (YNB salts 
with ammonium sulfate with 
10 mM glucose [Glu], 0.2% 
[wt/vol] amino acids from 
yeast synthetic dropout 
medium) 
 




Yes, PYO 30 
(1) LB media 
 
E. coli  (TOP10, S17-1 K-
12, AG100); P. aeruginosa 
(PAO1, PAO1 soxR 
mutant, PA14 , PA14 phz2 
mutant, PA14 phz mutant);  







(1) LB media, (2) TSB-DC 
(Chelex-treated trypticase soy 
broth dialysate) with glycerol 
and monosodium glutamate, 
(3) TSB-DC containing 10 % 
adult bovine serum, 10% 
adult human serum, adult 
human plasma, (4) Iron-
sufficient medium with 
addition of FeCl3 to TSB-DC 
 
P. aeruginosa PA01 wild 
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Table A2.5 (continued) 
 
Growth Media P. aeruginosa strains and other pathogens 
Used to Study 
Phenazines? Ref. 
 
(1) LB media, (2) M9 
minimal medium (BD) 
supplemented with 0.1 % 
Casamino acids and 0.5 % 
glucose] 
 
E. coli DH5α, 




Yes, study on phenazine 
operons in particular 33 
 
(1) LB media 
 
P. aeruginosa PA01 and 
PA14, E. coli wild type  No 34 
 
(1) LB media, (2) Modified 
MOPS 
(morpholinepropanesulfonic 
acid) smedium (50 mM 
MOPS at pH 7.2, 93 mM 
NH4Cl, 43 mM NaCl, 2.2 
mM KH2PO4, 1 mM 
MgSO4·7H2O, and 3.6 µM 
FeSO4·7H2O 
 
P. aeruginosa PA14 wild-






(1) LB media 
 
P. aeruginosa PA14 wild-





(1) LB media, (2) TSB-DC, 
chelexed trypticase soy broth 
dialysate containing 1% (v/v) 
glycerol and 0.5 M 
monosodium glutamate 
(either iron-deficient or –
sufficient) 
 
P. aeruginosa PA01 and 




(1) TSB media with 0.2% 
glucose, (2) Brain Heart 
Infusion (BHI) Broth, and (3) 
LB media supplemented with 
2% glucose 
P. aeruginosa PA01, 
PA6077 and ATCC No 39 









Table A2.5 (continued) 
 
Growth Media P. aeruginosa strains and other pathogens 
Used to Study 
Phenazines? Ref. 
 
(1) Frank’s medium (FM) + 1 
% yeast extract, (2) FM + 0.5 
% tryptone, (3) FM + 0.1 % 
KNO3, (4) FM + 1 % bacto-
peptone, (5) FM + 0.1 % 
glucose, (6) peptone, (7) 
nutrient broth, (8) King’s 
Medium (20 g peptone, 1.4 g 
magnesium chloride, 10 g 
potassium sulphate, 15 g agar 
in 1 l of distilled water, pH 
7.0 ± 0.2 
 
Pseudomonas wild type and 
mutant strains 
 
Yes, PYO 40 
(1) LB media 
 
P. aeruginosa ATCC 27853 
and six clinical isolates (P1-
P6) from burn wound 
infections 
 
Yes, PYO 41 
(1) LB media, (2) MOPS 
minimal medium 
 
P. aeruginosa PA14 and 
∆phz mutant strains 
 
Yes, PCA, PYO 42 
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